introvivo reduces the amount of the virus that causes hepatitis c infection . incivo is used for the treatment of adults and children aged 18 years and older who are already taking peginterferon alfa , ribavirin and telaprevir ( medicines called ns3 - 4a protease inhibitors ). incivo works by inhibiting the nns3 - foura enzyme , which is essential for hepatitis c virus to multiply . it can also be used in patients who have previously been treated with an interferon - based regimen . if you have any further questions on the use of this product , ask your
do not take incivo - if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking incivo if you : - are taking peginterferon alfa or ribavirin . your doctor may need to adjust the dose of incivo or theirraindications ( e . g . pregnancy precautions ). incivo should not be used in patients who have already been treated with a combination of peginerferon ava and ribavir . if any of these apply to you ,
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will prescribe the appropriate dose regimen for you . the recommended dose regimen is 3 mg twice a day , taken in the morning and evening , with or without food . this is equivalent to a daily dose of 3 mg , 6 mg , 2 mg , 8 mg or 6 mg . if you have both hepatitis c virus infection and human immunodeficiency virus infection , your doctor may give you efavirenz . if any of the above applies to you , consult your doctor before taking inc
like all medicines , this medicine can cause side effects , although not everybody gets them . rash tell your doctor immediately if you get an itchy skin rash . the rash is usually mild to moderate . other symptoms of the rash may include : a severe skin reaction . if you notice a skin rash , seek medical help immediately . your rash may progress to other symptoms . a rash may be accompanied by fever , tiredness , swelling of the face , or swelling of lymph glands . a wide - spread rash with peeling skin , fever and flu - like symptoms . painful skin blisters or blisters in the mouth , eyes , and
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the bottle after exp . this medicine does not require any special temperature storage conditions . incivo tablets should be kept in the bottle tightly closed in order to protect from moisture .
what incivo contains - the active substance is telaprevir . each tablet of incivo produces 375 mg teleprevir ( as mesilate ). - the other ingredients are tablet core hypromellose acetate succinate , calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose , silica colloidalanhydrous , sodium lauryl sulphate , croscarmellose sodium , sodium stearyl fumarate . film - coat polyvinyl alcohol , macrogol , talc , titanium dioxide ( e171 ), iron oxide yellow ( e172 ). what incivo looks
the active substance of zinbryta is daclizumab beta , a monoclonal antibody . how zinborryta works zinbolta belongs to a group of medicines called cytokines and is used to treat multiple sclerosis ( ms ). it is used together with therapy ( two ms treatment courses ) or with other treatments to reduce inflammation and the protective sheath around the nerves in the central nervous system ( brain and spinal cord ). this loss of myelin ( demyelination ) can lead to relapsing ms , which can be characterised by repeated attacks ( relapses ) and symptoms
you must not be given zinbryta : if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine ( listed in section 6 . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have liver problems . your doctor may need to monitor you more closely while you are being treated with this medicine . you have any other autoimmune disorders . you are taking any other medicines , including herbal supplements . this is because these may increase the risk of liver side effects . if any of these apply to you , tell your
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose of zinbryta is 150 mg once a day . your doctor will ask you to have a blood test to check how well your liver is working . if you have the impression that the effect of the medicine is too strong or too weak , talk to your doctor . the recommended starting dose is one 40 mg tablet once daily . this blood test will be repeated every three weeks . if your doctor wants to change your dose , your doctor may ask you for a
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with zinbryta : tell your doctor or pharmacist straight away if you notice any of the following serious side effects : liver problems : very common ( may affect more than 1 in 10 people ): unexplained nausea ( feeling sick ) vomiting ( being sick ) stomach pain increased tiredness loss of appetite ( anorexia ) your skin or whites of your eyes turn yellow dark ( tea - coloured ) urine 41 uncommon ( might affect up to 1 in 100 people ): severe inflammation of the liver may lead to death
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe / pen label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the zinbryta pre - filled syringe in its original package in order to protect from light . if you are not sure , talk to your doctor , pharmacist or nurse before using it . if the solution is not clear or colourless , it may be stored in the original package and can be removed from the refrigerator for a single period of
what zinbryta contains - the active substance is daclizumab beta . each pre - filled syringe contains 150 mg of dacluzumabbeta . 1 ml of solution for injection : each pref - filled pen contains either 150 mg or 300 mg daclzumab alpha . - the other ingredients ( excipients ) are : 1 tablet core : sodium succinate , succinic acid , sodium chloride , polysorbate 80 ( e433 ) ( see section 2 under ' important information about some of the ingredients of zin bryta '), sodium ' ( see ' zin
what wilzin is wilzin belongs to a group of medicines called metabolism products . wilson ' s disease is due to a rare inherited defect in copper excretion from the liver to the eyes and brain . this defect leads to liver damage and neurological disorders . how wilzin works wilzin attaches to copper in the intestine and blocks its further accumulation in the body . this results in an increase in the amount of copper that can be excreted by the liver in the blood . this reduces the absorption of copper from the body by the body , which can lead to a higher level of copper . this is very important for wilson
do not use wilzin - if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of wilzin ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using wilzin wilzin is used for initial therapy in adults who have signs and symptoms of wilson ' s disease . you are currently being treated with another anti - copper agent , penicillamine . wilzin should be used during the initial treatment in adults , adolescents and children who are already being treated in combination with other anti - copper agents , such as penicillinamine . your doctor will
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the different dose regimens are as follows : 25 mg and 50 mg : 1 capsule of wilzin 50 mg in the morning , and 2 capsules wilzin 25 mg at the end of the day , and 1 capsule with wilzin . 50 mg and 60 mg : 2 capsules each wilzin 75 mg film - coated tablet is available in packs containing 1 or more tablets . not all pack sizes may be marketed in your country . your doctor will prescribe the right dose for you . if you have the impression
like all medicines , wilzin can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) uncommon ( affects 1 to 10 users in 100 ) very rare ( affects less than 1 users in 1 , 000 ) rare : very rare : not known ( frequency cannot be estimated from the available data ) very small number of patients have experienced the following adverse effects after treatment : changes in blood tests , an increase in some liver and pancreatic enzymes , and a decrease in blood red and white cells . reporting of side
keep out of the reach and sight of children . do not store above 25 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains - the active substance is zinc . each hard capsule contains 25 mg of zinc ( equivalent to 83 . 92 mg zinc acetate dihydrate ). each 50 mg capsule contains 75 mg of the active substances , equivalent to 167 . 84 mg zinc ( corresponding to 85 . 86 mg of magnesium stearate ). - the capsule shell contains gelatin , titanium dioxide ( e171 ) and brilliant blue fcf ( e110 ). what wilzin looks like and contents of the pack wilzin 25 mg hard capsules are white to off - white , capsule - shaped with wilzin 50 imprinted on one side . the printing
biktarvy contains the active substance bictegravir , which is an antiretroviral medicine known as an integrase strand transfer inhibitor . the other active ingredient is emtricitabine , an antiviral medicine ( known as a nucleoside reverse transcriptase inhibitor ( nrti ) tenofovir alafenamide , an antirubiciral medicine called a nucleotide reverse transcriptases inhibitor ( trti ). biktarv is used for the treatment of human immunodeficiency virus 1 ( hiv - 1 ) in adults , adolescents and children aged 1
do not take biktarvy if : you are allergic to bictegravir , emtricitabine , tenofovir alafenamide or any of the other ingredients of this medicine ( listed in section 6 ). you are taking the following medicines : - rifampicin used to treat some bacterial infections such as tuberculosis - st . john ' s wort ( hypericum perforatum ) a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor or pharmacist before taking bikarvy : if you have or have ever had liver problems . liver disease
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . your doctor may also prescribe antacids to help prevent stomach ulcers , heartburn and acid reflux . the other ingredients are aluminium and magnesium hydroxide mineral supplements , vitamins , magnesium and iron . see section 2 " important information about these medicines and biktarvy " for further information . patients on dialysis do not need to take any more of the above . if you have any further questions on the use of this medicine , ask your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects : inflammation or infection in patients with advanced hiv infection ( opportunistic infections ( infections caused by a weak immune system ). symptoms of inflammation from previous infections may occur soon after hiv treatment is started . these symptoms may be due to an improvement in the body ' s immune response , enabling the body to fight infections that may have no obvious symptoms . autoimmune disorders ( when the immune system attacks the body tissue ) can occur many months after you start treatment . if you have any
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the bottle after exp . this medicine does not require any special temperature storage conditions . after opening the bottle , the seal should be used immediately .
what biktarvy contains - the active substances are bictegravir , emtricitabine and tenofovir alafenamide . each biktravir tablet contains bic tegravira sodium equivalent to 50 mg of biccheglevir , 200 mg of emtritabine , 1000 mg of ten ofovir anufenamide fumarate equivalent to 25 mg / tablet ( 10ofovira alfaenamide ). - the other ingredients are tablet core microcrystalline cellulose , croscarmellose sodium , magnesium stearate
novondorm is an oral antidiabetic medicine containing repaglinide , which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which a person cannot make enough insulin to control the sugar in their blood or where their body does not respond normally to the insulin it produces . novonorm helps control the level of sugar in your blood by helping your body make better use of its insulin . your doctor will tell you how long you should continue to follow the advice about diet and exercise that your doctor has given you . if you have the impression that the effect
do not take novonorm : - if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). if you have type 1 diabetes . if the acid level in your blood is too high ( diabetic ketoacidosis ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you : - have a severe liver disease . - are taking gemfibrozil ( a medicine used to lower increased fat levels in the blood ). 47 - have liver problems . your doctor may need to adjust your dose of no vonorm . - have
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 0 . 5 mg tablet once a day . swallow the tablet whole with a glass of water . you can take novonorm with or without food . try to take the tablet at about the same time each day . do not exceed the recommended daily dose of 30 mg . if you cannot reach your daily dose , talk to your doctor , pharmacist or nurse . it may take up to 4 weeks for you to reach your normal daily dose . your doctor may increase your dose to
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect of novonorm ( may affect up to 1 in 10 people ) is a hypo in section 2 . hypoemic reactions are generally mild / moderate . however , in some cases , the severity may be severe and may require immediate medical attention . if this happens to you , you should contact your doctor or go to the nearest hospital straight away ( see section 2 ). if you experience any of the following symptoms : swelling , difficulty in breathing , rapid heartbeat , feeling dizzy or sweating ( an
what novonorm contains - the active substance is repaglinide . - the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate anhydrous , maize starch , polacrilin potassium , povidone ( polyvidone ), glycerol , magnesium stearate , meglumine , poloxamer , iron oxide yellow ( e172 ). 1 mg tablet contains iron oxide red ( e 172 ) and 2 mg tablets contain iron oxide black ( e 171 ). what no vonorm looks like and contents of the pack novonm tablets are white to off - white , round , flat
pumarix is a vaccine used to protect adults ( aged 18 years and older ) against pandemic flu ( influenza ). it is a type of influenza that happens at intervals not known ( cannot be estimated from the available data ). it spreads rapidly around the world . it may affect up to 10 in 100 people . this is a very rapid change in the way things happen . pandemic influenza is similar to ordinary flu . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will produce its own protection ( antibodies ) against the disease . none of the ingredients in the vaccine can cause flu
pumarix should not be given : if you have had a sudden life - threatening allergic reaction to any ingredient of this vaccine ( listed in section 6 ) or to any of the ingredients that may be present in trace amounts as follows : egg , chicken protein , ovalbumin , formaldehyde and sodium deoxycholate . signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of the face or tongue . if any of these apply to you , tell your doctor or nurse immediately . the vaccine may not fully protect all persons who are vaccinated . medical treatment may be needed in case of an
pumarix is recommended for use in adults 18 years of age and older . pumarix contains a similar h5n1 as03 to those found in the blood . children and adolescents there is no information on the use in children under the age of 18 years . there is limited information about the safety and efficacy of this vaccine in this age group . children aged 3 - 9 years and adolescents aged 10 - 17 years should not receive pumarux . the vaccine is given as an injection into a muscle ( usually in the upper arm ). if you have any further questions about the use of thisvaccine , ask your doctor
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions if allergic reactions occur , dangerously low blood pressure may lead to shock and need emergency treatment . the following side effects have been reported : very common ( may affect more than 1 in 10 people pain at the site of the injection headache feeling tired aching muscles joint pain common : may affect up to 1 in every 10 people redness or swelling where the injection is given fever sweating shivering diarrhoea feeling sick uncommon : may affects up to1 in every 100 people bruising a hard lump or itching warmth swollen glands in your neck feeling dizz
keep this vaccine out of the sight and reach of children . do not use this vaccine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . after preparation of the vaccine , the suspension should be used immediately . if the vaccine is not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 to 30 .
what pumarix contains - the active substance is split influenza virus ( a / 2005 , pr8 - ibcdc - rg2 ) in 0 . 5 ml . - the other ingredients are haemagglutinin , which is used to prevent the pandemic in which the vaccine contains an ' adjuvant ' as03 . this adjuvvant contains squalene , dl - α - tocopherol , polysorbate 80 and adjuvants are used to improve the body ' s ability to produce its own protection ( antibodies ) against the influenza virus . - other ingredients in the suspension
somakit t is a radiopharmaceutical product containing the active substance edotreotide . the powder contains a radioactive substance called gallium ( 68ga ) chloride . the active ingredient in somakit to be used for this procedure is gallium , which is produced by recombinant dna technology in the manufacturing process . the content of the powder is a white to off - white powder . it is injected directly into a vein or into the body areas . this is a medical imaging procedure called positron emission tomography ( ptom ) ( pet scan ). the purpose of this medical procedure is to obtain images of
do not take somakittoc - if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if you have experienced any kind of allergic reaction ( see section 4 , " what you need to know before you receive somakttoc "). if you suffer from kidney or liver problems , or renal or hepatic disease . children and adolescents do not give this medicine to children under 18 years of age because of the risk of dehydration . the examination will be repeated every 28 days
there are strict laws on the use , handling and disposal of radiopharmaceutical products . somakittoc will only be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this product and will keep you informed of their actions . 29 the nuclear medicine doctor supervising the procedure will decide the quantity of somakttoc to be administered . the usual dose is 100 to 200 megabecquerel per kilogram of body weight each day . the dose may be increased or decreased depending on the condition of the patient . administration of
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with somakittoc : allergic reactions ( hypersensitivity ) have been reported in patients receiving somakiton t . symptoms may include warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing . allergic reactions may also include stinging at the injection site due to ionising radiation , cancer and hereditary abnormalities . reporting of side effects if you get any side effects talk to your nuclear medicine doctor . this includes any possible side effects not listed in this leaflet . you can also report side effects
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials and radiolabelling . the following information is intended for the specialist only : somakit t will be stored in a refrigerator ( 2 - 8 ). storage at room temperature ( up to 25 ) does not require any special temperature storage conditions . do not freeze . the product should not be used if it is noticed that it contains visible signs of deterioration of radioactive products .
what somakit t contains - the active substance is edotreotide . one vial of powder contains 40 mg edotreaotide ( as 10 - phenanthroline ). - the other ingredients are gentisic acid , mannitol , formic acid ( e421 ), sodium hydroxide , water for injections , sodium and radiolabelling . - the solution contains hydrochloric acid . what somAKit t looks like and contents of the pack somakiton t is presented as a kit for radiopharmaceutical preparation . it is supplied as a glass vial with black flip - off cap
afinitor is an anticancer medicine that contains the active substance erolimus . everolimus stops the growth and spread of cancer cells . afinitor inhibits the activity of hormone receptor - positive advanced breast cancer in postmenopausal women . it belongs to a group of non - steroidal aromatase inhibitors , which are used to keep the disease under control . it is used in combination with a medicine called exemestane ( a steroid aromatase inhibitor ) and hormonal anticancer therapy to treat advanced tumours ( neuroendocrine tumours that affect the stomach , bowels , lung or pancreas
you must not be given afinitor if you are undergoing cancer treatment . warnings and precautions talk to your doctor , pharmacist or nurse before you are given any of the following : you may not be able to be given the medicine if : you are allergic to everolimus , sirolimus , temsurolimus or any of these other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . you are breast - feeding . you should not receive the medicine unless your doctor tells you to . you have ever had any problems with your liver . you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended starting dose is one tablet of 10 mg of afinitor once a day . if you have liver problems , your doctor may prescribe a lower dose of Afinitor ( between 5 mg and 5 mg ) or a higher dose of 7 . 5 mg . the dose may be adjusted if you experience certain side effects . your doctor will tell you how long you should continue to take the tablet . do not stop treatment unless your doctor tells you to . how long to take afininitor continue
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking afinitor and tell your doctor straight away if you experience any of the following signs of an allergic reaction : difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin , with a red rash or raised bumps . the following side effects have been reported with the combination of the two active substances , afinavitor : very common ( may affect more than 1 in 10 people ) - increased temperature - chills ( signs of infection ) - fever - coughing - difficulty breathing - wheezing - inflammation
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . the word " exp " refers to the last day of that month . store below 25 . store in the original package in order to protect from moisture . once opened the blister , the tablets should be used immediately . this medicine does not require any special temperature storage conditions , and should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what afinitor contains - the active substance is everolimus . - each tablet contains either two or three tablets . - the other ingredient is tablet core : alfuzosilab . - one tablet contains 2 . 5 mg , of which at least one has been absorbed by the body , and the other tablet contains 5 mg of everlimus . each tablet is available in blister packs containing 10 tablets , or in tablet containers containing 10x1 , 10x2 , or 100x1 tablets . the other ingredients are : tablet coating : butylhydroxytoluene , magnesium stearate , lact
what laventair ellipta is the active substance in this medicine is umeclidinium bromide ( also called vilanterol ). this belongs to a group of medicines called bronchodilators . what it is used for and how it works it helps to control the breathing difficulties of copd . chronic obstructive pulmonary disease ( copd ) copd is a long - term condition characterised by breathing difficulties that occur every day . in copd the muscles around the airways tighten . this medicine works by tightening these muscles in the lungs , making it easier for air to get in and out of
do not use laventair ellipta 31 - if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : you have asthma . this medicine should not be used in patients with asthma . you have heart problems or high blood pressure . you think you may have an eye problem called narrow - angle glaucoma ( an enlarged prostate , difficulty passing urine , or a blockage in your bladder ). you have epilepsy or thyroid gland problems . you
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should inhale this medicine every day for 24 hours at the same time each day . do not use more than your doctor tells you to use . if you use more laventair ellipta than you should contact your doctor , pharmacist or nurse immediately if you have any of the following symptoms : - a sudden attack of breathlessness or wheezing . to control this attack you may use a quick - acting reliever inhaler ( such as
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions if you experience any of the following symptoms stop using laventair ellipta and contact your doctor immediately : uncommon side effects ( may affect up to 1 in 100 people ): skin rash ( hives ) redness rare side effects : may affect upto 1 in 1 , 000 people : swelling mainly of the face or mouth ( angioedema ), which may make you feel very wheezy , coughing , having difficulty in breathing , feeling weak or light headed , collapse or loss of consciousness . immediate breathing difficulties if you have immediate
what laventair ellipta contains - the active substances are umeclidinium bromide and vilanterol . each single inhalation provides a delivered dose of 55 micrograms ( 23 microlitres ) for each individual delivered dose ( dose ) that contains either : - omeclidoinium , 65 microgrambromide , or - o meclidindinium hydroxyphonylurea , equivalent to 22 microgramp / ml ( 3 . 0 microlitre ) of the other ingredients ( excipients ) - the other ingredient is trifenatate ,
the active substance of tremfya is guselkumab , which is a monoclonal antibody . this medicine contains the active substance " il - 23 ". this belongs to a group of proteins called cytokines , and is used to treat psoriasis . it is used in adults and children with moderate to severe " plaque psORiasis " which is an inflammatory condition that affects the skin and nails . it can improve the condition , the appearance of nails , and reduce symptoms such as scaling , shedding , flaking , itching , pain and burning .
do not use tremfya if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have ever had an active infection or active tuberculosis warnings , precautions , and precautions before you receive tremfaya , tell your doctor or pharmacist if you have an infection or an infection with tuberculosis . tuberculosis is a serious , sometimes life - threatening , condition that can affect up to 36 people . tell
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of tremfya is 100 micrograms ( 1 pre - filled syringe ) injected under the skin ( subcutaneous injection ) every 4 to 8 weeks . your doctor will tell you how long you should continue to use it . if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor or nurse straight away if you notice any of the following side effects : signs of serious allergic reaction : difficulty breathing or swallowing , swelling of the face , lips , tongue or throat , severe itching of the skin , a red rash and raised bumps other side effects if you get any side effects talk to your doctor , nurse or pharmacist . this includes any possible side effects not listed in this leaflet . some side effects may be serious : common ( may affect up to 1 in 10 people ): upper respiratory infections common
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the pre - filled syringe label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep away from the freezer compartment . keep the prepared syringe in theouter carton in order to protect from light . this medicine should not be used if the solution is cloudy or contains large particles . if the product is not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer
what tremfya contains - the active substance is guselkumab . each pre - filled syringe contains 100 mg of gusel kumab in 1 ml solution . - the other ingredients are histidine , histidine monohydrochloride monohydrate , polysorbate 80 , sucrose and water for injections . what tremfa looks like and contents of the pack solution for injection in a vial is a clear , colourless to pale yellow solution . tremfaya is supplied in a carton pack containing one single - dose glass syringe and a multipack containing 2 packs of 1 vial of
the active substance of trepulmix , treprostinil , belongs to a group of medicines called prostacyclins , a hormone that lowers blood pressure by relaxing blood vessels and preventing blood from clotting . the active substance in trepulemix is used to treat inoperable chronic thromboembolic pulmonary hypertension ( cteph ). it is used when persistent or recurrentcteph is not well controlled by surgical treatment or exercise capacity . symptoms of the disease can vary from patient to patient , but the most common ones are : chronic thrrombolic lung hypertension ( i . e ., blood pressure
do not use trepulmix if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). if you have a disease called " pulmonary veno - occlusive disease ". this is a disease in which the blood vessels in the lungs become swollen , leading to a higher pressure in the blood arteries between the heart and the lungs . if you suffer from severe liver disease . if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor or pharmacist before you are given this medicine if : you have ever had a heart problem such
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . trepulmix is given as a continuous subcutaneous infusion ( injection under the skin ) into a small tube ( cannula ) in the abdomen or thigh . your doctor will show you how to use it . you will be carefully monitored by your doctor while you are using it . the recommended dose is one tablet once a day . you may inject trepulemix yourself using a portable pump . your treprostinil will be pumped into the pump through the infusion line to prevent accidental
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): widening of blood vessels pain at the infusion site reaction . this may be the case if you have any of the following at the time of infusion site bleeding or bruising . at the site of the infusion , headaches , nausea , diarrhoea jaw pain common : may affect up to 1 in every 10 people dizziness light - headedness fainting low blood pressure skin rashes muscle pain ( myalgia ) joint pain ( arthralgia ) swelling of feet , ankles ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the vial after exp . store in a refrigerator ( 2c 8c ). do not freeze . keep a trepulmix vial in the outer carton in order to protect from light . after dilution , the product may be used for up to 30 days as continuous subcutaneous infusion in a single reserve ( syringe ) of undiluted turbulmix . if not used immediately , in - use storage times and conditions prior to use
what trepulmix contains - the active substance is treprostinil ( as sodium ). each vial contains 1 mg / ml of solution for injection . each 2 . 5 ml ampoule contains 10 mg of solutionfor injection . - the other ingredient ( s ) ( excipients ) ( isminutinil ) and sodium salt ) ( see section 2 ). each 3 . 5 millilitre ampoules contains 2. 5 mg of preparation for injection and 10 mg or 25 mg of the other active substance ( sminutrinil ) as sodium salt ). each 5 milliliter ampou
the active substance of thorinane is enoxaparin sodium . it is a low molecular weight heparin ( lmwh ). the recommended dose of thorzinane is 1 mg per kilogram of body weight to prevent existing blood clots from forming . 2 mg is a single dose for preventing or stoppingblood clots forming in your blood . your doctor will prescribe the dose that is right for you . your dose will be adjusted by your doctor .
do not use thorinane : if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction may include rash , swallowing or breathing problems , swelling of your lips , face , throat or tongue . if you think you may be allergic to heparin or other low molecular weight heparins ( e . g . nadroparin , tinzaparin , dalteparin ). if you have ever had a reaction to any of these , especially if you were taking heparrin , you may experience a severe drop in the
like other similar medicines ( medicines to prevent blood clotting ), thorinane may cause bleeding . if the bleeding is severe or if you experience any bleeding event that does not stop immediately ( exceptional weakness , tiredness , paleness , dizziness , headache ), or unexplained swelling , stop taking your medicine and contact your doctor immediately . if you are not sure , talk to your doctor , pharmacist or nurse . warnings and precautions your doctor may need to change your medicine or discontinue the use of the product if you : experience a severe allergic reaction ( difficulty breathing , swelling of the lips , mouth , throat or eyes ), blockage
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store below 25 . after dilution the solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 8 hours at 2ºc - 8ºc unless dilution has taken place in controlled and validated aseptic conditions . this medicine should not be disposed of via wastewater or household waste . the thorinane pre - filled syringes
what thorinane contains the active substance is enoxaparin sodium . each pre - filled syringe contains 100 micrograms of dextrose ( 10 mg / 0 . 2 ml ). each vial contains 2 , 000 microgram ( 20 mg / 1 ml ) of enoxapearin sodium and is for single use only . after reconstitution with water for injections , the solution is clear and colourless type i neutral glass syringe barrel with fixed needle and needle shield with chlorobutyl rubber stopper and a blue polypropylene plunger rod . pack size of 2 vials or 10 pre -
senstend contains two active substances : lidocaine and prilocaine . both belong to a group of medicines called local anaesthetics . senstend is used to prevent lifelong premature ejaculation in adult men . it works by attaching itself to the head of the penis , helping to control the rate of ejaculation .
do not use senstend : - if you are allergic to lidocaine , prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if you : - have a history of allergy or sensitivity to local anaesthetics ( amide - type local analgeshetics ). - have or have had a genetic disease or other condition that affects your red blood cells ( glucose and phosphate deficiency ) - have anaemia ( methaemoglobinaemia ). medicine sensitivities or sensitivity may be life - threatening . -
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use the recommended dose of senstend is 3 sprays ( 1 spray in each head of your penis ) every 3 hours for 24 hours . use in children and adolescents the recommended starting dose is 4 sprays per day . use the spray container at the same time each day . follow the pump mechanism to avoid contact with eyes , nose , mouth and ears . after using the pump , apply 1 spray into the foreskin of your head , preferably of the penis .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with senstend : very common ( may affect more than 1 in 10 people ) inability to develop or maintain an erection in the penis feeling of burning in the area of the penis uncommon ( might affect up to 1 in 100 people ) headache local irritation of the throat or irritation in the skin redness failure to ejaculate during sexual intercourse abnormal orgasm tingling in the penis pain or discomfort when the penis itching in the space between the penis and the vagina a high temperature other side effects include : common (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the metal container after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the container tightly closed in order to protect from light . after first opening , the product may be stored at room temperature ( up to 25 ) for a period of up to 12 months . once opened , use themetal container to puncture and burn the product immediately after it has been removed from the refrigerator and has reached room temperature or below 25 , but do not throw away any
what senstend contains - the active substances are lidocaine and prilocaine . each ml of solution contains 150 micrograms lidocain ( as 50 microlitres per ml ). - the other ingredients are : - tablet core : lidocaine 50 microgram ( as 7 . 5 microlitre per ml ) lidocane ( as 2 . 5 milligrams per ml ), and - tablet coating : pvc / pemphigus . each spray container contains 6 . 5 to 20 sprays . - each spraycontainer contains 5 to 12 sprays of light yellow cutaneous spray .
opdivo is a medicine used to treat advanced melanoma ( a type of skin cancer ) in adults melanoma can be treated with complete resesection in adults ( treatment without surgery or adjuvant therapy ). advanced non - small cell lung cancer ( advanced renal cell carcinoma ) advanced kidney cancer in adults classical hodgkin lymphoma has been previously treated with an autologous stem - cell transplant or a transplant . advanced cancer of the head and neck in adults advanced urothelial carcinoma ( bladder and urinary tract cancer ) a medicine called nivolumab , which is a monoclonal antibody
do not take opdivo - if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before you are given opsdivo : if you have problems with your heart such as a change in the rhythm of the heartbeat or an abnormal heart rhythm . your lungs may have breathing difficulties or cough . inflammation of the lungs ( pneumonitis or interstitial lung disease ) if you get diarrhoea , watery , loose or soft stools , or any symptoms of inflammation of any intestines ( colitis ),
always take opdivo exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . how much to take your doctor will tell you how many tablets to take each day . the recommended dose is one tablet ( 240 mg ) twice a day ( 2 tablets of 480 mg ) for the first 4 weeks . your doctor may prescribe a higher or lower dose if necessary . how to take the tablets you will always take ipilimumab as prescribed by your doctor . the treatment will usually be started by a doctor who is experienced in the treatment of skin cancer . the usual dose of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the vial label after exp . store below 25 for a single period of 48 hours . the infusion solution should be used immediately . any unused medicine or waste material should be disposed of in accordance with local requirements .
what opdivo contains - the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg of nivlumab ( as 40 mg / ml ). each 4 ml vial contains 100 mg of 10 mg or 240 mg of 24 mg ( as 300 mg / l ). - the other ingredients are : sodium citrate dihydrate , sodium chloride ( see section 2 under " opDivo contains sodium "), mannitol ( e421 ), pentetic acid , polysorbate 80 , sodium hydroxide , hydrochloric acid and water for injections . what op
clopidogrel tad contains the active substance ' clopilogrel '. it belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures in the blood , which clump together during blood clotting . by reducing the amount of this clumping and the amount necessary for antiplatelets medicinal products to stop blood clots from forming , it reduces the risk of a rare , but potentially life - threatening , process of thromboembolism ( see also section 2 ' important information about some of the ingredients of clopid
do not take clopidogrel tad : if you are more than 30 years of age . if you think you are ( or might become ) allergic to clopidineogrel or any of the other ingredients of this medicine ( listed in section 6 ); if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain ; if you suffer from severe liver disease . if any of these apply to you ( or you are not sure ), talk to your doctor , pharmacist or nurse before taking the tablet . warnings and precautions you should tell your doctor or pharmacist before taking
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel tad per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may prescribe a lower dose ( up to 300 mg once a day ), such as one 300 mg tablet taken orally at the start of treatment ,
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of an
what clopidogrel tad contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopidaogrel ( as hydrochloride ). the other ingredients are : tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone , macrogol 6000 and hydrogenated castor oil in the tablet core ; tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide [ e172 ]) and talc andmacrogol 3000 in the film - coating .
tacforius contains the active substance tacrolimus , which is an immunosuppressant . after your organ transplant ( liver and kidney ), your body ' s immune system will try to reject the new organ . tacforius will help to prevent rejection of the transplanted organ by your liver , kidney and heart by your doctor or nurse if you have had any previous treatment after your transplantation .
do not take tacforius if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to sirolimus , to any macrolide , antibiotic , erythromycin , clarithromycin or josamycin . warnings and precautions talk to your doctor , pharmacist or nurse before you are given tacofius immediate release capsules ( e . g . , tacni ) and after the expiry date which is stated on the carton and on the blister after " exp ". if this applies to you ,
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine should only be prescribed by a doctor who is experienced in the use of this medicine . transplant patients should take the same tacrolimus medicine as adults . however , if you have had a transplant , your doctor may prescribe you a higher or lower dose . your doctor will tell you how many capsules to take . if you take more tacforius than you should if you accidentally take too many capsules , talk to a doctor or go to a hospital straight away . take the medicine pack with you
like all medicines , this medicine can cause side effects , although not everybody gets them . infections tell your doctor or nurse straight away if you notice any of the following serious or potentially life - threatening infections while you are being treated with tacforius : severe effects of allergic and anaphylactic reactions ( benign or malignant tumours ) have been reported in patients receiving ticforius treatment : pure red cell aplasia ( a very severe reduction in red blood cell counts ), agranulocytosis ( a severely lowered number of white blood cells ), haemolytic anaemia ( decreased number of red blood cells
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep all the prolonged - release hard capsules in the outer carton in order to protect from light . after first opening the aluminium wrapping , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what tacforius contains - the active substance is tacrolimus . each hard capsule contains 0 . 5 mg . each prolonged - release hard capsule releases 1 mg ( 3 mg ) of tacrulimus ( as monohydrate ). each capsule releases 2 mg ( 4 mg ). each hard - release capsule releases 3 mg ( 6 mg ) on each day of the week . each capsule release 3 mg contains 3 mg of tacrolamus (as monohydrate ) each capsule released 5 mg ( 5 mg ) in the week after the last dose of the year . the other ingredients are : capsule content hypromellose 29
clopidogrel zentiva is a medicine that belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures in the blood , which clump together during blood clotting . by reducing the amount of this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process known as thromboembosis ). clopidoggingrelzentiva helps to prevent bloodclots ( thrombi ) forming in hardened blood vessels ( arteries ), a process called atherothrombosis , which can
do not take clopidogrel zentiva : - if you are allergic ( hypersensitive ) to clopilogrel or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have a medical condition that is currently causing bleeding such as a stomach ulcer , bleeding within the brain or severe liver disease . if this applies to you , tell your doctor . warnings and precautions the following apply to you and your family : if any of these apply to your ( or you are not sure ), talk to your doctor , pharmacist or nurse before taking clop
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel zentiva per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you a lower or higher dose of 300 mg ( one 300 mg film - coated tablet ) once a day for up to 4
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of an
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicinal product does not require any special temperature storage conditions . clopidogrel zentiva is for single use only . aluminium blisters : do not store above 30 . store in the original package in order to protect from moisture . keep the tablet in the outer carton in order for protect from light . bottle : keep the bottle tightly closed to protect the tablet from moisture , and do not throw away any medicines via wastewater or household waste
what clopidogrel zentiva contains - the active substance is clopidoogrel . each tablet contains 75 mg of clopridogrel ( as hydrogen sulphate ). - the other ingredients are ( see section 2 under ' important information about some of the ingredients in clopidiogrelzentiva '): - tablet core : lactose ' ( as hydrolysed ), - tablet coating : macrogol 6000 , low - substituted hydroxypropylcellulose , lactose monohydrate ( milk sugar ), hypromellose ( e464 ), triacetin , red iron oxide ( e
yttriga is a radioactive medicine that must not be used after the expiry date which is stated on the label and carton after exp . this medicine does not require any special storage conditions . it must be used immediately after dilution with another medicine . tiny radiation doses are used for the treatment of radiolabelled medicinal product .
you must not be given yttriga - if you are allergic ( hypersensitive ) to chloride or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be pregnant or are planning to become pregnant , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . - ytriga is not a radioactive medicine . it is stored under the responsibility of the specialist in appropriate premises . - it is not known if it passes into radioactivity . - this medicine is stored in a special storage facility in the outer carton
your doctor will supervise the treatment . method of administration yttriga is for radiolabelling of medicinal products for specific diseases . your doctor will decide on the appropriate dose for you . the treatment will be supervised by a doctor who is experienced in the use of this product and who is knowledgeable in the treatment of patients with appropriate treatment .
like all medicines , yttriga can cause side effects , although not everybody gets them . if any of the side effects gets serious , or if you notice any side effects not listed in this leaflet , please tell your doctor or pharmacist . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
yttriga will be stored under the responsibility of the specialist in appropriate premises . local regulations on radioactive substances are in place to protect the environment . any unused product or waste material should be disposed of in accordance with local requirements .
what yttriga contains the active substance is chloride . 1 ml sterile solution contains 1 mg of hydrochloric acid ( equivalent to 3 mg / ml ). the vial is closed with a v - capped bottom . it is a colourless type i glass vial of 10 ml with a flat bottom and a silicon stopper and an aluminium seal .
ciambra is a medicine used in the treatment of cancer . the active substance in ciambra , cisplatin , is another anti - cancer medicine . it is used for treatment of malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , in adults who have not received prior chemotherapy . in this case , the other active ingredient in the medicine ( s ) will be called " mesodysplatin " and will be given to you by your doctor for the initial treatment . if you have lung cancer that has spread to other parts of your body , your doctor will
you must not be given ciambra : if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients in this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you are breast - feeding . during or after treatment , your doctor may decide to delay or discontinue your treatment . you have recently received or might receive a vaccine against yellow fever . if any of these apply to you ( or you are not sure ), tell your doctor or pharmacist as soon as possible . you are being treated with ciam
the recommended dose of ciambra is 500 micrograms for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of the body . your doctor will work out this body surface area based on your weight and your response to treatment . this will depend on your blood cell counts and on your general condition . the hospital pharmacist or nurse will have mixed the cimbra powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution for injection before it is given to you . the doctor will then give you a single infusion of cisplatin by infusion
like all medicines , this medicine can cause side effects , although not everybody gets them . 52 tell your doctor immediately if you experience : fever or infection with a temperature greater than 38ºc or sweating . this may be a sign of infection . if you have less white blood cells than normal which may increase the risk of infection ( sepsis ), which may be severe and could lead to death . chest pain with a fast heart rate . pain , redness , swelling or sores in your mouth . allergic reaction : skin rash ( often with burning or prickling sensation ) or fever . these may be signs of skin reactions that
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . the reconstituted solution should be used immediately after preparation . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 to 8 , and 15 to 25 . from a microbiological point of view , the product should be administered immediately . any unused solution must be discarded
what ciambra contains the active substance is pemetrexed . each vial contains 100 mg / ml of the reconstituted solution for infusion . one vial of 100 mg contains 500 mg of pemrexed ( as pemphrexed disodium hemipentahydrate ). the other ingredient ( s ) are mannitol ( e421 ) and hydrochloric acid ( for ph adjustment ) and sodium hydroxide ( e524 ) ( e507 ) ( to adjust ph adjustment ). see section 2 for further information about some of the ingredients . what ciamra looks like and contents
immunogam belongs to a group of medicines called immunoglobulins ( antibodies ). immunogam can help prevent certain infections from getting in and out of your blood . your doctor will test your body for increased levels of human hepatitis b immunoglubulins . immunogloglobulin g ( gg ) is a protein produced naturally in the body . it is produced by biotechnology in the blood plasma of healthy people . immunogogam is used to treat hepatitis b virus in haemodialysed patients who have not received vaccination because they lack the ability to produce a hepatitis birus carrier .
immunogam should not be used : - if you have ever had an allergic reaction to human immunoglobulins or other blood products , or to any of the other ingredients of immunogam ( listed in section 6 ). if you know that you have an iga deficiency , or if you suspect you may have had an allergy reaction to iga containing products . children and adolescents ( from 18 years of age ) immunoglubulins can cause adverse reactions such as chills , headache , fever and vomiting . allergic reactions may also include nausea ( arthralgia ), joint pain , low blood pressure and
immunogam will be given to you by a doctor or nurse who is experienced in the care of patients with vaccination against hepatitis b virus . the first vaccine dose will be made using human hepatitis b immunoglobulin ( hbv ). administration prevention the recommended dose of hepatitis b is 500 micrograms per kg body weight given every 24 hours for 72 days . the recommended recommended dose is : hepatitis b in haemodialysed patients of 2 mg / kg bodyweight given every 2 weeks , followed by seroconversion following vaccination activities . immunogam is prepared by recombinant dna technology ( rd
like all medicines , immunogam can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) uncommon ( affects 1 to 10 users in 100 ) not known ( frequency cannot be estimated from the available data ): very rare ( affects less than 1 users in 1 , 000 ) rare : very rare : may affect up to 1 in 10 , 000 not known very rare cases : may be fatal . the exact frequency of undesirable effects is not known . clinical trials have shown very limited efficacy in patients treated with immun
keep out of the reach and sight of children . do not use immunogam after the expiry date which is stated on the carton and on the label of the vial after exp . store in a refrigerator ( 2c 8c ). do not freeze . keep the container in the outer carton in order to protect from light . immunogogam should not be used if the solution is cloudy or contains deposits . medicines should not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what immunogam contains - the active substance is human hepatitis b immunoglobulin . one vial contains 1 mg or 5 mg of human plasma protein , corresponding to a concentration of 96 micrograms / ml . - the other ingredients are polysorbate 80 and water for injections ( see section 2 ). what immunogaman looks like and contents of the pack immunogamer is a solution for injection in a glass vial . it is a clear to slightly opalescent , colourless to pale yellow liquid . each pack contains 1 vial of immunogams .
remicade contains the active substance infliximab . infliximab is a monoclonal antibody a type of protein that recognises and attaches to a specific target in the body called tumour necrosis factor ( tnfα ). remicade belongs to a group of medicines called ' ntp blockers '. it is used to treat the following inflammatory diseases : rheumatoid arthritis , psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ) and psoriasis in adults , adolescents and children aged 6 years and older . these diseases are also known
do not take remicade : - if you are allergic to infliximab or any of the other ingredients of remicitade ( listed in section 6 ) - if your doctor thinks you may be allergic ( hypersensitive ) to the active substance or to any of its other ingredients if you have tuberculosis ( tb ) or another serious infection , e . g . pneumonia , sepsis or heart failure . warnings and precautions talk to your doctor or pharmacist before you are given remicades . if you think any of these apply to you , tell your doctor , pharmacist or nurse before being given remiacade
what remicade is used for the treatment of : rheumatoid arthritis the usual dose is 3 mg for every kg of body weight . psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ), psoriasis , ulcerative colitis and crohn ' s diseases the usual starting dose is 5 mg for each kg of weight . your doctor will decide how many treatments you need . how remicades is given remicine will be given as an infusion ( drip ) over 2 hours into one of your veins ( usually in your arm ). the third treatment will
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious side effects and may require treatment . tell your doctor or nurse straight away if you notice any of the following side effects during or after your treatment with remicade : signs of an allergic reaction include swelling of your face , lips , mouth or throat , which may cause difficulty in swallowing or breathing , skin rash , hives and swelling of the hands , feet or ankles . these reactions are usually mild and disappear within a few days . if you have an allergy reaction , tell
remicade will be stored by the health professionals at the hospital or clinic . keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the vial label after exp . store in a refrigerator ( 2 8 ). do not freeze . chemical and physical in - use stability of remicade has been demonstrated for 3 hours at 2 to 8 and for 28 hours at 25 . from a microbiological point of view , the product should be used immediately . however , if not used immediately , it may be stored for an additional 24
what remicade contains the active substance is infliximab . each vial contains 100 mg of inflixamab . after dilution , each ml of concentrate contains 10 mg / ml . the other ingredients are sucrose , polysorbate 80 , monobasic sodium phosphate , dibasicodium phosphate . what remicades looks like and contents of the pack remicad is supplied as a glass vial containing a powder for concentrate for solution for infusion . the powder is white to off - white and the solvent is clear to opalescent and colourless . each pack contains 1 , 2
rasagiline mylan is used to treat parkinson ' s disease in adults . it is used in combination with levodopa ( another medicine used in the treatment of parkinson ', s disease ). due to the disease , there is a loss of cells that produce dopamine in the brain . dopamine is a chemical that is involved in movement control . rasagilinea mylan works by increasing the amount of dopamine that can be produced in your brain .
do not take rasagiline mylan : - if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). if you have severe liver problems . warnings and precautions talk to your doctor , pharmacist or nurse before taking the following medicines : - rasaline mylan contains monoamine oxidase ( mao ) inhibitors , used to treat depression and parkinson ' s disease . - medicinal or natural products containing st . john ' s wort . - pethidine , a strong pain killer . see section 14 for further information . if you think any of these
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 tablet once a day by mouth . you can take rasagiline mylan with or without food . try to take your daily dose at about the same time each day . it is important that you continue with your normal diet and exercise plan until your doctor tells you otherwise . swallow the tablet whole with a glass of water . do not crush , chew or break the tablet . if you cannot take your tablets with food , please contact your doctor . if possible , take your
like all medicines , this medicine can cause side effects , although not everybody gets them . side effects of the combination of rasagiline mylan and placebo have been reported with frequency not known ( cannot be estimated from the available data ). very common abnormal movements ( dyskinesia ) headache common abdominal pain uncommon rare ( may affect up to 1 in 1 , 000 people ) fall allergy fever flu ( influenza ) feeling of being unwell neck pain chest pain ( angina pectoris ) low blood pressure with symptoms such as light headedness ( orthostatic hypotension ) decreased appetite , constipation , dry mouth ,
what rasagiline mylan contains - the active substance is raspiline . each tablet contains a single milligram of rasagailine tartrate ( equivalent to 1 mg rasgailine ). - the other ingredients are microcrystalline cellulose , tartric acid , maize starch , pregelatinized maize starch ( maize starch ), talc , stearic acid . see section 2 for further information about some of the ingredients of the tablet core . what rrasagilinea mylan looks like and contents of the pack rasagleiline tablets are 11 . 5 mm
do not use hulio : if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe infection ( tuberculosis ). if symptoms of infections include fever , wounds , feeling tired , dental problems . if you suffer from moderate or severe heart failure or have a serious heart condition . warnings and precautions allergic reaction allergic reactions are symptoms of an infection such as chest tightness , wheezing , dizziness , swelling or a rash . tell your doctor or nurse straight away if you notice any of these reactions . infections if your child has an infection other than
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . polyarticular juvenile idiopathic arthritis in children and adolescents from 2 to 17 years of age weighing 10 kg or more the usual dose is 30 mg once a day . hulio will be given as 20 mg twice a day ( 1 tablet in the morning and 2 tablets in the evening ). for children and teenagers from 2 - 17 years old weighing less than 30 kg , your doctor will decide the right dose for you . your child ' s doctor will determine the correct dose for your child .
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may require urgent medical treatment . tell your doctor straight away if you notice any of the following serious side effects ( seen in section 4 of this leaflet ) after the last hulio injection : allergic reaction including heart failure severe rash or hives swollen face , hands or feet trouble breathing or swallowing pale complexion , dizziness , persistent fever , bruising or bleeding . signs and symptoms of infection include fever , feeling sick , wounds , dental problems , burning on urination , feeling weak or
what hulio contains - the active substance is adalimumab . - the other ingredients are : monosodium glutumate , sorbitol , methionine , polysorbate 80 , hydrochloric acid and water for injections . what hulaio looks like and contents of the pack hulios 40 mg solution for injection is a sterile solution containing 40 mg of adlimumab in 0 . 8 ml solution . the solution is clear to slightly opalescent and colourless to pale yellow . it is closed with a rubber stopper . pack size of 1 , 2 , 1 sterile injection sy
what yellox is yellox contains the active substance bromfenac . it belongs to a group of medicines called non - steroidal anti - inflammatory drugs ( nsaids ) which reduce inflammation . how yellox works it is used to treat eye inflammation following cataract surgery in adults .
do not use yellox if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). if you have asthma , skin allergy or intense inflammation in your nose . warnings and precautions talk to your doctor , pharmacist or nurse before using yellox . you may need other nsaids such as acetylsalicylic acid , ibuprofen , ketoprofen or diclofenac . this medicine may be used with topical steroids such as cortisone , which may increase unwanted side effects and bleeding problems ( e . g . haemophilia
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose of yellox is one drop in the affected eye ( s ) once a day . use in children and adolescents your doctor will tell you how many drops you need to use in each eye . if you use more yellox than you should if you accidentally use too many drops , talk to a doctor or go to a hospital straight away . you may need to take the drops for the next day or two after your cataract surgery . method of administration yellox
what yellox contains - the active substance is bromfenac . each ml of solution contains bromenac ( as sodium sesquihydrate ). each vial of 33 ml contains 33 mg / ml of bromnac . - the other ingredients are boric acid , borax , sodium sulphite anhydrous , benzalkonium chloride , tyloxapol , povidone ( k30 ), disodium edetate and sodium hydroxide to maintain acidity levels . what yellox looks like and contents of the pack yellox is a clear yellow liquid ( solution
dzuveo contains sufentanil , which belongs to a group of strong painkillers called opioids . it is used to treat sudden moderate - to - severe pain in adults .
do not take dzuveo if you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious lung or breathing problem . warnings and precautions talk to your doctor , pharmacist or nurse before taking dzuvoo if : you have any condition that affects your breathing ( e . g . asthma , wheezing or shortness of breath ). this is more likely to happen when you start taking this medicine . your doctor may need to adjust your dose or stop treatment . you have recently had a head injury or brain tumour . your heart
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the single - dose administration device is for single use only . do not take more than the recommended dose of this medicine . if you take more dzuveo than you should if you have taken strong painkillers such as sufentanil , you should contact your doctor immediately . the recommended starting dose is 30 mg once a day . the sublingual tablet should be taken with or without food . you should take the tablet with the disposable single -dose applicator provided in
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects : - severe breathing problems , especially slow and shallow breathing . stop taking dzuveo and see a doctor immediately . very common side effects ( may affect more than 1 in 10 people ): - nausea ( feeling sick ), vomiting ( being sick ) and feeling hot . common side side effects that may affect up to 1 in every 10 people : - inability or difficulty sleeping , feeling anxious or confused , dizziness , headache , drowsiness , feeling sleepy ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light and oxygen . this medicine does not require any special temperature storage conditions or any other chemical or physical in - use stability or deterioration prior to use . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the environment
what dzuveo contains - the active substance is sufentanil . each single - dose tablet contains 30 mg . - the other ingredients ( excipients ) are : tablet core : mannitol ( e421 ), dicalcium phosphate , hypromellose , croscarmellose sodium , indigo carmine ( e132 ), stearic acid , magnesium stearate . tablet coating : white to off - white , round edges , with a diameter of 3 mm . each tablet is supplied in asingle - dose applicator ( labelled [ sublingual tablet ]). the applicator contains
elleada is a cancer medicine that contains the active substance apalutamide . it is used to treat adult men with prostate cancer that has spread to other parts of the body or cannot be removed by surgical treatments . it also helps to prevent sensitive prostate cancer from coming back to the body after surgical treatment . it reduces the levels of testosterone in the blood in men with this type of resistant prostate cancer . erleada also reduces the amount of androgens produced by the cancer . by reducing the levels , androgens can also help to kill prostate cancer cells .
do not take erleada if you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be pregnant or are planning to become pregnant ( see section " pregnancy , breast - feeding and contraception section "). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . this medicine may cause seizures . tell your doctor if you take , have recently taken or might take any medicines to prevent blood clots ( e . g . warfarin or acenocoumarol ) if you have any heart or blood vessel conditions
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is one 240 mg tablet once a day . your doctor may increase your dose to a maximum of 60 mg once daily . take erleada at about the same time each day . this medicine should be taken by mouth . you should swallow the tablet whole with a glass of water . do not crush , chew or break the tablet . if you take more erleade than you should if you accidentally take too many tablets , contact your doctor immediately . other medicines and er
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking erleada and see a doctor immediately if you experience any of the following symptoms : reddish , non - elevated , target - like , circular patches on the trunk , central blisters , skin peeling , ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes may be accompanied by fever and flu - like symptoms . toxic epidermal necrolysis is a group of serious side effects . the most common side effects are fits ( seizure ) which may affect up to 1 in 100 people
what erleada contains - the active substance is apalutamide . each film - coated tablet contains 60 mg of appalutamide ( as mesilate ). - the other ingredients are colloidal anhydrous silica , croscarmellose sodium , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose ( e460i ), silica ( e572i ), talc , and titanium dioxide ( e171 ). what erlead looks like and contents of the pack erleADA film - coating is off - white to slightly yellowish . it is supplied
this medicine is a radiopharmaceutical product . axumin contains the active ingredient fluciclovine . it is used to carry out a scan ( called a pet scan ) in adults who have previously had treatment for prostate cancer . it may be used together with other tests to determine prostate specific antigen ( psa ), the type of antigen that is present in the cancer . an axumin pet scan can help your doctor determine if the cancer has spread to your prostate . the scan will be done under the supervision of a doctor who is experienced in the use of this type of medicine . your doctor and the nuclear medicine doctor have
do not use axumin - if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using axumin if you have kidney problems . you must follow a low sodium diet . axumin is given once a day for the duration of the axumin scan ( see section 4 for more information ). during the scan , you will be given your usual medicines to take during the latest 60 minutes before and after your axumin injection . urination may occur during and after the scan . children and adolescents axumin
there are strict laws on the use , handling and disposal of radiopharmaceutical products . axumin will only be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this medicine and will keep you informed of their actions . the nuclear medicine doctor supervising the procedure will decide the quantity of axumin to be used in each case . the usual dose is 370 megabecquerel per kilogram of body weight . how axumin is given for the procedure axumin must be injected into a vein by a flush of sodium chloride solution
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies , the following side effects were observed : very common ( may affect more than 1 in 100 people ): when using the medicine , side effects associated with axumin may occur uncommonly . these may affect up to 1 in every 100 people : pain , rash , altered taste in the mouth , altered sense of smell . when using this radiopharmaceutical , low amounts of ionising radiation may increase the risk of cancer and hereditary abnormalities . reporting of side effects if you get any side effects talk to your nuclear medicine doctor . this includes
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only . do not use axumin after the expiry date which is stated on the label after exp .
what axumin contains the active substance is fluciclovine . axumin 1600 mg : each vial contains 1600 mg of fluciniclovine ( corresponding to 1600 mg / 16000 iu ). axumin 3200 mg / 3200 iu : each millilitre contains flucIClovine 3200 micrograms / 32 000 iu . the other ingredients are sodium citrate , concentrated hydrochloric acid and sodium hydroxide ( see section 2 " axumin is sodium "). what axumin looks like and contents of the pack white to off - white powder for solution for injection . ax
azopt contains brinzolamide which belongs to a group of medicines called carbonic anhydrase inhibitors . it works by reducing pressure within the eye . azopt eye drops help to reduce high pressure in the eye , which can lead to an illness called glaucoma . if the pressure in your eye is too high , it can damage your sight .
do not take azopt if you have severe kidney problems if you are allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to medicines containing sulphonamides ( medicines used to treat diabetes or infections ) or to diuretics ( water tablets ). warnings and precautions talk to your doctor or pharmacist before taking azopt . the same allergy may apply to some people : if you develop too much acidity in your blood ( hyperchloraemic acidosis ) if any of these apply to you ( or you are not sure ), talk
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . azopt should only be used in the eyes . the recommended dose is 1 drop in the affected eye each day . do not use azopt in both eyes at the same time each day ( see section 1 , 2 , 3 ). take the azopt bottle with you . wash your hands . remove the cap from the bottle . the cap can be removed with a snap collar . hold the bottle tightly with your thumb and a finger . tilt your head back . pull down your eyelid with a clean finger
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with azopt : common side effects ( may affect up to 1 in 10 people ) - effects in the eye : blurred vision , eye irritation , eye pain , eye discharge , itchy eye , dry eye , abnormal eye sensation , redness of the eye . other side effects include : bad taste . uncommon side effects : - effects on the eye including sensitivity to light , inflammation or infection of the conjunctiva , eye swelling , eyelid itching , red or swelling , deposits in eye , glare , burning
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . to protect from infections , a pack containing a single bottle should be used immediately .
what azopt contains - the active substance is brinzolamide . each vial contains 10 mg of brin zolamide ( as benzalkonium chloride ). - the other ingredients are carbomer 974p , edetate disodium , mannitol , purified water , sodium chloride , tyloxapol , hydrochloric acid and sodium hydroxide ( to maintain acidity levels and ph levels ). what azopt looks like and contents of the pack azopt is a milky liquid ( a suspension ) supplied in a 5 ml plastic ( droptainer ) bottle with a screw cap .
the active substance of forxiga is dapagliflozin . it belongs to a group of medicines called medicines taken by mouth to treat diabetes . it works by reducing the amount of sugar in your blood . it is used in adults and adolescents ( aged 18 years and older ) to treat the following types of diabetes : type 1 diabetes : your body does not make enough insulin to control the level of diabetes in your body . your body hardly makes any insulin . the insulin that your body makes does not work as well as it should . this can lead to diabetes . you may be overweight or obese . type 2 diabetes :
do not take forxiga - if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking for xiga if you : - experience feeling sick or being sick , stomach pain , excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness , a sweet smell to your breath , or a sweet or metallic taste in your mouth , a different odour to your urine or sweat , or rapid weight loss . contact your doctor straight away if you have one of the above
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of forxiga is one tablet once a day . if you have type 2 diabetes , your doctor may increase your dose to between 10 mg and 5 mg . your doctor will tell you how many tablets to take . do not take a double dose to make up for a forgotten dose . if your doctor thinks that you do not need the tablets anymore , talk to your doctor . for xiga can be taken with or without food . for type 1 diabetes : your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking forxiga and see a doctor straight away if you notice any of the following serious side effects : angioedema ( rare , may affect up to 1 in 10 , 000 people ): angioEDema may cause swelling of the face , tongue or throat which may cause difficulties swallowing , hives and breathing problems . diabetic ketoacidosis ( rare ), if you have type 1 diabetes ( very common , affects less than 1 user in 10 ) or type 2 diabetes ( uncommon , affects 1 to 10 users in 1 , 000
what forxiga contains - the active substance is dapagliflozin . - eachforxiga 5 mg film - coated tablet ( tablet ) contains a single tablet of dapabliflzin propanediol monohydrate equivalent to 5 mg dapagalifloin . - the other ingredients are : tablet core : microcrystalline cellulose , lactose ( see section 2 ' for important information about lactose '), crospovidone , silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), macrogol 3350 , yellow
mifamurtide , which blocks the action of certain bacteria in the immune system , stops them from growing and dividing . mepact is used to treat osteosarcoma ( bone cancer ) in adult patients between 2 and 30 years after surgery to remove the tumour . it is used when chemotherapy has stopped the growth of cancer cells and cancer has come back .
do not take mepact if : you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). you are taking medicines containing ciclosporin and other calcineurin inhibitors ( non - steroidal - anti - inflammatory drugs ) ( nsaids ). you have problems with your heart or blood vessels such as blood clots ( thrombosis ), bleeding ( haemorrhage ) or inflammation of the veins ( vasculitis ). warnings and precautions talk to your doctor , pharmacist or nurse before taking mypact . some of the effects
treatment mepact will be given to you by a doctor or nurse . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take adults the recommended dose of meepact is 2 mg mifamurtide once a day for 12 to 24 hours . your doctor will tell you how long you need to take your mepact treatments . this will depend on your chemotherapy schedule and on how you respond to your chemotherapy . the usual dose is 36 mg per kg body weight . you will receive treatment once a week . how to prepare me
like all medicines , mepact can cause side effects , although not everybody gets them . chills , fever and fatigue have been reported in patients receiving treatment with mypact ( transient use of paracetamol ). if you experience fever during or after treatment , you should contact your doctor immediately . stomach problems ( nausea , vomiting and loss of appetite ) have been very common in people receiving chemotherapy . tell your doctor or nurse immediately if you have continuing fever or chills . these may be signs of an infection ( rash ) or any problems breathing , wheezing or any stomach problems . very common side effects ( may affect
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial in outer carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . reconstituted suspension : sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection may be stored at room temperature ( up to 30 ) for up to 6 hours . this medicine must not be used if you notice any visible signs of deterioration .
what mepact contains - the active substance is mifamurtide . each vial contains 4 mg mifamanurtide ( as besilate ). after reconstitution and suspension , each ml contains 0 . 08 mg ( 0 . 07 mg ) of mifmurtide per ml . - the other ingredients are 1 - palmitoyl - 2 - ol - sn - glycero - 3 - phosphocholine ( see end of section 2 ) 2 - dioleoyl , 2 - nicolyl , 3 - phosphate - l - serine monosodium salt ( see
mirvaso contains the active substance brimonidine which belongs to a group of medicines called alpha agonists . it is used on the skin and face to reduce redness associated with rosacea ( redness of the face ) and to reduce the occurrence of rossacea associated with high levels of blood flow in the facial skin and enlargement ( dilution ) of the small blood vessels of the skin . mirvaso acts by blocking the blood vessels , thus reducing the excess blood flow and redness .
do not take mirvaso - if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 , " contents of the pack and other information "). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you : - have had 6 or more of the following side effects while taking the medicine under the skin : - are taking certain medicines used to treat depression or parkinson ' s disease ( monoamine oxidase ( mao ) inhibitors such as selegiline , moclobemide , tricyclic antidepressants ( such as im
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . mirvaso should only be applied to the skin on the face . this medicine should not be injected into any other part of your body . if your body surfaces , such as your eyes , mouth , nose or vagina , do not use more than once a day . if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse . how much mirvasos to use the recommended dose is one tablet twice a day ( one tablet in the morning and one tablet
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects : severe skin irritation or inflammation , skin rash , skin pain or discomfort , dry skin , warm skin sensation , tingling , sensation of pins and needles or swelling . common side effects ( may affect up to 1 in 10 people ): worsening of rosacea . stop the treatment immediately and contact your doctor if you have symptoms ( see section 2 " warnings and precautions "). contact allergy : allergic reaction may include rash , rare angioedema ( a serious allergic reaction with swelling mainly of the face , mouth and tongue ).
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and tube and pump after exp . store in the original package in order to protect from moisture .
what mirvaso contains - the active substance is brimonidine . one ml of gel contains 3 . 3 mg of bromonidine . each vial of 5 ml contains 5 mg / ml of brimonine tartrate . - the other ingredients are : carbomer , methylparahydroxybenzoate , phenoxyethanol , glycerol , titanium dioxide ( e171 ), propylene glycol , sodium hydroxide , purified water ( see section 2 under " important information about methylparhydroxy benzoate "), propylene Glycol . what mirvasoa looks like and contents of the
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody ( a type of protein that recognises and attaches to a specific target in the immune system , the body ' s natural defences ). it is used to defend the body from infection and cancer by blocking the activity of a protein called human vascular endothelial growth factor ( vegf ), which is found in large amounts in the lymph vessels of the body . by blocking its action , thevegf protein allows blood vessels to expand and supply oxygen to the tumour . by preventing tumour growth , mvas
do not use this medicine - if you are allergic ( hypersensitive ) to bevacizumab or any of the other ingredients of this medicine ( listed in section 6 ) if you ( or your child , if they are allergic , hypersensitive ), are breast - feeding . warnings and precautions talk to your doctor , pharmacist or nurse before using mvasi : - if your child has been previously treated with other types of chinese hamster ovary ( cho ) cell products ( see section 4 ). - if the child is pregnant . - if any of these apply to your child ( or you are not sure ),
dose and frequency of administration your doctor will work out the dose of mvasi you will receive based on your body weight and the type of cancer you have . the usual starting dose is 5 mg , 7 . 5 mg or 10 mg per kg of body weight . your doctor may increase your dose to 15 mg / kg depending on the size of your tumour . how often you will be treated your doctor or nurse will tell you how many treatments you need and how long you will need to keep receiving this medicine . you will usually be treated with either one or two infusions per week for 2 or 3 weeks . the number
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with mvasi : tell your doctor or nurse straight away if you notice any of the side effects listed below . these may be signs of a problem with your immune system ( the body ' s natural defences ) after chemotherapy . these side effects are usually mild to moderate and will usually disappear after a few days or weeks . if any of these effects occur , stop using mvai and seek medical advice straight away . allergic reactions if you have an allergic reaction , including difficulty in breathing , chest pain , redness
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the vial label after exp . store in a refrigerator ( 2 to 8 ). do not freeze . keep the vials in theouter carton in order to protect from light . infusion solutions should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 - 8 unless dilution has taken place in controlled and validated aseptic
what mvasi contains - the active substance is bevacizumab . each ml of concentrate contains 25 mg / ml ( 1 . 4 mg / 16 . 5 mg ) solution . each 4 ml vial contains 100 mg / m2 ( 3 . 0 mg ) of bevacsizumaab . one vial of 1 . 3 ml contains 16 mg / 400 mg ( 3. 0 mg / 25 ml ) solution and one ml of solution contains 400 mg / 2 ml ( 4 . 3 mg / 100 mg ). - the other ingredients are trehalose dihydrate , sodium phosphate , polys
tecartus is a gene therapy medicine used to treat mantle cell lymphoma ( mcl ). it is used in combination with other medicines to treat refractory mantle cancer . tecartus consists of your own white blood cells called autologous anti - cd19 - transduced cd3 + cells . mantlecell lymphoma is a cancer that affects the immune system ( the body ' s natural defences ). b - lymphocytes are a type of cell that are involved in transmitting messages between the body and the lymph tissue ( the bone marrow ) that make up blood . when mcl is cut off , the number of the
do not use tecartus if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before using the medicine if : you have a problem with the number of white blood cells in your blood ( lymphodepleting chemotherapy , see section 3 ) you have or have had problems with a number of these cells ( these include low numbers of a certain type of red blood cells called " autologous use ") you have tests or checks
tecartus consists of your own white blood cells . your cells will be collected and given to you by a doctor or nurse through a catheter placed in your vein ( a procedure call leukapheresis ). the number of these cells will depend on the type of medicine in your blood . your blood will be taken by infusion into a vein every 3 to 6 weeks . the total number of times you will be given tecartus is based on the number and number of your whiteblood cells . the usual starting dose is 2 to 3 million cells per week . medicines given before and at the start and end of tecart
like all medicines , this medicine can cause side effects , although not everybody gets them . if your side effects get serious , or if you notice any side effects not listed in this leaflet , please tell your doctor or nurse . you may need urgent medical attention . the following side effects have been reported during the tecartus infusion : very common ( may affect more than 1 in 10 people ): fever , chills , reduced blood pressure . symptoms may include dizziness , lightheadedness , fluid in the lungs . all symptoms could be signs of a condition called cytokine release syndrome ( loss of consciousness ). decreased level of consciousness may
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . infusion bag contains liquid nitrogen equivalent to 150 mg / ml . this medicine contains genetically modified human blood cells and human - derived material . the product is stable for 36 hours .
what tecartus contains - the active substance is autologous anti - cd19 - transduced cd3 + cells . each patient - specific single infusion bag contains a dispersion of anti - cd19 car t cells equivalent to 68 x 2 or 106 x 106 anti cells . - the other ingredients are sodium chloride and human albumin ( see section 2 " important information about some of the ingredients of tecartu ') and water for injections . what tecartuses looks like and contents of the pack teCartus is a clear , colourless to pale yellow solution for infusion . it is supplied in an infusion
januvia contains the active substance sitagliptin which belongs to a group of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4 inhibitor ) which help to control blood sugar levels in adult patients with type 2 diabetes mellitus . this medicine helps to increase the levels of insulin produced after a meal and decreases the amount of sugar made by the body . your doctor has prescribed this medicine to help lower your blood sugar , which is too high because of your type2 diabetes . your diabetes can also occur if you are taking certain other medicines ( insulin , metformin , sulphonylure
do not take januvia : if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). if you have inflammation of the pancreas ( pancreatitis ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if any of these apply to you ( or you are not sure ), or if you notice any signs of pancreatitis ( see section 4 ). blistering of the skin may be a sign of bullous pemphigoid ( a type of protein in your blood ). these medical conditions can increase the risk of pancreat
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended starting dose is one 100 mg film - coated tablet 63 once daily by mouth . if you have kidney problems , your doctor may increase your dose to 25 mg or 50 mg once daily depending on how you respond to this medicine . your doctor will tell you how many tablets of this medicine to take . this medicine may be taken with certain other medicines that lower blood sugar . it is important that you continue to follow the advice about diet and exercise given to you by your doctor , pharmacist or nurse
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact a doctor immediately if you notice any of the following serious side effects : severe and persistent pain in the abdomen ( stomach area ) which might reach through to your back , with or without nausea and vomiting , as these could be signs of an inflamed pancreas ( pancreatitis ). if you have a serious allergic reaction ( frequency not known ): rash , hives , blisters on the skin , peeling skin , swelling of the face , lips , tongue , and throat that may cause difficulty in breathing or
what januvia contains - the active substance is sitagliptin . each film - coated tablet ( tablet ) contains sitaglptin phosphate monohydrate equivalent to 25 mg sitaglioptin . - the other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate , croscarmellose sodium , magnesium stearate , and sodium stearyl fumarate . the tablet film - coating : poly ( vinyl alcohol ), macrogol 3350 , talc , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide . what jjuvia looks like and
xultophy helps to control blood glucose in patients with type 2 diabetes mellitus . diabetes is when your body does not produce enough insulin to control the level of blood sugar . your doctor has prescribed insulin degludec ( a long - acting basal insulin ) to help control your blood sugar levels . liraglutide ( a type of glp - 1 ) is a substitute for insulin during meals . xultophy may be used alone or in combination with oral medicines for diabetes . it is important to take oral medicines when you are taking metformin , pioglitazone or sulfonylurea
do not take xultophy : - if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). - if 39 you are taking a sulfonylurea such as glimepiride or glibenclamide . your doctor will tell you how long you should continue to take your sulfonyllurea dose . your blood sugar levels should be checked regularly while you are being treated with this medicine . if you have type 1 diabetes mellitus or ' ketoacidosis ', your doctor may want to reduce your blood
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . do not use more than the recommended dose , unless your doctor tells you to . your doctor may ask you to change the dose , if you have been blind or have poor eyesight , or if your blood sugar level is too low . the usual starting dose of xultophy is 41 mg once a day . you should inject xultue every day at about the same time each day , with or without food . use in children and adolescents do not give this medicine to children under 8 years of age
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects : low blood sugar ( very common : may affect more than 1 in 10 people ) if your blood sugar level gets low you may pass out or become unconscious . this could be a sign of serious hypoglycaemia ( which may cause brain damage ). low blood glucose is not a cure for your condition . your doctor will check your bloodugar level regularly to make sure that you are taking the right medicine for you . if you are not sure , talk to your doctor
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicinal product does not require any special storage conditions . after first opening : store in a refrigerator ( 2 - 8 ). do not freeze . store in the original package in order to protect from light . after opening : chemical and physical in - use stability has been demonstrated for 8 hours at room temperature ( 20 - 25 ). from a microbiological point of view , the product should be used immediately . however , if not used immediately , it should be
what xultophy contains - the active substances are insulin degludec and liraglutide . each vial contains 100 units of insulin degluudec 3 . 6 mg / ml of the active substance ( as besilate ). each ml of solution contains 300 units ( 1 . 5 mg ) of insulin gludec or 10 . 8 mg ( 2 . 0 mg ) lirglutime . - the other ingredients are glycerol , phenol , zinc acetate , hydrochloric acid , sodium hydroxide ( for ph adjustment ) and water for injections ( see section 2
giotrif is a medicine that contains the active substance afatinib . it blocks the activity of two proteins called egfr [ epidermal growth factor receptor - 1 ] ( egfr1 ) and her2 [ erbb2 ] ( erbb3 ]. these proteins are involved in the growth of cancer cells . this medicine stops these proteins from working properly and stops them from multiplying and growing . this will slow down the rate at which these proteins die and may help to stop cancer cells from growing . your doctor has prescribed this medicine for the treatment of cancer of the lung ( non - small cell lung cancer ). g
do not take giotrif : if you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ) if you have low body weight ( less than 50 kg ) warnings and precautions talk to your doctor or pharmacist before taking this medicine if you : have kidney problems , as this medicine may increase the risk of side effects . have lung inflammation ( interstitial lung disease ). have liver problems . your doctor may need to perform some liver tests before and during treatment with this medicine . have a severe liver disease . have eye problems . have severe dry eyes . have inflammation of the transparent
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual starting dose is one 40 mg tablet once a day . your doctor may increase your dose depending on how you respond to this medicine . giotrif can be taken with or without food . swallow the tablet whole with a glass of water . you can take the tablet at any time of the day . do not crush , chew or split the tablet . you may take this tablet with food or between meals . it is recommended that you take the tablets at least 1 hour before or 3 hours after
like all medicines , giotrif can cause side effects , although not everybody gets them . the following side effects have been reported during treatment : diarrhoea ( very common , may affect more than 1 in 10 people ). if you have diarrhoehoea , see section 2 " warnings and precautions " for more information . severe diarrhoee ( with or without fluid loss ) has been reported very rarely ( may affect up to 1 in every 10 people ) in patients with low blood potassium and worsening kidney function . if you experience diarrhoeea or diarrhoegoes you should contact your doctor immediately . appropriate antidiarr
what giotrif contains - the active substance is afatinib . each film - coated tablet contains 20 mg of afinib . - the other ingredients are : tablet core : lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica , crospovidone , magnesium stearate . tablet coating : hypromellose , macrogol 400 , titanium dioxide ( e171 ), polysorbate 80 , and water for injections . what giotratif looks like and contents of the pack white to off - white , round , biconvex , 20 mm
orkambi contains two active substances called lumacaftor and ivacavor . it is a medicine used for long - term treatment of cystic fibrosis ( cf ) in patients aged 6 years and older with a mutation called f508del mutation . this mutation affects the function of a protein called cftr , which is involved in the normal functioning of the body ' s immune system . the mutation causes the body to produce more of an abnormal cfr protein than it does when it is bound to a protein ( e . g ., bg ) called bg or cftl . orkamb
do not take orkambi : - if you are allergic to lumacaftor or ivacafor or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given , or kambi . if you have been told by your doctor that you have the f508del mutation , your doctor may need to change your dose or stop giving you , or your child ' s doctor may want to monitor you more closely while you are being treated with this medicine . children and adolescents do not give this medicine to children under 6 years
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended starting dose is one 6 mg tablet once a day for the first 12 weeks . your doctor will tell you how many tablets to take . the recommended orkambi tablet is 6 to 11 mg twice a day . the maximum recommended dose for the second 12 weeks is one or two or three or four or six tablets a day , depending on how you respond to the medicine . the doctor may also prescribe a higher or lower dose for you . if you take more ork
like all medicines , this medicine can cause side effects , although not everybody gets them . some of the side effects may be serious . stop taking orkambi and ivacaftor and talk to your doctor straight away if you notice any of the following serious side effects while you are being treated with this medicine : very common ( may affect more than 1 in 100 people ): pain or discomfort in the upper right stomach ( abdominal ) area yellowing of your skin or the whites of your eyes loss of appetite nausea or vomiting confusion dark urine other side effects include : common : may affect up to 1 in 10 people : cough sp
what orkambi contains - the active substance is lumacaftor . each tablet contains either : - one tablet of ivacftor ( 100 mg ) or - two tablets of ivaconaftor ( 125 mg ). each tablet of orkammi 200 mg contains either ( one tablet ) of 125 mg or ( two tablets ) of 200 mg of lumacaptor ( 200 mg ) of ivancaftor , or kambi 100 mg contains less than 125 mg of either . - the other ingredients are : tablet core : cellulose , microcrystalline , croscarmellose sodium ,
the active substance of lynparza is olaparib , a type of cancer medicine known as a parp inhibitor ( poly [ adenosine diphosphate - ribose ] polymerase inhibitor ). it works by preventing mutations ( changes ) in a gene called brca ( breast cancer gene ). in some types of cancer , parp inhibitors cause death of cancer cells by stopping the production of an enzyme needed to repair dna . the active substance in this medicine is called parp , which is involved in the repair of dna in cancer cells . lynparz is used to treat adult patients with ovarian cancer called
you must not be given lynparza - if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . children and adolescents do not give this medicine to children below the age of 6 years . the use in children below 2 years is not recommended . if you have any further questions on the use of this product , ask your doctor or pharmacist . if any of these apply to you ( or you are not sure ), talk to the doctor or nurse . if your child is
always take lynparza capsules exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended starting dose for adults is one 100 mg capsule twice a day . your doctor may increase your dose to 150 mg once a day depending on how you respond to the dose . the doctor will tell you how many tablets to take . if you take more than one tablet a day , you may need to take a smaller dose of a capsule . how to take take your tablet at about the same time each day . you can take the tablet with or without food . if
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): feeling short of breath , feeling very tired , pale skin , fast heart beat . these may be symptoms of a decrease in the number of red blood cells ( anaemia ). uncommon ( might affect up to 1 in 100 people ): allergic reactions including hives , difficulty breathing or swallowing , dizziness . signs and symptoms of hypersensitivity reactions are listed below . other side effects include : very common : these may affect less than 1in 10 people : feeling sick ( nausea ) being sick (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store in a refrigerator ( 2 8 ). do not freeze . any lynparza capsules that are not stored in the refrigerator may be removed from the refrigerator and left at room temperature ( up to 30 ) for a single period of up to 3 days . discard any capsules that have been frozen . store the capsules in the original blister in order to protect from light .
what lynparza contains - the active substance is olaparib . each hard capsule contains 50 mg olaparateib . - the other ingredients are lauroyl macrogol - 32 glycerides , hypromellose , titanium dioxide ( e171 ), gellan gum , potassium acetate , iron oxide black ( e172 ). what lynparz looks like and contents of the pack white , opaque , hard capsule imprinted with " olam 50 mg " on one side and " astrazeneca logo on the other side . the hard capsule is a white to off - white hard capsule with "
what nyxoid is this medicine contains the active substance naloxone which is used to treat opioid overdose in adults . opioids can include heroin , methadone , fentanyl , oxycodone , buprenorphine and morphine . how it works nyxoids is used as a nasal spray during the emergency treatment of opioid overdose . opioid overdose is fatal in adults , adolescents and children aged 14 years and above . overdose may lead to breathing problems and severe sleepiness . if you have an opioid overdose , stop taking opioids and contact your doctor or get emergency medical care immediately .
do not use nyxoid - if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . you may need emergency medical care or emergency services if you think you may have an opioid overdose . the signs and symptoms may be similar to those of an overdose . if you have any further questions on the use of this nasal spray , ask your doctor or pharmacist . see section 2 to 3 " how to use a new nasal spray " at the end of this leaflet . do not
always use nyxoid nasal spray exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . 1 . symptoms should be : shoulders , ears , breastbone , sternum or inside the ear . fingernail . 2 . clear the mouth and nose of any blockages . breathe in through your mouth or nose . 3 . breathe out through your nose . 4 . breathing is the chest moving through the chest . you may hear breathing sounds and breath on the cheek . overdose may occur if you have a lack of response to touch or sounds , slow uneven breathing
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : stop taking nyxoid and seek medical help immediately : acute withdrawal symptoms have been reported in patients taking opioid drugs . symptoms include fast heart rate , high blood pressure body aches , stomach cramps , feeling sick , vomiting , diarrhoea , sweating , fever , goose bumps , shivering , trembling changes in behaviour , including violent behaviour , nervousness , anxiety , excitement , restlessness , irritability unpleasant or uncomfortable mood increased skin sensitivity difficulty in sleeping . this is uncommon ( may affect up
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains - the active substance is naloxone . each nasal spray contains 1 . 8 mg of the following active substances : ndaloxone ( as hydrochloride dihydrate ) and trisodium citrate diydrate . - the other ingredients are sodium chloride , hydrochloric acid , sodium hydroxide and purified water . what nyxox looks like and contents of the pack nyxoids is a white to off - white , 0 . 1 ml solution for injection in a pre - filled nasal spray . it is supplied in a single dose container . each pack contains one single dose
this medicine contains the active substance follitropin alfa , which is a gonadotropin ( a type of hormone that is produced naturally in the body ). fsh is involved in the growth and development of the sacs ( follicles ) in the ovaries , and in the production of sperm . ovaleap is used to produce a viable egg cell after treatment with a medicine called " clomifene citrate ". it is used in adult women undergoing assisted reproductive technology procedures ( procedures to help get pregnant ) and in children who are not able to take a medicine known as " lutropin alkal
do not use ovaleap : if you are allergic to follitropin alfa , follicle stimulating hormone or any of the other ingredients of this medicine ( listed in section 6 ) if you have a tumour in your hypothalamus or pituitary gland ( the part of the brain that produces large ovaries and sacs of fluids ) if your ovaries do not produce enough ovarian cysts if you experience unexplained vaginal bleeding if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : you have ovarian failure ( early menop
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . this medicine is given as an injection into the tissue just under the skin ( subcutaneous injection ). if you have irregular periods , your doctor may give you this medicine for the first 7 days of your menstrual cycle . your doctor will tell you how long you should use the medicine . the recommended dose is one 75 mg / 150 mg tablet of this medicine once daily for 7 days ( corresponding to 14 days of each menstrual cycle ). the medicine can be divided into two equal doses .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with ovaleap : serious side effects in women allergic reactions such as skin rash and raised itchy areas of skin . severe allergic reactions may cause weakness , drop in blood pressure , difficulty breathing and swelling of the face . 37 rare ( may affect up to 1 in 10 , 000 people ). if you experience this type of reaction , your ovarian hyper - stimulation syndrome ( ohss ) may occur and the ovaries may stop the treatment . large ovarian cysts ( see section 2 under " ovarian hypersensitivity syndrome (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the cartridge label after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . after first opening , this medicine may be stored for a maximum of 3 days below 25 . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 - 8 unless the cartridge has been stored at room temperature
what ovaleap contains - the active substance is follitropin alfa . each cartridge of ovaleep 300 iu / 0 . 5 ml solution for injection contains 300 micrograms ( equivalent to 22 microlitres ) of follitrofa in 0 . 05 ml of solution . - the other ingredients are : - each cartridge contains 450 iu of 33 microlitre of follitonropin alpha in 0. 75 ml . - each carton contains one 600 iu ( 3 . 0 ml ) of the solution , corresponding to a concentration of 600 to 44 microliters ( 23 . 0 micro
voriconazole accord contains the active substance voriconazol . it is an antifungal medicine . it works by killing or stopping the growth of the fungi that cause infections . this medicine is used in adults and children from the age of 2 years to treat invasive aspergillosis ( a type of fungal infection caused by aspergonillus sp .) and candidaemia ( an advanced form of serious invasive candida sp .) in non - neutropenic patients ( patients with abnormally low white blood cells count ) to prevent and treat candida Sp . infections when the fungus is resistant to flu
do not take voriconazole accord : - if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). - if your child is taking any other medicines , including herbal medicines . ask your doctor or pharmacist for advice before taking the medicines listed below . warnings and precautions talk to your doctor , pharmacist or nurse before you are given any of these : - during vorateazole accord treatment 46 - terfenadine ( used to treat allergy ) astemizole ( used for allergy ) cisapride ( used in stomach problems ) pimozide
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will work out your dose based on your weight and the type of infection you have . the usual starting dose is 40 mg once a day . this will be given as 40 mg twice a day for 24 hours . the dose may be increased to 400 mg once daily for 12 hours and then increased to 200 mg once every 12 hours for the 24 hour period . the maximum recommended dose is 200 mg twice daily for 100 days . depending on how you respond to treatment , your doctor may increase your dose
like all medicines , this medicine can cause side effects , although not everybody gets them . if any side effects occur , you should contact your doctor immediately . serious side effects stop taking voriconazole accord and tell your doctor straight away : rash , jaundice , changes in blood tests of liver function ( pancreatitis ). other side effects very common ( may affect more than 1 in 10 people ): visual impairment ( change in vision , blurred vision , visual color alterations , abnormal intolerance to visual perception of light , colour blindness , eye disorder , halo vision , night blindness , swinging vision , seeing sparks , visual aura , visual
what voriconazole accord contains - the active substance is vorinazole . each film - coated tablet contains 50 mg of voronazole ( as perforated tablet ). - each tablet contains 200 mg of the other active substance ( aspergonazole ). - the other ingredients ( excipients ) are : tablet core : lactose monohydrate , pregelatinised starch , croscarmellose sodium , povidone , magnesium stearate . tablet coating : hypromellose ( e464 ), titanium dioxide ( e171 ), lactosemonohydrate and triacetin
mvabea is a vaccine to protect you against ebola virus disease in the future . it is given to adults , adolescents and children from 1 year of age and older who are at high risk of getting ebola virus . a 2 - dose course of vaccinations will be given to you to prevent you from coming into contact with the zaire ebolavirus and filovirus . this vaccine does not contain any of the other ingredients in the vaccine ( listed in section 6 ). if you are not sure , talk to your doctor , pharmacist or nurse before you are given this vaccine . the amount of filov
follow carefully all instructions given to you by your doctor , pharmacist or nurse . you should not receive the vaccine : if you have ever had a severe allergic reaction to any of the ingredients in the vaccine ( listed in section 6 . if you know that you have a severe allergy reaction to an antibiotic called ' gentamicin ', the vaccine may not fully protect all persons who are vaccinated . warnings and precautions talk to your doctor or nurse before receiving mvabea if you or your child : have a history of asevere allergic reaction or have received any other vaccine injection . fainted during the injection . bleeding or bruise easily
your doctor or nurse will give you the vaccine by injection into a muscle ( intramuscular injection ) in the upper arm or thigh or into a blood vessel . the first dose of vaccination will be given with zabdeno vaccine 8 weeks later . your doctor will decide if mvabea vaccine should be given at the same time as the second vaccine . the second dose of vaccine is given with a different type of medicine . children and adolescents primary vaccination first vaccination : with a single dose ( 0 . 5 ml ) of zab deno red cap vial . second vaccination with a second dose ( 1 . 5
like all medicines , this vaccine can cause side effects , although not everybody gets them . the following side effects may happen with mvabea : very common ( may affect more than 1 in 10 people ): pain , warmth , swelling where the injection is given feeling very tired muscle ache joint pain common : may affect up to 1 in every 10 people : feeling sick ( vomiting ) itching where the vaccine is given uncommon : may effect up to one in every 100 people : redness , skin hardness where the needle is given generalised itching . the most common side effects are seen in children and adolescents aged 1 to 17 years :
what mvabea contains the active substance is zaire ebolavirus 29 produced by recombinant dna technology in tai forest ebolavirus nucleoprotein marburg at a concentration of 0 . 7 to 108 kb / m2 . the other ingredients are chicken embryo embryo fibroblast cells . this vaccine contains trace residues of gentamicin , sodium chloride , trometamol , water for injections , and hydrochloric acid ( for ph adjustment ). what it looks like and contents of the pack the vaccine is a suspension for injection in a single - dose glass vial with a rubber stopper
bondronat contains the active substance ibandronic acid . this belongs to a group of medicines called bisphosphonates . it is used to treat breast cancer that has spread to your bones ( called ' bone ametastases '). it helps to prevent your bones from breaking ( fractures ) and other bone problems that may need surgery or radiotherapy bondronat can also be used if you have a raised calcium level in your blood due to a tumour . it reduces the amount of calcium that is lost from your bones . this helps to stop the bones from getting weaker .
do not take bondronat : if you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ) if you have low levels of calcium in your blood . warnings and precautions a side effect called osteonecrosis of the jaw ( onj ) ( bone damage in the jaw ) has been reported very rarely in cancer - related conditions . if you get onj , stopping treatment may increase your risk of developing onj . onj is a painful condition that can be difficult to treat . therefore , you should be carefully checked by your doctor for any signs of developing osteone
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will decide how much bondronat you need and how often you need to be treated for cancer . the recommended dose is one infusion into your vein every 3 - 4 weeks . you will receive an infusion in your vein over about 15 minutes . if you have a raised calcium level in your blood , your doctor may decide to increase the dose by 1 to 2 mg every 2 weeks depending on your illness . the medicine will be given to you as an infusion once a week , usually over a period
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : rare ( may affect up to 1 in 1 , 000 people ): persistent eye pain or inflammation new pain , weakness or discomfort in your thigh , hip or groin . this may be a sign of unusual fracture of the thigh bone . very rare ( might affect less than 1 in 10 , 000 persons ): pain or sore in your mouth or jaw . these may be signs of severe jaw problems ( necrosis ( dead bone tissue ) in the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the vial label after exp . this medicine does not require any special storage conditions . after dilution the infusion solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2ºc - 8ºc unless dilution has taken place in controlled and validated aseptic conditions . your healthcare professional will ensure that this medicine is used correctly and
what bondronat contains - the active substance is ibandronic acid . each 2 ml vial contains a concentrate for solution for infusion that contains 2 mg ibondronic acid ( as sodium monohydrate ). - the other ingredients are sodium chloride , acetic acid , sodium acetate , water for injections . what the solvent looks like and contents of the pack the clear , colourless to pale yellow solution for injection is supplied in a glass vial with a bromobutyl rubber stopper .
what zeposia is and what it can be used for it is a medicine that belongs to a group of medicines that affect the number of white blood cells ( lymphocytes ) in the body . it is used to treat adults who have relapsing remitting multiple sclerosis ( rrms ), a rare but active disease that affects the nerves of the brain and spinal cord . symptoms include numbness , difficulty in walking , and problems with vision and balance . relapses remitting ms attacks on the nerve cells , causing the symptoms to disappear for a period of time . some problems can be life - threatening . how zep
do not take zeposia if you are allergic to ozanimod or any of the other ingredients of this medicine ( listed in section 6 ) if you have a severely weakened immune system ( e . g . a heart attack , angina , stroke , mini - stroke , or transient ischemic attack ( tia ) warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have severe heart failure within the last 6 months you have irregular or abnormal heartbeats ( arrhythmia ) your heart is not working properly after treatment you have or have had severe infection such as
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor will work out your dose of zeposia based on your heart rate . you will be given a ' treatment initiation pack ' during treatment . the recommended starting dose is 4 capsules ( 0 . 23 mg ozanimod ) once a day . this will be gradually increased by 1 capsule per day . after 4 weeks of treatment , your doctor may increase your dose to a maximum of 3 capsules per day ( equivalent to 0 . 46 mg ozmod ). the recommended dose
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects : very common ( may affect more than 1 in 10 people ): slow heart rate urinary tract infection ( increase in blood pressure ) uncommon : may affect up to 1 in 100 people : allergic reaction . the signs may include a rash . other possible side effects include : common : side effects may affect less than 1in 10 people : infections of the nose or nostrils , nasal cavity , mouth , throat ( pharynx ) or voice box ( larynx
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store below 25 . store in the original package in order to protect from moisture . this medicine does not require any special temperature storage conditions . if you notice any damage to the pack , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment
what zeposia contains - the active substance is ozanimod . each capsule contains either 0 . 23 mg or 0 . 22 mg ozanimog ( as hydrochloride ). each capsule shell contains 0 . 46 mg of zanimod ( as hydration ). - the other ingredients are : capsule shell : microcrystalline cellulose , silica , colloidal anhydrous , croscarmellose sodium , magnesium stearate . capsule shell ( 0 . 03 mg ): gelatin , titanium dioxide ( e171 ), yellow iron oxide ( e172 ), black iron oxide and red iron oxide black ( see section
the active substances of temybric ellipta are fluticasone furoate , umeclidinium bromide and vilanterol . fluticastone fureate belongs to a group of medicines called corticosteroids ( steroids ). umecylidinIUM bromate and vilterol belong to a class of medicines known as bronchodilators . what temybrexta is used for temybolric elliptical is used to treat chronic obstructive pulmonary disease ( copd ). copd is a long - term condition characterised by breathing difficulties .
do not use temybric ellipta : - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if you think any of these apply to you , tell your doctor or pharmacist before being given temybi ellipta . asthma should not be used in patients who have asthma . your doctor should tell you if you have heart problems , high blood pressure , liver problems , tuberculosis (
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . this medicine should be used within 24 hours after your last dose of temybric ellipta . try to use it at the same time each day . do not take more than your doctor tells you to . if you do not feel better after 24 hours , talk to your doctor . how much to use the usual dose is two inhalations twice a day ( 1 inhalation ) once in the morning and one in the evening . you should use
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties if your breathing or wheezing gets worse while taking this medicine , tell your doctor straight away . pneumonia ( infection of the lung ) copd ( the most common side effect of temybric ellipta ) symptoms of a lung infection may include fever , chills , increased mucus production , change in mucus colour , increased cough and increased breathing difficulties common side effects ( may affect up to 1 in 10 people ) sore or raised patches in the mouth or throat possibly due to a fungal infection ( candidiasis )
what temybric ellipta contains - the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each delivered dose provides 92 micrograms of the combined active substances flutic as 65 micrograms of umclidatinium bromeide and 55 microgramms of umeleclidinicium ( corresponding to 22 microgramrams of vilterol ) and trifenatate . - the other ingredients are lactose monohydrate ( see section 2 under ' temchybric ellipta contains lactose '
zinforo is an antibiotic medicine that contains the active substance ceftaroline fosamil . it belongs to a group of medicines called 'cephalosporin antibiotics '. zinforo helps to prevent infections of the skin and the tissues below the skin . it may also help to prevent an infection of the lungs called ' pneumonia '. how zrinforo works your doctor will tell you how long you should keep using it . your doctor may tell you to stop using it if you do not feel better or if you feel worse after you have used it . zin foro works by killing certain bacteria that cause
do not use zinforo : if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to othercephalosporin antibiotics . if you have had previous severe allergic reactions to other antibiotics ( e . g . penicillin or carbapenem ). warnings and precautions talk to your doctor or pharmacist before you are given this medicine . if any of these apply to you ( or you are not sure ), tell your doctor , pharmacist or nurse before being given zin foro . warnings and
always use zinforo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 600 mg once a day for the first 12 weeks . your doctor may increase your dose to 600 mg every 8 weeks if you have some infections . it may be up to 8 to 12 weeks depending on how you respond to treatment . it is given as a drip into a vein ( intravenously ) over a period of 5 to 60 minutes . if you weigh 120 kg or more , you may receive an increased dose . the duration of treatment is 5 to 14 days . if
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zinforo and see a doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : sudden swelling of your lips , face , throat or tongue , a severe rash , or swallowing or breathing problems . these could be signs of a severe allergic reaction ( anaphylaxis ). diarrhoea , stool , blood or mucus may occur . your doctor may decide to reduce the dose or stop treatment completely or to stop you taking the medicine altogether . your dose may need to be adjusted or
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store below 30 . store in the original package in order to protect from moisture . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains the active substance is ceftaroline fosamil . the other ingredients are arginine and water for injections ( see section 2 ). what zzinforo looks like and contents of the pack zincforo is a pale yellowish to light yellow powder for concentrate for solution for infusion in a vial . it is available in packs containing 10 vials .
pregabalin pfizer belongs to a group of medicines used to treat epilepsy , neuropathic pain and generalised anxiety disorder ( gad ) in adults . peripheral and central neurological pain pregabalin pumpfizer is used to relieve long lasting pain caused by damage to the nerves . a variety of diseases can cause peripheral neurological pain , such as diabetes or shingles . pain sensations may be described as hot , burning , throbbing , shooting , stabbing , sharp , cramping , aching , tingling , numbness , pins and needles , and may be life - threatening and may require immediate medical attention .
do not take pregabalin pfizer : - if you are allergic to pregaabalin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking any of these medicines . some patients who have taken a large dose ( more than one tablet in one day ), have experienced symptoms suggesting an allergic reaction . these symptoms include swelling of the face , lips , tongue , and throat , as well as diffuse skin rash . should you experience one of these reactions , you should contact your doctor immediately . the use in children and adolescents of pre
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . pregabalin pfizer is for oral use . peripheral and central neuropathic pain , epilepsy or generalised anxiety disorder the usual dose is one 150 mg capsule twice a day . your doctor may increase your dose to 600 mg once a day depending on how you respond to the medicine . you should swallow the capsule whole with a glass of water . do not crush , chew or break the capsule . you can take your capsule with or without food . if you have the impression that the effect of pre
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): dizziness , drowsiness , headache . common : may affect up to 1 in every 10 people : increased appetite , feeling of elation , confusion , disorientation , decrease in sexual interest , irritability , disturbance in attention , clumsiness , memory impairment , loss of memory , tremor , difficulty with speaking , tingling feeling , numbness , sedation , lethargy , insomnia , fatigue , feeling abnormal , blurred vision , double vision , vertigo ,
what pregabalin pfizer contains - the active substance is pregaabalin . each hard capsule contains either 25 mg , 50 mg , 75 mg , 100 mg , 150 mg , 200 mg , 225 mg or 300 mg of pregon . - the other ingredients are lactose monohydrate , maize starch , talc , gelatine , titanium dioxide ( e171 ), sodium laurilsulphate , anhydrous colloidal silica ( e551 ). - the printing ink contains black ink , shellac , black iron oxide ( e172 ), propylene glycol ( e1521 ), potassium hyd
xadago is a medicine that contains the active substance safinamide . it works by increasing the levels of dopamine in the brain . dopamine is a chemical that is involved in movement and is important for the brain to function normally . in parkinson ' s disease , changes in the amount of dopamine are made in the body . these changes can lead to sudden swings in the ability of people to move , and difficulties moving . xadago can be used alone or in combination with the medicine levodopa , or other medicines used to treat the condition .
do not take xadago if : you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). you are taking the following medicines : monoamine oxidase ( mao ) inhibitors ( e . g . selegiline , rasagiline ), moclobemide , phenelzine , isocarboxazid , and tranylcypromine ( which are all used in treatment of parkinson ' s disease and depression ) pethidine ( a strong pain killer ) which is used in children and adolescents up to 7 years of age .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . xadago is available in two strengths : 50 mg and 100 mg . the recommended dose is one tablet taken by mouth once a day . your doctor will prescribe the strength that is right for you . if you have moderately reduced liver function , your doctor may prescribe a lower dose of 50 mg . take your tablet at about the same time each day . take the tablet with food . it does not matter whether you take it with or without a meal . you should swallow the tablet whole with a glass of
like all medicines , this medicine can cause side effects , although not everybody gets them . hypertensive crisis : very high blood pressure may lead to collapse ( neuroleptic malignant syndrome ). signs may include confusion , sweating , muscle rigidity , hyperthermia , increase level of enzyme creatine kinase in your blood ( serotonin syndrome ), confusion , hypertension , muscle stiffness and hallucinations ( hypotension ). the following side effects have been reported with the use of parkinson ' s disease in combination with safinamide and levodopa and other medicines used to treat the condition : common ( may affect up to 1 in 10 people ): insomnia
what xadago contains - the active substance is safinamide . each 50 mg or 100 mg film - coated tablet contains a substance called methansulfonate . - the other ingredients are : - tablet core : microcrystalline cellulose , crospovidone type a , magnesium stearate , silica colloidal anhydrous - tablet coating : hypromellose , macrogol , titanium dioxide ( e171 ), iron oxide red ( e172 ) what xadadago looks like and contents of the pack xadagon 50 mg are white to off - white , biconcave
zytiga is a medicine that contains the active substance abiraterone acetate . it is used to treat prostate cancer that has spread to other parts of the body . zytiga increases the levels of testosterone in your blood when you have prostate cancer . your doctor will test your blood to make sure that it is normal for you to have this type of disease . it may also be used together with hormone therapy ( a treatment that lowers testosterone ( androgen deprivation therapy ) or together with another medicine containing prednisone . prednisolone is used in adults with high blood pressure because it reduces the amount of
do not take zytiga : if you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be pregnant . warnings and precautions talk to your doctor or pharmacist before taking ztiga . if you have severe liver damage or prostate cancer . this medicine should not be taken with this medicine . tell your doctor before taking this medicine if you : have liver problems such as high blood pressure , heart failure , low blood potassium . have heart rhythm problems or other heart or blood vessel problems . have an irregular or rapid heart rate , shortness
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of 1 , 000 mg twice a day . you should continue taking this medicine until your doctor tells you otherwise . this medicine should only be taken by mouth . if you have the impression that the effect of zytiga is too strong or too weak , talk to your doctor , pharmacist or nurse . take the tablet at about the same time each day . do not chew or crush the tablet . if your doctor advises you to take more tablets than you should , contact your
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and contact your doctor immediately if you experience : muscle weakness , muscle twitches , a pounding heart beat or palpitations . the level of potassium in your blood is low . your doctor will check your potassium regularly . other side effects may include : very common ( may affect more than 1 in 10 people ): fluid in your legs or feet . low blood potassium ( seen in liver function test ). high blood pressure . urinary tract infection . diarrhoea . common : may affect up to 1 in every 10 people : high
what zytiga contains - the active substance is abiraterone acetate . each tablet contains nominally 250 mg abdominalateroneacetate . - the other ingredients are : tablet core : microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 ), colloidal anhydrous silica , sodium laurilsulfate . see section 2 " important information about some of the ingredients in this medicine " for more information . what zytigra looks like and contents of the pack - ztiga tablets are white to
hefiya contains the active substance adalimumab , which is a medicine used for the treatment of inflammatory diseases : polyarticular juvenile idiopathic arthritis , enthesitis - related arthritis , paediatric plaque psoriasis and paediatric crohn ' s disease paediatric non - infectious uveitis . the active ingredient in hefiya , adalumab , is a monoclonal antibody ( a type of protein that recognises and attaches to a specific target in the body ). monoconlonal antibodies are proteins that recognise and attach to specific target proteins in body cells . the target of ad
do not take hefiya : - if your child is allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your child ' s doctor , pharmacist or nurse before taking this medicine if : - your child has a severe infection , such as tuberculosis , sepsis ( blood poisoning ), or other opportunistic infections ( unusual infections caused by a weakened immune system ). symptoms of infections may include fever , wounds , feeling tired , dental problems . your child may have moderate or severe heart failure or have a serious heart condition . allergic reaction : allergic reactions may
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose is one 40 mg tablet once a day . your doctor will tell you how many tablets to take . the dose may later be increased to 20 mg , 40 mg , 20 mg or 40 mg . polyarticular juvenile idiopathic arthritis age and body weight how much to take adults , adolescents and children from 2 years of age weighing 30 kg or more 40 mg every other week . children and adolescents from 2 to 10 years old weighing 30 mg or more 20 mg each other . ent
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . side effects may occur up to 4 months after the last hefiya injection . signs of allergic reaction may include heart failure , severe rash , hives , swollen face , hands , feet , trouble breathing , swallowing , shortness of breath and swelling of the feet . signs and symptoms of infection may include fever , feeling sick , wounds , dental problems , burning on urination , feeling weak or tired or coughing . symptoms of nerve problems may include ting
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the pre - filled syringe after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the syringe in the outer carton in order to protect from light . after first opening , the product may be stored at room temperature ( up to 25 ) for a single period of up to 14 days . once removed from the refrigerator for room temperature storage , you may take his / her solution back to your refrigerator and use it within 14 days
what hefiya contains - the active substance is adalimumab . each pre - filled syringe contains 20 mg of adlimumab in 0 . 4 ml solution . - the other ingredients are adipic acid , citric acid monohydrate , sodium chloride , mannitol ( e421 ), polysorbate 80 , hydrochloric acid and sodium hydroxide and water for injections . what hefaya looks like and contents of the pack hafiya 20 mg solution for injection ( injection ) is a clear to slightly opalescent , colourless to slightly yellowish solution in a clear type i glass
the active substance in ritemvia is called rituximab . this is a type of protein called a " monoclonal antibody ". it sticks to a specific target in a certain type of white blood cell called " b - lymphocyte ". by sticking to the target of the target protein it allows the cell to grow and divide . by sticking firmly to the surface of this cell ( called " granulocyte - colony stimulating factor ") it helps to control the growth and division of the cell . when used in combination with other medicines ( such as chemotherapy ), the treatment can be continued for up to 2 years after
do not take ritemvia : if you are allergic to rituximab , other proteins that are derived from the needles of yew trees , or any of the other ingredients of this medicine ( listed in section 6 ) if you have a severe active infection with a weak immune system . if you suffer from severe heart failure or severe uncontrolled heart disease . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . children and adolescents do not give this medicine to children or adolescents under 6 years of age because there is no information available on its safety in this age group . if your child has a
your doctor will decide how much ritemvia you will receive and how often you will need this treatment . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you have any side effects , your doctor may decide to reduce your dose . your doctor will tell you how many tablets to give to you . the recommended dose is one tablet a day . you will usually be given ritvia by a drip ( intravenous infusion ). medicines given before each ritemvia administration you will be given either ritamvia with other medicines ( pre - medication
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number of
what ritemvia contains - the active substance is rituximab . each ml of concentrate contains 100 mg of ritukimab ( as besilate ). each vial of 10 ml contains 10 mg / ml of solution for injection . - the other ingredients are : sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what ritvia looks like and contents of the pack ritemva is a clear , colourless solution for infusion in a glass vial . pack size of 2 vials .
capecitabine teva belongs to a group of medicines called " cytostatic medicines ", which stop the growth of cancer cells . capecitabrine teva is a type of medicine known as a cytokostatic medicine . it is an active anti - cancer medicine that can be used in the treatment of certain types of colon , rectal , gastric , or breast cancers . furthermore , capecitabe teva can be prescribed to you if you have advanced stage of colon cancer after complete removal of the tumour by surgery . if you are certain that this medicine has been prescribed for you , you should talk to your
do not take capecitabine teva - if you are allergic to cape citabine or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may have an allergy , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before taking this medicine if you have : - severe reactions to fluoropyrimidine therapy ( a group of anticancer medicines such as fluorouracil ) - are pregnant - have low levels of white cells or platelets in the blood ( leucopenia , neutropenia or thrombocytopenia )
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . capecitabine should only be prescribed by a doctor experienced in the use of anticancer medicines . your doctor will prescribe a dose and treatment regimen that is right for you . the recommended dose of cape citabine teva is based on your body surface area ( height and weight ). the usual dose for adults is 1250 mg / m2 of body surface surface taken once daily . for children and adolescents ( 6 years of age and above ), the usual starting dose is one tablet of 150 mg /
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva and contact your doctor immediately if you experience any of these symptoms : diarrhoea : if you have an increase of 4 or more bowel movements compared to your normal bowel movements . if you get any diarrhea at night , vomiting , vomit , nausea , or lose your appetite . stomatitis : pain , redness , swelling , or sores in your mouth and / or throat . hand or foot skin - reaction : pain and swelling , including redness and tingling of hands and or feet
what capecitabine teva contains - the active substance is capecabine . each film - coated tablet contains 150 milligrams of capecitabiline . - each tablet contains 500 milligram ( mg ). - the other ingredients are : tablet core : lactose , microcrystalline cellulose , hypromellose , croscarmellose sodium , magnesium stearate , macrogol 400 , talc . tablet coating : hypromellaose , titanium dioxide ( e171 ), yellow iron oxide ( e172 ) and red iron oxide [ e172 ]). what capecitaberine te
silodosin recordati belongs to a group of medicines known as alpha1a - adrenoreceptor blockers . silodosic recordati works by blocking signals to the prostate , bladder and urethra . this helps to maintain smooth muscle in these tissues . it also reduces your symptoms . your doctor will tell you how long you should continue to take this medicine , and will explain to you how to treat your symptoms when you have stopped taking it . what is silodosein recordi used for silosin Recordati is used to treat the urinary symptoms associated with benign enlargement of the prostate ( prostatic hyper
do not use silodosin recordati - if you are allergic to siliodosin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if you have undergone eye surgery , you may experience cloudiness of the lens ( cataract surgery ) in one part of the eye 26 during treatment . if this happens , your doctor may decide to temporarily or permanently stop treatment with silosinrecordati . this is because medicine may cause a loss of muscle tone in the iris ( the coloured part of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of silodosin recordati is 8 mg once a day . patients with kidney problems if you have moderate kidney problems , your doctor may prescribe a lower dose . your doctor will prescribe this dose for you . swallow the capsule whole with a glass of water . do not crush or chew the capsule . you can take this dose with or without food . try to take your daily dose at about the same time each day . it is important that you continue to take sil
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions swelling of the face or throat , difficulty in breathing , feeling faint , itchy skin and hives may be the most common side effect of silodosin recordati . dizziness if you experience dizziness , or occasionally fainting , you may feel weak or dizzy . the symptoms may include dizziness and fainty . if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse . warnings and precautions talk to your doctor or pharmacist before you are given silod
what silodosin recordati contains - the active substance is silosin . each capsule contains 8 mg of silodosein . - the other ingredients are : capsule content : mannitol ( e421 ), magnesium stearate , sodium laurilsulfate . capsule shell : gelatin , titanium dioxide ( e171 ). what silodosesin filmati looks like and contents of the pack capsule contents : white , opaque , hard gelatin capsules , size 0 , approximately 21 . 7 mm x 7 . 6 mm . capsule shells : gelatin ( titanium dioxide ) printing ink : shellac , yellow iron oxide ( e
kinzalmono belongs to a class of medicines known as angiotensin ii receptor antagonists . angiotENSin ii is a substance produced in the body which causes your blood vessels to narrow , thus increasing your blood pressure . kinzalono blocks the effect of angiotenin ii so that the blood vessels relax , and your bloodpressure is lowered . kinzonmono is used to treat essential hypertension ( high blood pressure ) in adults . ' essential ' means that the high blood blood pressure is not caused by any other condition . high bloodpressure , if not treated , can damage blood vessels in several
do not take kinzalmono if you are allergic to telmisartan or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , do not take the tablet and talk to your doctor , pharmacist or nurse before taking it . if you ( or your child ) are more than 3 months pregnant , think you may be pregnant , or are planning to have a baby , ask your doctor for advice before taking this medicine . ( see section " pregnancy and breast - feeding " in section 4 ). if you have severe liver problems such as cholestasis or biliary obstruction
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . try to take the tablet at the same time each day . the tablets can be taken with or without food . it is important that you take kinzalmono every day until your doctor tells you otherwise . your doctor will tell you how many tablets to take . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious and need immediate medical attention : you should see your doctor immediately if you experience any of the following symptoms : sepsis ( often called " blood poisoning "), a severe infection with whole - body inflammatory response , rapid swelling of the skin and mucosa ( angioedema ). these side effects are rare ( may affect up to 1 in 1 , 000 people ). the following side effects have been reported with kinzalmono common side effects ( affects more than 1 user in 10 ): low blood pressure (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special temperature storage conditions . once your medicine has been diluted , your kinzalmono tablet should be used immediately . if the blister is damaged , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what kinzalmono contains - the active substance is telmisartan . each tablet contains 20 mg telmisantan . - the other ingredients are povidone , meglumine , sodium hydroxide , sorbitol ( e420 ), magnesium stearate ( e470b ) and water for injections ( see section 2 ). what kinzalao looks like and contents of the pack kinzalanmono 20 mg tablets are white to off - white , round , flat , biconvex , and embossed with " gsi " on one side and plain on the other
afstyla is a human clotting ( coagulation ) factor viii product produced by recombinant dna technology ( rdna ). the active substance is lonoctocog alfa . afstylfa is used to treat and prevent bleeding episodes in patients with haemophilia a ( inborn factor v iii deficiency ). recombinant viii is a natural constituent of blood clotting . it helps blood to clot . patients with an increased tendency to bleed have been shown to have been more likely to have factor iii deficiency than patients who do not have it in their blood ( for example , due to
do not use afstyla : - if you have had an allergic reaction to any of the ingredients of this medicine ( listed in section 6 ). if you are allergic to hamster proteins 46 warnings and precautions talk to your doctor , pharmacist or nurse before using the product . you should check with your doctor or pharmacist if you think any of these apply to you . the dose and the batch number may differ from the general information contained in your treatment diary . do not increase the dose or discontinue the treatment unless your doctor tells you to . if you experience allergic ( hypersensitivity ) reactions , stop using the medicine and
your treatment will be overseen by a doctor experienced in the treatment of blood clotting disorders . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one vial of afstyla per day . dose and duration of treatment depending on the severity of your disease the site and the bleeding your clinical condition will be decided by your doctor . reconstitution and administration general instructions the powder and the solvent ( liquid ) should be used immediately after preparation . in case of aseptic conditions , the solution should be mixed with other medicines or sol
like all medicines , afstyla can cause side effects , although not everybody gets them . symptoms of allergic reactions allergic reactions include the following symptoms : hives generalised urticaria ( itchy rash , tightness of the chest , difficulty in breathing , wheezing ), low blood pressure and dizziness ( anaphylaxis ). bleeding has been reported in patients treated with factor viii medicines ( inhibitor antibodies ) ( see section 2 " warnings and precautions "). very common ( may affect more than 1 in 10 people ) patients receiving previous treatment with factor iii ( more than 150 days of treatment ) the risk is uncommon
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the afstyla powder in the outer carton in order to protect from light . after reconstitution , the reconstituted product should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 8 hours at 2 - 8 unless dilution has taken place
what afstyla contains the active substance is lonoctocog alfa . each vial contains 250 iu / 2 . 5 ml of solution for injection and injections the solution contains 100 iu ( 2300 iu ) ( 2401 iu ). after reconstitution and dilution and diluution with 2 . 0 ml of solutions for injection , each ml contains 200 micrograms ( 2301 iiu ) ( 2302 iu) ( 2402i ) ( 2502i ). the other ingredient ( s ) ( excipients ) ( see section 2 ) is lonctoc
what praxbind is and what it is used for the active substance in this medicine , idarucizumab , is a recombinant agent . it is very similar to dabigatran ( pradaxa ), a blood thinner medicine used to prevent blood clot formation in adults . what is it used for ? what is used ? when a person is given a medicine to rapidly trap dabrigatran , it is unlikely that they will be given too much . your doctor will tell you how much medicine to give to your child . what are the benefits of giving to a child that is being treated with prax
do not take praxbind : if you are allergic to idarucizumab or any of the other ingredients of this medicine ( listed in section 6 . if you have a genetic disease called hereditary fructose intolerance ( hfi ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . serious adverse reactions have been reported with the use of the active substance dabigatran . other medicines may increase the risk of blood clots ( see section " other medicines and dabigATran ") if your body is at a high risk of getting clots . medicines can increase the chances of blood
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is 5 mg ( 2 . 5 mg ) dabigatran per kilogram of body weight . you will be given this medicine once every day for 5 days . this medicine will be injected into a vein ( intravenously ) by a healthcare professional . your doctor will decide how long you should be treated with this medicine . your treatment will be overseen by a doctor who is experienced in the treatment of blood clot formation . if you have any further questions on the use of
like all medicines , this medicine can cause side effects , although not everybody gets them . reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what praxbind contains - the active substance is idarucizumab . - the other ingredients are sodium acetate trihydrate , acetic acid , sorbitol ( e420 ) and polysorbate 20 ( e433 ). - the solvent is water for injections ( see section 2 " important information about some of the ingredients of Praxbind "). what praxbinding looks like and contents of the pack the solution for injection is clear to slightly opalescent and colourless to slightly yellow solution . it is supplied in a clear glass vial with a butyl rubber stopper and an aluminium cap
temomedac contains a medicine called temozolomide . this medicine is an antitumour agent . temomedac is used for the treatment of specific forms of brain tumours : - in adults with newly - diagnosed glioblastoma multiforme . - in children and adolescents ( 3 years of age and older ) - in adult patients whose disease has not responded to radiotherapy ( concomitant phase of treatment ) or monotherapyphase of treatment ( phase 3 ). - in patients with malignant glioma , such as gliOBlastoma multipurpose or anaplastic astrocyt
do not take temomedac if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ). if you have had an allergic reaction to dacarbazine ( an anticancer medicine sometimes called dtic ). signs of allergic reaction may include feeling itchy , breathlessness or wheezing , swelling of the face , lips , tongue or throat . if blood cells are severely reduced ( myelosuppression ) ( e . g . your white blood cell count and platelet count ). these blood cells help your body to fight infection when proper blood clotting is not
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage and duration of treatment your doctor will work out your dose of temomedac based on your height and weight . this is especially important if you have a recurrent tumour that has not responded to chemotherapy treatment in the past and you are taking other medicines ( anti - emetics ) that are similar to temomedic ( except for nausea and vomiting ). patients with newly - diagnosed glioblastoma multiforme the first course of treatment will be followed by treatment with radiotherapy ( concomitant
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience a severe allergic ( hypersensitive ) reaction , including hives , wheezing or other breathing difficulty , uncontrolled bleeding , seizures ( convulsions ), fever , chills and severe headache . temomedac treatment may cause a reduction in certain kinds of blood cells . this may result in increased bruising or bleeding , anaemia ( reduced number of red blood cells ), fever and reduced resistance to infections . the reduction in blood cell counts is usually short - lived . in some cases , it may be life - threatening
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special temperature storage conditions . after first opening of the bottle : do not store above 30 . store in the original package in order to protect from moisture . any change in the appearance of the capsules should be promptly reported to your pharmacist .
what temomedac contains ∑ the active substance is temozolomide . ∑ each capsule of temomedax 5 mg contains 5 mg temozolsomide ∑ temomedacon 20 mg : each capsule contains 20 mg of temozlomide ( see section 2 ). ∑ if you are not sure , talk to your doctor , pharmacist or nurse before you take this medicine ∑ your doctor may decide to increase the dose of temoledac to 100 mg , depending on the dose you need to take to get the desired effect ∑ you may need to increase your dose to get a suitable
cialis is a treatment for adult men with erectile dysfunction . this is when a man cannot get , or keep a hard , erect penis suitable for sexual activity . cialis will only help you to obtain a hard erect penis if you have agreed with your partner that it would be best for you to engage in sexual activity with someone who is willing to help you get a hard erection for a long period of time . your doctor will tell you how long you should continue to take this medicine . the active substance tadalafil belongs to a group of medicines known as phosphodiesterase type 5 inhibitors . how c
do not take cialis if you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ) if you have a history of taking organic nitrate or nitric oxide donors ( e . g . amyl nitrite ) or medicines (" nitrates ") used to treat angina pectoris (" chest pain "). warnings and precautions talk to your doctor , pharmacist or nurse before you are given any of these medicines : if you know that you may be at increased risk of taking nitrate if you : have serious heart disease have recently had a heart attack within the
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . cialis tablets are for oral use . swallow the tablet whole with a glass of water . the tablets can be taken with or without food . the usual starting dose is between 5 mg and 2 . 5 mg per day . your doctor will tell you how many tablets to take . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse . how much to take your doctor may tell you to take cial
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with the medicine : allergic reactions including rashes ( frequency not known ) and chest pain have been reported in patients taking nitrates . the frequency is not known ( frequency cannot be estimated from the available data ). priapsim may cause a prolonged and possibly painful erection . stop taking cialis and get an erection straight away ( see section 4 " warnings and precautions "). contact your doctor immediately if you experience sudden loss of vision . this is not of the frequency listed above . other side effects very common ( may
what cialis contains - the active substance is tadalafil . each tablet contains 2 . 5 mg of dlabs ( as mesilate ). - the other ingredients are : tablet core : lactose monohydrate ( see end of section 2 ), croscarmellose sodium , hydroxypropylcellulose , microcrystalline cellulose , sodium laurilsulfate , magnesium stearate . film - coating : tablet - core : hypromellose , triacetin , titanium dioxide ( e171 ), talc . tablet coating : iron oxide yellow ( e172 ), iron oxide red
enyglid is an oral antidiabetic medicine containing repaglinide , which helps your pancreas make better use of insulin when your blood sugar is high ( glucose ). type 2 diabetes is a disease in which your body does not make enough insulin to control the sugar in your body . the insulin that your body makes does not work as well as it should . enygalid helps control the level of sugar in the blood when you have type 2abetes . treatment is usually started by diet and exercise and weight reduction . your blood blood sugar may be increased when you take enyglide in combination with met
do not take enyglid : if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). if you have type 1 diabetes . if the acid level in your blood is too low ( diabetic ketoacidosis ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have a severe liver disease . you are taking gemfibrozil ( a medicine used to lower increased fat levels in the blood ). you have liver problems . you have moderate liver 28 disease . see section 2 . if any of these apply to
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 0 . 5 mg tablet once a day . swallow the tablet whole with a glass of water . you can take enyglid with or without food . the usual starting dose is 30 mg twice a day for 4 weeks . your doctor may increase your daily dose to 30 mg once every 16 weeks . if your blood sugar is too low , you may get a hypo . do not take a double dose to make up for a forgotten dose . if you have any further questions
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia ( the most common side effect of enyglid ) is very rare ( may affect up to 1 in 10 , 000 people ) but may be life - threatening ( see also section 2 ). if you notice any of the following , stop taking the medicine and contact your doctor straight away : hypoglycasemic reactions are generally mild / moderate and may occasionally lead to a brief but severe form of hypocaemic unconsciousness ( coma ). allergy allergy has been reported in very rare cases ( affects less than 1 user in
what enyglid contains the active substance is repaglinide . each tablet contains 0 . 5 mg , 1 mg or 2 mg repagginide . the other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate , anhydrous , croscarmellose sodium , povidone k25 , glycerol , magnesium stearate , meglumine , poloxamer , yellow iron oxide ( e172 ) only in 1 mg tablet only in 2 mg tablet . tablet coating : red ironoxide ( e 172 ) only for 2 mg tablets only in 0 .
azacitidine mylan contains an active substance called an anti - cancer agent . your doctor has determined the active substance in this medicine is acetylsalicylic acid ( a substance derived from the needles of yew trees ). your doctor will determine the correct dose of azacitine mylan . what azapitidine milan is used for the treatment of patients who have not received a stem cell transplantation , is used to treat : higher - risk myelodysplastic syndromes ( mds ) chronic myelomonocytic leukaemia ( cmml ) acute myeloid le
do not take azacitidine mylan - if you are allergic to azapitidine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have advanced liver cancer . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you : - have decreased counts of platelets , red or white blood cells - have kidney disease or liver disease - have a heart condition ( such as heart attack ) - have lung disease your doctor will do blood test before you start treatment . your doctor may decide to reduce the dose or stop treatment with
before starting azacitidine mylan you will be given another medicine to prevent nausea and vomiting . the recommended dose is one 75 mg tablet of this medicine per day . your doctor will work out your dose based on your height and weight . you will usually be given one tablet once a day . if you have the impression that the effect is too strong or too weak , talk to your doctor or pharmacist . how much to take the usual starting dose of azaccitidine melan is one tablet per day for 3 days . this " treatment cycle " will then be repeated every 4 to 6 weeks . this medicine will be
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience any of the following serious side effects : drowsiness or shaking , jaundice ( abdominal bloating or easy bruising ), which may be symptoms of liver failure , swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue . these may be the symptoms of kidney failure . a fever may be a sign of an infection with low levels of white blood cells . chest pain or short
keep this medicine out of the sight and reach of children . do not use azacitidine mylan after the expiry date which is stated on the vial label and carton after exp . this medicine does not require any special temperature storage conditions . after reconstitution , the suspension must be used within 1 hour . before use , chemical and physical in - use stability has been demonstrated for 1 hour at 25ºc . after preparation , it should be used immediately . if not used immediately , when stored in a refrigerator ( 2 - 8 ). if the azaccitidine Mylan suspension is stored in the refrigerator (
what azacitidine mylan contains - the active substance is azapitidine . one vial of powder contains 100 mg of azacituidine . after reconstitution , 4 ml of water for injections is sufficient . the reconstituted suspension contains 25 mg / ml ( 0 . 25 %) azaccitidine . - the other ingredient is mannitol ( e421 ). see section 2 , " important information about some of the ingredients in this medicine " for further information on the ingredients , see section 4 , " what azacnitidine melan looks like and contents of the pack acit
duotrav eye drop solution contains a combination of two active substances , travoprost and timolol in one drop . travostrost is a prostaglandin analogue , which helps to lower pressure in the eye when it is used in adult patients , and is a beta blocker that reduces the amount of fluid within the eye . duotrav helps to reduce pressure within theeye when you are using it in adults , adolescents , children and infants aged one month and above , as well as in children aged one year and weighing less than one kg . duetrav eye drops are used to treat high pressure in
do not take duotrav - if you are allergic to travoprost , prostaglandins , timolol , beta blockers or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has respiratory problems such as asthma , severe chronic obstructive bronchitis or severe lung disease ( wheeziness , difficulty in breathing , long - standing cough , breathing problems ), severe hay fever ( a slow heartbeat ), heart failure ( a disorder of heart rhythm , irregular heartbeat ), or if your eye becomes cloudy . warnings and precautions talk to your doctor or pharmacist before taking duotra :
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one drop in the affected eye or eyes once a day . do not use duotrav in your eyes unless your doctor tells you to . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse . how to use wash your hands before using duotrave . the recommended starting dose is 1 drop in each affected eye each day , followed by 2 , 3 , 4 drops each day . a bottle is provided with
like all medicines , this medicine can cause side effects , although not everybody gets them . stop using the drops and tell your doctor immediately . duotrav can cause very common side effects ( may affect more than 1 in 10 people ) effects on the eye eye redness . this is a common side effect that may affect up to 1 in every 10 people . the effect of the eye surface inflammation or surface damage may include eye pain , blurred vision , abnormal vision , dry eye , itchy eye and eye discomfort . signs and symptoms of eye irritation such as burning or stinging may occur . uncommon side effects that may show up in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store below 30 . store in the original package in order to protect from moisture . once opened , duotrav should be used within 4 weeks to prevent infections .
what duotrav contains - the active substances are travoprost and timolol . each vial contains 40 mg of tritonavir . - the other ingredients are : o tablet core : travioprost 5 mg / ml , sunset yellow fcf ( e110 ) o tablet coating : timovol maleate , polyquaternium - 1 , mannitol , propylene glycol , polyoxyethylene hydrogenated castor oil 40 mg o film - coating : boric acid , sodium chloride , sodium hydroxide , hydrochloric acid , purified water ( e524 ), sodium hyd
nplate ' s active ingredient is romiplostim . it is a protein that is used to reduce low platelet counts caused by the immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is a disease in which your body ' s immune system does not produce enough platelets . platelets are important in keeping blood clots free of blood . you may have very lowplatelet counts , which can lead to bruising and serious bleeding ( see section 1 ) if you have had your spleen removed . you have chronic itp previously treated with corticosteroids or
do not take nplate if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before taking nplate : if you have a low blood platelet count ( thrombocytopenia ). if this applies to you , tell your doctor as soon as possible . nplate may reduce yourplatelet count , which may increase the risk of blood clots . your doctor may want to monitor you more closely for signs of blood clotting .
always use nplate exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . use in children and adolescents from 1 to 17 years of age the recommended dose of nplate is one tablet once a day . your doctor will tell you how many tablets to use and how long you should continue to take nplate . nplate will be given to you as an injection under the skin ( subcutaneous ) over a period of at least 1 hour . if you use more nplate than you should if you think you may have injected too much nplate , talk to your doctor . your
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with itp : very common ( may affect more than 1 in 10 people ): headache , allergic reaction , upper respiratory tract infection ( very common ) common : may affect up to 1in 10 people : bone marrow disorder , increased bone marrow fibres , trouble sleeping ( insomnia ), dizziness , tingling or numbness of the hands or feet ( paraesthesia ), migraine , redness or the skin ( flushing ), blood clot in a lung artery ( pulmonary embolism ), nausea , diarrhoea
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . after first opening , the product should be used within 30 days . store in the original package in order to protect from moisture .
what nplate contains - the active substance is romiplostim . each vial of nplate 125 mg solution for injection contains 230 mg ( 1 , 000 mg ) romplostim ( 125 mg / ml ). each single - dose glass vial contains 125 mg ( 2 , 000 iu ) romiplormous . each single dose contains a deliverable amount of 0 . 25 ml solution ( corresponding to a total of 125 mg romiplim per ml ). - the other ingredients are : 500 mg : nplate 250 mg : 375 mg ( 3 , 500 mg ) the active ingredient in nplate is : rom
this medicine contains an active substance called glycopyrronium bromide which belongs to a group of medicines called bronchodilators . what tovanor breezhaler is used for this medicine is used to treat breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). in copd , the muscles around the airways tighten , making breathing difficult . this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the lungs . using this medicine will help to reduce the effects of copd on your everyday life .
do not use tovanor breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if you have kidney problems , or have an eye problem called narrow - angle glaucoma ( difficulty passing urine ). your doctor may decide to reduce your dose , or stop treatment , if necessary . if any of these apply to you , tell your doctor or pharmacist immediately . you may experience tightness of the chest , coughing ,
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much tovanor breezhaler to use the recommended dose of this medicine is one inhalation once a day . you should inhale this medicine every 24 hours at about the same time each day . your doctor will tell you how many capsules to use and how long you should continue to use it . the maximum recommended dose is 75 inhalations per day . do not use more than one inhaler twice a day for a total of four days . how to inhale the medicine - this medicine
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each hard capsule contains 63 micrograms glycopirroniumbromide , equivalent to a minimum of 50 microgram ( 23 . 5 microgram ) glycopyronium . each delivered dose ( the delivered dose that leaves the mouthpiece of the inhaler ) provides a delivered dose of 44 microgram / m2 of body surface area ( i . e ., one inhalation dose ) of glycopYRronium per kilogram of the inhaled dose . - the other ingredients are lact
adasuve contains the active substance loxapine and belongs to a group of medicines called antipsychotics . it works by stimulating the brain to produce dopamine and serotonin which are important for calming effects and relieving aggressive behaviour . adasuve is used to treat acute symptoms of mild - to - moderate agitation in adults with schizophrenia and bipolar disorder . these are diseases characterised by symptoms ( for example , schizophrenia ) hearing , seeing things which are not there ( mistaken beliefs ), incoherent speech and behaviour and emotional flatness . people with bipolar disorder may also feel depressed , guilty , anxious or tense . the signs of bipolar disorder
do not take adasuve : - if you are allergic to loxapine or any of the other ingredients of adasve ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given adsasuve if you : - have lung problems like asthma , chronic obstructive pulmonary disease ( copd ), narrowing of the airways ( bronchospasm ), wheeze , cough , chest tightness or shortness of breath 25 - have neuroleptic malignant syndrome ( nms ), a group of symptoms that have been reported with antipsychotic medicines . these symptoms
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 9 . 1 mg tablet once a day . your doctor may increase your dose to 2 to 4 . 5 mg depending on your condition . the tablet can be taken with or without food . adasuve is for oral use . it should be taken by mouth . swallow the tablet whole with a glass of water . do not chew , crush or split the tablet . if you use more adsasuve than you should contact your doctor immediately if you experience any of the following symptoms :
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking adasuve and see a doctor straight away if you notice any of the following serious side effects : - any breathing symptoms such as wheezing , cough , shortness of breath , chest tightness , irritating your airways ( asthma or copd ). - light - headedness or fainting . these may be signs that your blood pressure is getting too high . - worsening agitation , confusion , fever and muscle stiffness . these could be signs of a severe condition called neuroleptic malignant syndrome . other side effects include :
keep this medicine out of the sight and reach of children . do not use adasuve after the expiry date which is stated on the carton and on the blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the blister in the outer carton in order to protect from light and moisture . the product does not require any special temperature storage conditions . if you notice any visible signs of physical damage , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
always use adasuve exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation per day . each single - dose inhaler delivers 5 mg of loxapine per day , and delivers 4 . 5 mg / m2 of body weight each day . do not use more than your doctor tells you to use . if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse .
azacitidine betapharm contains an anti - cancer agent which belongs to a group of medicines called ' anti - metabolites '. azacitrixbetapharm works by inhibiting the activity of the immune system ( the body ' s natural defence system ). what azaccitidine betabarm is used for the treatment of adult patients with myelodysplastic syndromes ( mds ) and chronic myelomonocytic leukaemia ( cmml ) and acute myeloid leukemia ( aml ). these are diseases that affect the bone marrow , where normal blood cell production is not maintained .
do not take azacitidine betapharm - if you are allergic to azapitidine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have advanced liver cancer . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . some patients being treated with this medicine have experienced decreased counts of platelets , red or white blood cells . these may be signs of kidney disease . tell your doctor if you have liver disease , a heart condition , heart attack or lung disease . your doctor will do blood test before you start treatment with
before starting azacitidine betapharm , you will be given another medicine to prevent nausea and vomiting . the recommended dose is one 75 mg tablet of this medicine per day . your doctor will work out your dose based on your height and weight . you will usually be given one tablet once a day . if you have the impression that the effect is too strong or too weak , talk to your doctor or pharmacist . how much to take the usual starting dose of azaccitidinebetapharm is one tablet per day for 3 days . this " treatment cycle " will then be repeated every 4 to 6 weeks . this
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience any of the following serious side effects : drowsiness or shaking , jaundice ( abdominal bloating and easy bruising ), which may be symptoms of liver failure . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue ( symptoms of kidney failure ). a fever may be a sign of an infection with low levels of white blood cells . chest pain or shortness of breath may
keep this medicine out of the sight and reach of children . do not use azacitidine betapharm after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 8 ). do not freeze . store the vials in the outer carton in order to protect from light . any unused azaitidinebetapharm must be disposed of in accordance with local requirements . this medicine is for single use only . after preparation , the suspension should be used within 45 minutes . if not used immediately , in - use storage times and conditions prior to use
what azacitidine betapharm contains - the active substance is azacitonidine . one vial contains 100 mg azacituidine . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / ml azaccitidine . - the other ingredient is mannitol ( e421 ). see section " important information about some of the ingredients in this medicine " for further information on the contents of this medicine ( see section 2 ). what azacsitidinebetapharm looks like and contents of the powder and solvent for solution for injection in a glass vial ,
the active substance in cerdelga is eliglustat . it is used for the long term treatment of gaucher disease type 1 in adults . gaucher diseases type 1 is inherited condition in which a substance called glucosylceramide is not removed from your body . this substance is mainly produced by the spleen , liver and bones . if you do not respond normally to the medicine , you may not be able to take it . your doctor will test your affected organs to make sure that it is working properly . this medicine will be prescribed to you by a doctor who is experienced in the care of patients with this condition .
do not take cerdelga if : you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). you are taking medicines known as moderate cyp2d6 inhibitors ( e . g . quinidine , terbinafine ). 31 you have moderatecyp3a inhibitors such as erythromycin or itraconazole . these medicines are used to improve your body ' s ability to absorb nutrients . if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor or pharmacist before you are given Cerdelga .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is one tablet twice a day with or without food . your doctor will tell you how many tablets to take . the amount of metaboliser to take depends on how much you are taking . the recommended daily dose is two tablets ( two tablets each day ) with food . swallow the tablets with a glass of water . if you take more cerdelga than you should if you accidentally take too many tablets , contact a doctor or the nearest hospital straight away . take the tablet
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): headache dizziness change in taste ( dysgeusia ) palpitations ( throat irritation ) heartburn ( dyspepsia ) feeling sick ( nausea ) diarrhoea constipation abdominal pain stomach ache ( upper abdominal pain ) acid reflux disease ( gastrooesophageal reflux diseases ) bloating ( abdominal distension ) inflammation of the stomach ( gastritis ) 34 difficulty swallowing ( dysphagia ) vomiting dry mouth gas ( flatulence ) dry skin h
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the sleeve after exp . this medicine does not require any special temperature storage conditions . store in the original package in order to protect from moisture . the following information is intended for the specialist only : do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what cerdelga contains - the active substance is eliglustat . each hard capsule contains 84 mg of eliglustant . - the other ingredients are : capsule content : microcrystalline cellulose , lactose monohydrate ( see section 2 ' cerdelaga contains lactose '), hypromellose , glycerol dibehenate , gelatin , potassium aluminium silicate , titanium dioxide ( e171 ), yellow iron oxide ( e172 ), indigotine ( e132 ). printing ink : shellac , black iron oxide , propylene glycol and ammonia solution . what cerDelga looks like and contents of
the active substance in zoledronic acid hospira is zoledor acid , which belongs to a group of substances called bisphosphonates . zoledron acid works by attaching itself to the bone and slowing down the rate of bone change . it is used to prevent bone complications , e . g . fractures , in adult patients with bone metastases ( a type of cancer that affects the primary site of bone ). it reduces the amount of calcium in the blood in patients where it is too high due to the presence of a tumour . tumours can accelerate normal bone change in such a way that the release of calcium
follow carefully all instructions given to you by your doctor , pharmacist or nurse . your doctor will carry out blood tests before you start treatment with zoledronic acid hospira and will check your response to treatment regularly during treatment . if you are not sure if any of the above applies to you , talk to your doctor or pharmacist before you are given this medicine . warnings and precautions talk to the nuclear medicine doctor or nurse before you have been given the medicine : if you think you may be allergic ( hypersensitive ) to zoledron acid or another bisphosphonate ( the group of substances to which the medicine in
zoledronic acid hospira will be given to you by a doctor or nurse who is experienced in the use of bisphosphonates intravenously ( into a vein ). ' iv ' administration is recommended in order to reduce dehydration . how much zoledronic acidic hospira is given the recommended dose is 4 mg once a day . if you have a kidney problem , your doctor may lower your dose . if your kidney problem is not well controlled , your dose may be reduced . how often zolingronic acidospira is used in patients with a history of bone complications ( such as bone metastases ), your doctor will decide
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the most frequently reported side effects are : common ( may affect up to 1 in 10 people ): severe kidney impairment ( will be determined by your doctor with certain specific blood tests ). low level of calcium in the blood . uncommon : may affect upto 1 in 100 people : pain in the mouth , teeth and / or jaw , swelling or non - healing sores inside the mouth . jaw discharge , numbness or a feeling of heaviness or loosening of a tooth . these could be signs of bone damage in the jaw
your doctor , pharmacist or nurse knows how to store zoledronic acid hospira properly .
what zoledronic acid hospira contains - the active substance is zolingronic acid . one vial contains 4 mg zoledron acid ( as monohydrate ). - the other ingredients are mannitol , sodium citrate and water for injections . what zoledic acid hospir looks like and contents of the pack zoledicle acid hospire is supplied as a liquid concentrate for solution for infusion (' sterile concentrate ') which is supplied in a glass vial . each pack contains one single - use vial of concentrate .
varuby contains the active substance rolapitant . it is used to treat adults with cancer feeling sick ( nauseous ) or being sick ( vomiting ) during cancer treatment chemotherapy . this type of chemotherapy destroys nerve cells in the brain . this can cause people to have vomiting and being sick . varuby works by killing these nerve cells . it also reduces the chance of nausea and vomiting .
do not take varuby if : you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). you are taking an herbal medicine called st john ' s wort ( hypericum performatum ). you have depression or difficulty sleeping ( see section 2 " warnings and precautions "). this medicine should not be used 27 if you have severe liver or kidney problems . you are currently taking certain medicines containing rifampicin ( used to treat tuberculosis and other infections ), such as carbamazepine ( used for epilepsy and nerve pain ), phenobarbital ( used in epilepsy
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 180 mg tablet once a day for up to 90 days . swallow the tablet whole with a glass of water . you can take varuby with or without food . take the tablet at least 2 hours before or at the start of your chemotherapy cycle . your doctor will tell you how many days of chemotherapy you need to take . if you have sickness or if you feel sickness , take it as soon as you remember . then take your next dose at its regular time . do not
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with varuby : very rare ( may affect up to 1 in 1 , 000 people ): symptoms of an allergic reaction may include sudden shortness of breath , swelling of the lips or tongue , change in taste or swelling of skin or tissue , sudden rash , fever and faster heartbeats . tell your doctor immediately , as appropriate treatment may be needed . other side effects include : very common : may affect more than 1 in 10 people : headache ; constipation ; feeling tired ; uncommon : might affect up
what varuby contains - the active substance is rolapitant . each tablet contains 90 mg rolapitant . - the other ingredients are : tablet core : lactose monohydrate ( see section 2 under ' varubsy contains lactose '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , polysorbate 80 . tablet coat : blue 100 mg film - coated tablet
what enerzair breezhaler is and what it is used for the active substance is indacaterol - glycopyrronium - mometasone frescoatedol - neuraminidase ( mf ) glycopyronium belongs to a group of medicines called bronchodilators . it relaxes the muscles in the small airways in the lungs . this helps to open the airways and makes it easier for air to get in and out of the lungs and helps to lower the amount of stuff that people breathe . what is mf increased in levels of eosinophils
do not use enerzair breezhaler if you are allergic to indacaterol , glycopyrronium , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using this medicine if you : - have heart problems - have an irregular or fast heartbeat - have thyroid gland problems or diabetes - have high blood sugar - have seizures - have severe kidney problems , have severe liver problems or have a low level of potassium in your blood
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one inhaler twice a day . the medicine should be inhaled once a day at about the same time each day . if you use more enerzair breezhaler than you should if your asthma is getting worse or if your symptoms get worse , contact your doctor straight away . how to use and when to use it use your inhaler as instructed by your doctor , pharmacist or nurse . it does not matter whether you use it with or without food
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious stop using enerzair breezhaler and see a doctor straight away if you notice any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching and hives . these may be signs of allergic reaction . other side effects other possible side effects are listed below . common : may affect up to 1 in every 10 people : sore throat , runny nose , sudden difficulty breathing , feeling of tight
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special temperature storage conditions . the capsules should be used within one month after first opening .
what enerzair breezhaler contains - the active substances are indacaterol ( as acetate ), glycopyrronium ( as bromide ), and mometasone furoate . each capsule contains 150 micrograms of the active substance , and contains 63 microgigadromes ( as glycopyroniumbromide ). each delivered dose contains 50 microgogadromis ( as hydroxygeodromes ), 160 microgagadrome ( as monogramide ) and 160 microgramm ( as dihydramide ). - the delivered dose
clopidogrel acino pharma gmbh contains the active ingredient clopridogrel which belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures , which clump together during blood clotting . by reducing the amount of this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process known as thrombo - occlusion ). furthermore , this process can lead to a process called atherothrombosis ( a condition in which the body cannot completely break down the throm
do not take clopidogrel acino pharma gmbh : - if you are allergic ( hypersensitive ) to the active substance clopidineogrel ( see section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking the tablet if : - you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . - you suffer from severe liver disease . if any of these apply to you , tell your doctor or pharmacist . if you think any of the above applies to you ( or you are in any doubt at all ), talk to
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual starting dose is one 75 mg tablet per day to be taken orally with or without food , and at the same time each day . your doctor will tell you the dose to take . you can take either one tablet daily or two tablets daily depending on your condition and on the type of bleeding that you are suffering from . if you take more clopidoogrel aclara than you should if you accidentally take too many tablets ,
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) uncommon ( affects 1 to 10 users in 100 ) rare ( affects less than 1 users in 1 , 000 ) very rare : very rare ( affecting less than1 users in 10 , 000 not known ( frequency cannot be estimated from the available data ) very common : may affect up to 1 in 10 people contact your doctor immediately if you experience : fever , signs of
store in the original blister in order to protect from moisture . keep out of the reach and sight of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton and on the blister after exp . this medicinal product does not require any special temperature storage conditions . accidental ingestion can cause damage of blister or film - coated tablets . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what clopidogrel acino pharma gmbh contains - the active substance is clopridogrel . each tablet contains 75 mg of clopidaogrel ( as besilate ). - the other ingredients are : tablet core : macrogol 6000 cellulose , microcrystalline ( e460 ) crospovidone type a castor oil , hydrogenated film - coating : macromol 6000 ethylcellulose ( e462 ) titanium dioxide ( e 171 ) what clopIDogrelacino pharmá gmb h looks like and contents of the pack clopidi
delstrigo is used to treat hiv (' human immunodeficiency virus ') infection in adults who are already taking medicines called ' antiretroviral medicines '. the active substances in delstrigo are doravirine , a non - nucleoside reverse transcriptase inhibitor ( nnrti ), lamivudine , which is also known as a nucleosidermal necrolysis ( nrti ) and tenofovir disoproxil , which are all known to be active substances of the hiv virus ( aids (' acquired immune deficiency syndrome '). by controlling the virus
do not take delstrigo : if you are allergic to doravirine , lamivudine , tenofovir disoproxil or any of the other ingredients of this medicine listed in section 6 . if you take the following medicines : carbamazepine , oxcarbazepine and phenobarbital and phenytoin ( medicines used to prevent seizure ) rifampicin and rifapentine ( medicines to treat tuberculosis ) st . john ' s wort ( hypericum perforatum , a herbal remedy used to treat depression and anxiety ) products containing mitotane
always take delstrigo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is a complete regimen of one tablet a day . a single tablet is sufficient to treat hiv infection for up to 1 month . your doctor may prescribe you certain medicines ( e . g . doravirine ). your doctor will tell you which medicines to take . taking this medicine swallow the tablet whole with a glass of water . you can take this medicine with or without food . if you have any further questions on the use of this medicine , ask your doctor , pharmacist
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking delstrigo and see a doctor straight away if you notice any of the following serious side effects : very common ( may affect more than 1 in 10 people ): abnormal dreams difficulty in sleeping ( insomnia ) headache dizziness sleepiness cough nasal symptoms feeling sick ( nausea ) diarrhoea stomach pain vomiting wind ( flatulence ) hair loss rash muscle symptoms pain ( stiffness ) feeling tired fever blood tests showing increased levels in liver enzymes uncommon : may affect up to 1 in 100 people : nightmares , depression , anxiety , irritability , confusion and
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after " exp ". this medicine does not require any special temperature storage conditions . the medicine should be kept in the bottle tightly closed in order to protect from moisture .
what delstrigo contains the active substance is doravirine . each tablet contains 300 mg of lamivudine ( equivalent to 245 mg ). the other ingredients are tenofovir disoproxil ( as fumarate ), croscarmellose sodium e468 , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose e460 , silica , colloidal anhydrous , sodium stearyl fuma . a coating material containing carnauba wax e903 . the printing ink contains : hypromeellose , iron oxide yellow ( e172
spravato contains the active substance esketamine . it belongs to a group of medicines called anti - depressants . this medicine helps to control your depression and reduces the symptoms of depression , such as feeling sad , anxious or worthless , sleeping difficulties , change in appetite , loss of interest in favourite activities and feeling of being slowed down . spravato is used in combination with another antidepressant in adults , adolescents and children aged 2 years and older . antidepressant medicines should not be used alone .
do not use spravato - if you are allergic to esketamine , ketamine or any of the other ingredients of this medicine ( listed in section 6 ). if you have an aneurysm ( a weak spot in a blood vessel wall that bulges out ) or bleeding in the brain . if you recently had a heart attack which occurred within 6 weeks . a temporary increase in blood pressure can lead to serious complications in these conditions . if any of these apply to you , tell your doctor or pharmacist before you are given this medicine . warnings and precautions talk to your doctor , pharmacist or nurse before using sp
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the spravato nasal spray is for inhalation use only . the nasal spray device must be used within 1 hour . use in children and adolescents the recommended starting dose is 2 to 3 nasal spray devices per day . if you use more than one spray device per day , use at least 4 sprays in the day ( see section 4 ). if you forget or miss a dose , use it as soon as you remember . if it is more than 4 hours since your last dose of
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects : very common ( may affect more than 1 in 10 people ) feeling disconnected or having feelings and things around you feeling dizzy headache change in sense of taste feeling sleepy decreased feeling or sensitivity to noise in the mouth area spinning sensation ( vertigo ) vomiting nausea very common : may affect up to 1 in every 10 people feeling extremely happy ( euphoria ) feeling agitated feeling anxious in the eyes or ears feeling like your sense of touch are deceived or mimicked irritable panic
what spravato contains - the active substance is esketamine . each nasal spray device contains an excess of esketam hydrochloride equivalent to 28 mg esketa . - the other ingredients are citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water for injections . whatspravato looks like and contents of the pack sprivato is presented as a nasal spray solution . this medicine is a clear , colourless solution . it is available in a pack containing one single - use nasal spraydevice and one multipack of six ( 2 packs of 3 ) or 6 nasal
zelboraf is an anticancer medicine that contains the active substance vemurafenib . it is used to treat melanoma that has spread to other parts of the body or cannot be removed by surgery . this type of cancer has a change ( mutation ) in a gene responsible for producing melanoma cells . zelborab targets proteins that are involved in the growth and spread of your cancer .
do not use zelboraf - if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ). symptoms of allergic reactions may include swelling of the face , lips or tongue , difficulty breathing , rash and fainting sensation . if any of these apply to you , tell your doctor or pharmacist . warnings and precautions talk to your doctor , pharmacist or nurse before using the product . allergic reactions if allergic reactions occur while you are being treated with the product , or after you have been given the product ( see " allergic reactions " below ), your doctor may decide
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 4 mg tablet once a day for up to 8 weeks . if you take more than 4 tablets a day , your doctor may decide to reduce your dose to 4 tablets per day , depending on the severity of side effects and how you respond to your treatment . taking zelboraf with food you may experience vomiting . if this happens , take your tablet straightaway and then take your next tablet at the usual time . do not take a double dose to make up for a forgotten
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions , including swelling of the face , lips or tongue , difficulty breathing rash fainting sensation have been reported very rarely in patients receiving treatment for radiation . tell your doctor immediately if you experience any of the following symptoms : skin rash , blistering , peeling or discoloration of the skin shortness of breath , a cough , fever or chills ( pneumonitis ) difficulty or pain when swallowing , chest pain , heartburn or acid reflux ( esophagitis ) if you notice any changes in your
your doctor , pharmacist or nurse knows how to store zelboraf properly . these measures will help to protect the environment .
what zelboraf contains - the active substance is vemurafenib . each film - coated tablet contains 240 mg of vemurabenib ( as a co - precipitate of valsartan ). - the other ingredients are : tablet core : hypromellose acetate succinate , colloidal anhydrous silica , croscarmellose sodium , hydroxypropyl cellulose , magnesium stearate film - coating : iron oxide red ( e172 ), macrogol 3350 , polyvinyl alcohol , talc and titanium dioxide ( e171 ). what zelberaf looks
duoplavin contains two separate medicines called clopidogrel and acetylsalicylic acid ( asa ). these belong to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , blood vessels relax , allowing blood to flow in and out of the blood . by reducing the number of these smaller structures , antiplatelets reduce the chances of blood clots forming ( a process called atherothrombosis ). duoplavic is used to : prevent bloodclots forming in hardened
do not take duoplavin if you are allergic to clopidogrel , acetylsalicylic acid ( arsa ) or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic to other products called non - steroidal anti - inflammatory products if you suffer from painful and / or inflammatory conditions of muscles or joints if you have a medical condition ( e . g . asthma , nasal discharge , runny nose , polyps ( a type of growth in the nose ). if you currently have a risk of bleeding such as a stomach ulcer or bleeding within the
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will tell you how many tablets of duoplavin you need to take and how long you should continue to take your medicine . the recommended dose is one tablet a day . you should take the tablet at the same time each day . do not take more than one tablet in the morning . if you take more tablets than you should if you accidentally take too many tablets , talk to a doctor or go to the nearest hospital emergency department immediately . you may be at increased risk of bleeding . if
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of an
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store below 25 . store in the original package in order to protect from moisture . this medicine does not require any special temperature storage conditions . if you notice any visible sign of deterioration , do not throw away any medicines via wastewater . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
duoplavin 75 mg film - coated tablets each tablet contains 46 mg of the active substances , clopidogrel ( as acetylsalicylic acid ( aasa ), 75 mg of which the active substance is clopidineogrel . the other ingredients are acetyl salicylic acids ( aa ), mannitol ( e421 ), macrogol 6000 , microcrystalline cellulose , low substituted hydroxypropylcellulose , maize starch , hydrogenated castor oil ( see section 2 under ' duoplin contains hydrogenatedcastor oil '), stearic acid and
simbrinza contains two active substances called brinzolamide and brimonidine tartrate . brin zolamide belongs to a group of medicines known as carbonic anhydrase inhibitors , which work by blocking the action of a substance in the body called brimonidase . this substance is a stimulant of the central nervous system called alpha - 2 adrenergic receptor agonists , which help to reduce pressure within the eye . the effect of simbrinz is seen in the eyes of children and adolescents aged 18 years and older . it is used to treat eye conditions such as glaucoma ,
do not take simbrinza : if you are allergic to brinzolamide , brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic to sulphonamides ( medicines used to treat diabetes or infections ) or to diuretics ( water tablets ) or a monoamine oxidase ( mao ) inhibitors ( medicines to treat depression or parkinson ' s disease ). if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . simbrinza should only be used in the eyes . avoid touching your eyes or eyes with your hands . step 1 step 2 step 3 step 4 step 5 step 6 step 7 step 8 step 9 step 10 step 11 step 12 step 13 step 14 step 15 step 16 step 17 step 18 step 17 remove the cap and snap collar from the bottle . twist off the cap . hold the bottle , pointing down , between your fingers . tilt your head back . pull down your eyelid with a clean finger
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : if you have a reaction to the medicine ( frequency not known ): signs of an allergic reaction may include severe skin reactions , rash , redness or itching all over your body and / or eyes trouble breathing , chest pain , or irregular heart beat . contact your doctor immediately if you experience extreme tiredness or dizziness . other side effects have been reported with simbrinza in combination with other medicines containing brinzolamide or brimonidine . common side effects ( may affect up to
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . the first 4 weeks after first opening the bottle to prevent infections . store in the original package in order to protect from moisture . once opened the bottle , use a new bottle immediately .
what simbrinza contains - the active substances are brinzolamide and brimonidine tartrate . each ml of suspension contains 10 mg of the active substance , as well as 5 mg of brin zolamide ( as an add - on ) and 2 mg of bimonidine titrate equivalent to 1 . 3 mg / ml . - the other ingredients are : brionidine , benzalkonium chloride ( see end of section 2 under ' important information about some of the ingredients of simbrginza '), benzalkonaium chloride , propylene glycol , carbomer 974p ,
filgrastim ratiopharm is a medicine that contains the active substance filgrastam . filgrasterim is a protein produced by biotechnology in the body called escherichia coli . it belongs to a group of proteins called cytokines , and is very similar to a natural protein ( granulocyte - colony stimulating factor [ g - csf ]) produced by your own body but has a different structure and structure than natural proteins ( g - csf , g - dsf , gsk , gdf , granulocytes ) produced by the bile ducts of the bone marrow . fil
you must not be given filgrastim ratiopharm : if you are allergic ( hypersensitive ) to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if you have ever had a cough , fever or difficulty breathing , as these may be signs of a pulmonary disorder ( see section " possible side effects "). if you suffer from sickle cell disease 57 if you get left upper abdominal pain ( pain at the tip of your shoulder ) as this may be a sign of a sp
filgrastim ratiopharm will be given to you by a doctor or nurse who is experienced in the care of patients who are not able to take the medicine . your doctor will explain to you how to prepare and administer filgrastime ratiopharm . how often will you be given ? your doctor may decide to delay or stop your treatment depending on how well you respond . the recommended dose of filgrasterim ratitopharm treatment for adults with advanced stage of chemotherapy is 0 . 5 mg / kg body weight once daily for 60 days . this will be repeated every 30 days . your treatment will
you must not be given filgrastim ratiopharm : if you have sickle cell disease 57 if you get left upper abdominal pain or pain at the tip of your shoulder . if you suffer from a spleen disorder . see section 4 . possible side effects . your doctor will do regular blood tests before and during treatment . your child will be tested for neutrophils ( a type of white blood cells ) in your blood before treatment . children and adolescents this medicine is not recommended for use in children or adolescents under the age of 18 years because there is no experience with the use of this medicine in this age group
keep out of the reach and sight of children . do not use filgrastim ratiopharm after the expiry date which is stated on the carton and on the blister after exp . store in a refrigerator ( 2 8 ). do not freeze . filgrasteim ratisopharm may become cloudy if it is accidentally frozen . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what filgrastim ratiopharm contains - the active substance is filgrasterim . each ml of solution for infusion contains 60 mg of filgrasim . - each pre - filled syringe containing 30 ml of liquid solution for injection contains 30 million international units [ iu ] ( 1 . 5 mg / ml ] ( 2 . 5mg / ml ) filgrasteim ratiopharm 48 micrograms / 0 . 8 ml ( 48 microlitres ) the other ingredients are : sodium hydroxide , glacial acetic acid , sorbitol , polysorbate 80 and water
what riluzole zentiva is and what it is used for the active substance in this medicine is called lusutamide . lusetamide is a substance that belongs to a group of substances called cytokines , which are involved in the nervous system . what rilsuzolezentiva works by blocking the activity of the cytokines in the nerve cells , causing weakness , muscle waste and paralysis . the destruction of nerve cells in motor neurone disease may result in too much glutamate ( a chemical messenger ) in the brain and spinal cord , which can lead to problems such as too low levels of glutamate in
do not take riluzole zentiva : if you are allergic to rilizole or any of the other ingredients of this medicine ( listed in section 6 ). if you have any liver disease or increased blood levels of some enzymes of the liver called transaminases . if you think you may be pregnant or are planning to have a baby , ask your doctor or pharmacist for advice before taking this medicine . warnings and precautions talk to your doctor , pharmacist or nurse before taking any of these medicines if : you have yellowing of your skin or the whites of your eyes ( jaundice ), itching , feeling
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . the tablets should be taken by mouth at about the same time each day . if you take more riluzole zentiva than you should if you accidentally take too many tablets , contact your doctor , pharmacist or your nearest hospital emergency department immediately . if possible , show the doctor your pack of tablets . do not take a double dose to make up for a forgotten tablet . take the next tablet at the usual time . if necessary , your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : fever ( increase in temperature ) during treatment with riluzole zentiva . this may be due to a decrease in the number of white blood cells . your doctor will take a blood sample to check for these changes . if you notice any of the following symptoms : yellowing of your skin or the whites of your eyes ( jaundice ), itching , feeling sick or being sick . these may be signs of liver disease ( hepatitis ). your doctor may do regular blood tests while you are taking r
what riluzole zentiva contains - the active substance is rilanuzole . - the other ingredients are : tablet core : anhydrous dibasic calcium phosphate , micro crystalline cellulose ( e460i ), an hydrous colloidal silica , magnesium stearate . tablet coating : croscarmellose sodium , hypromellose , macrogol 6000 , titanium dioxide ( e171 ). not all the ingredients in the tablet core may be present in trace amounts as e . g ., white to off - white , round , biconvex , with a diameter of 50
emgality contains the active substance galcanezumab . this is a medicine that blocks the activity of a protein called calcitonin gene ( cgrp ). migraine is a condition in which the body produces increased levels of Cgrp . emgality is used to treat migraine in adults , adolescents and children aged 4 years and older . migraines have been reported in these patients . your doctor has determined the frequency of migraine headache and how often you should seek medical help to improve your quality of life . if you have any further questions on the use of this product , ask your doctor or pharmacist .
do not use emgality : if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious cardiovascular disease warnings and precautions serious cardiovascular diseases allergic reactions ecgality may cause serious allergic reactions . these reactions may occur within 40 minutes of a serious allergic reaction . you should see your doctor immediately if you experience such signs or serious side effects as described in section 4 . children and adolescents this medicine is not recommended for use in children or adolescents under the age of 18 years . other medicines and emgsality tell your doctor or pharmacist if
always use emgality exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one 240 mg tablet once daily . your doctor will decide the dose you need based on your weight and body surface area ( subcutaneous injection ). your doctor may decide to change the dose of the medicine you are using , depending on your condition and on how you respond to it . after proper training , your doctor can give you the desired dose of 240 mg . do not take a double dose to make up for a forgotten dose . if you use more em
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions to emgality may include rash and itching . serious allergic reactions ( rare , may affect up to 1 in 1 , 000 people ): difficulty breathing or swallowing , low blood pressure , dizziness or light - headedness , swelling of the neck , face , mouth , lips , tongue or throat , severe itching of the skin , a red rash and raised bumps . other side effects very common side effects ( may affect more than 1 in 10 people ): injection site pain . injection site reactions may include red skin , itching ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . after first opening the vial : store in a refrigerator ( 2 8 ). do not freeze . store in the original carton in order to protect from light . after dilution , the product may be stored for up to 8 days in the outer carton at temperatures up to a maximum of 7 and away from direct heat ( up to 30 ) for a single period not exceeding 30 days . do
what emgality contains - the active substance is galcanezumab . each pre - filled pen contains 120 mg of galcaneszumaab in 1 ml solution . - the other ingredients are l - histidine , l- histidine hydrochloride monohydrate , polysorbate 80 , sodium chloride , and water for injections . what emgonality looks like and contents of the pack emgalis is presented as a solution for injection in a clear glass syringe . the solution is colourless to slightly yellow . the syringe is supplied in single - dose pen packs of 1 , 2 , 3
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition called hepatic veno - occlusive disease ( hav ) in which the blood vessels in the liver become damaged and clogged with blood clots . it may be given to you by your doctor or nurse , or by medicines you have received prior to a stem cell transplantation . your doctor will tell you how many days of treatment you need . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse .
do not use defitelio : if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ) if you have been taking other medicines to prevent blood clots ( tissue plasminogen activator warnings and precautions ) if any of these apply to you , tell your doctor or nurse before using this medicine . if you suffer from bleeding , especially heavy bleeding , if you need a blood transfusion ( such as surgery ), if you or your family have problems with blood circulation and you have a constant blood pressure ( see section 1 ). if you take other medicines ( medicines
the treatment with defitelio will be started by a doctor who is experienced in the use of stem cells transplantation . it will be given by infusion into one of your veins ( known as an ' intravenous infusion ') or drip . the duration of this treatment is 21 days . if your symptoms do not improve after this 21 day period , your doctor may decide to permanently stop the treatment . if you are more than 18 years of age , you should not be given more than once a day . if any of the above applies to you , tell your doctor , nurse or pharmacist before you are given more defit
like all medicines , defitelio can cause side effects , although not everybody gets them . if any of the side effects gets serious , or if you notice any side effects not listed in this leaflet , please tell your doctor or pharmacist immediately . very common ( may affect more than 1 in 10 people ): low blood pressure . this may affect up to 1 in every 10 people . bleeding in general bleeding , including the nose bleeding , the brain bleeding , and the gut vomiting blood bleeding from the lungs bleeding from blood in the urine , the mouth bleeding , or the skin coagulopathy ( disturbance in blood clotting
keep this medicine out of the sight and reach of children . do not use defitelio after the expiry date which is stated on the carton and on the vial label after exp . this medicine does not require any special storage conditions . the infusion storage should be completed within 24 hours of dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 2 hours at 2 - 8 unless dilution has taken place in controlled and validated aseptic conditions . do this if you notice that the solution is cloudy or contains particles
what defitelio contains - the active substance is defibrotide . each ml of solution contains 2 . 5 mg or 200 mg of defabrotide ( as besilate ). each ml solution contains 80 micrograms ( 23 . 0 mg ) of defibotide . - the other ingredients are sodium citrate dihydrate , hydrochloric acid , sodium hydroxide ( for ph - adjustment ) and water for injections . see section 2 " defitelsio contains sodium " for further information . solvent vial : powder for concentrate for solution for infusion . pack size of 10 vials of
daklinza contains the active ingredient daclatasvir , which is used to treat hepatitis c , an infectious disease that affects the liver caused by the hepatitis c virus . this medicine works by blocking two different proteins that are involved in the blocking of these proteins , called the helicase 2 and helicase 3 . by blocking both of these protein - 2 proteins , this medicine stops both of them from coming into contact with each other and stops them from infecting each other again . by preventing hepatitis cirus from entering the body , the virus is eliminated from your blood . daklinz may be used in combination with
do not take daklinza : if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 ) if you have taken by mouth the following medicines : phenytoin , carbamazepine , oxcarbazepine and phenobarbital ( used to prevent epileptic seizures ) rifampicin , rifabutin and rifapentine ( antibiotics to treat tuberculosis ) dexamethasone ( a steroid used to treat allergic and inflammatory diseases ) medicines containing st . john ' s wort ( hypericum perforatum
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of daklinza is one 60 mg tablet once a day . do not chew , crush or split the tablet to avoid unpleasant taste . your doctor will tell you how many tablets to take each day . some other medicines may be more suitable for you . if you have any further questions on the use of this medicine , ask your doctor , pharmacist , or nurse . how long to take and how long you should continue to take it ? if you take dak
like all medicines , this medicine can cause side effects , although not everybody gets them . when daklinza is used in combination with sofosbuvir or ribavirin , the following side effects have been reported : very common ( may affect more than 1 in 10 people ): headache fatigue common ( likely to affect up to 1 in every 10 people ) difficulty sleeping dizziness migraine nausea ( feeling sick ) diarrhoea abdominal pain joint pain aching or tender muscles have also been reported in patients treated with either of the two active substances ( dakhlinza and sofosebuvir ) in combination of ribav
what daklinza contains - the active substance is daclatasvir . each film - coated tablet contains 30 mg or 60 mg of daclaasvir ( as dihydrochloride ). - the other ingredients are : tablet core : anhydrous lactose , microcrystalline cellulose , croscarmellose sodium , silicon dioxide , magnesium stearate . tablet coating : hypromellose , titanium dioxide ( e171 ), macrogol 400 , indigo carmine aluminum lake ( e132 ) and yellow iron oxide ( e172 ) 51 what the tablets look like and contents of
proquad is a vaccine that helps protect against measles , mumps , rubella , chickenpox ( varicella ) viruses . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will produce antibodies against the diseases , including mumps and rubella . these are usually caused by the same types of varicellis viruses . the antibodies help to prevent diseases caused by these viruses . how proquad works proquad causes the body to produce its own protection ( antibodies ) against several different types of diseases . these viruses are then grown in chicken eggs . proquad helps to protect against
do not receive proquad - if you are allergic to any varicella vaccine , measles , mumps or rubella vaccine , or any of the other ingredients of this vaccine ( listed in section 6 ) - if your doctor has told you that you have a blood disorder ( a type of cancer that affects the immune system ) or you are receiving treatment with medications that suppress your immune system ( e . g . low - dose corticosteroid therapy , asthma or replacement therapy ). warnings and precautions talk to your doctor or pharmacist before receiving proquad if you have : - a weakened immune system - a disease ( including aids
proquad is given as an injection into a muscle ( subcutaneously ) under the skin ( usually in the thigh or upper arm ). injections will be given into the muscle of the thigh area or into the upper arm . if you have a blood clotting disorder or low levels of platelets , the vaccine should not be given . injecting into the skin may increase the risk of bleeding or damage to the muscle . proquad will not be injected into a blood vessel . your doctor or nurse will show you how to inject proquad . children and adolescents proquad is intended for use in children aged 9 months to less than 12 years
like all vaccines and medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions ( hives ) these reactions may cause difficulty in breathing or swallowing . if you experience signs of an allergic reaction , contact your doctor immediately . other side effects that have been reported with proquad include : uncommon ( may affect up to 1 in 100 people ): seizures ( fits ) with a fever rare ( likely to affect less than 1 in 1 , 000 people ): bronchiolitis ( difficulty breathing , cough , unsteadiness with walking ) other possible side effects of proquad : very common : may affect more than 1
what proquad contains - the active substances are : measles virus1 , edmonston strain , 3 . 00 mg mumps virus1 ( jeryllynn™ level b ) strain , 4 . 30 mg rubella virus2 , strain 3 .00 mg varicella virus3 , merck strain ( 3 . 99 mg mrc ). - the other ingredients are : powder sucrose , hydrolysed gelatin , urea , sodium chloride , sorbitol ( e420 ), monosodium glutamate , sodium phosphate , sodium bicarbonate , potassium phosphate , potassium chloride 199 what proquad looks like and contents of the
jylamvo is an anticancer medicine which reduces unwanted reactions . it is an immunosuppressive agent . it acts on the body ' s own immune system ( immune system ) and neutralizes its own inflammatory activity . it belongs to a group of medicines called cytokines , and is used for the treatment of rheumatic and skin diseases : - active rheumatoid arthritis with polyarthritic forms of joints - severe juvenile idiopathic arthritis ( jia ) in children 3 years of age and older . - non - steroidal anti - inflammatory drugs ( nsaids ) used to treat inadequate o severe
do not use jylamvo : if you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ) if you have a severe kidney impairment or a liver impairment if you suffer from blood disorders ( e . g . bone marrow hypoplasia , leukopenia , thrombocytopenia , significant anaemia ) 34 if your body has a weakened immune system and you have ever had a serious infection such as tuberculosis ( hiv ) or ulcers in the stomach or intestines ( an inflammation of the mucous membrane of the mouth ) or mouth ul
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jylamvo can cause severe side effects , sometimes leading to even death . your doctor will discuss these with you and will adjust the dose and duration of the treatment . rheumatoid arthritis severe juvenile idiopathic arthritis severe psoriasis severe psoriatic arthritis if you have any of the above conditions , your doctor may suggest that your doctor give you a lower dose ( 0 . 5 mg / m2 ) once a week , as part of a long - term treatment . how j
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : wheeziness , difficulty in breathing , swelling of the eyelids , face or lips , rash or itching all over your whole body . other possible side effects include breathing problems , feeling of illness , dry , irritating cough , shortness of breath , difficulty or breathing , chest pain ( fever ), spitting or coughing blood , serious peeling or blistering of the skin unusual bleeding ( vomiting blood ), bruising nose bleeds nausea , vomiting , abdominal discomfort severe diarrhoea mouth ulcers , black or tarry
keep this medicine out of the sight and reach of children . do not use the medicine after the expiry date which is stated on the carton and on the vial label after exp . store below 25 . store in the original package in order to protect from light . the medicine should be used immediately after dilution . in the event of accidental spillage , chemical and physical in - use stability has been demonstrated for 3 hours prior to administration . any unused medicine or waste material should be disposed of in accordance with local requirements for cytotoxic products .
what jylamvo contains - the active substance is methotrexate . each ml of solution contains 2 mg of metotrexate ( as besilate ). - the other ingredients are macrogol 400 , glycerol , orange flavour , sucralose , ethyl parahydroxybenzoate ( e218 ), water for injections , sodium methyl parahydroxybenzzoate , citric acid , tri - sodium citrate , purified water . see end of section 2 " important information about some of the ingredients of jrylamvo " ( see endof section 2 for further information ). what
this medicine contains the active substance glycopyrronium bromide , which belongs to a group of medicines called bronchodilators . this medicine is used to help breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). in copd , the muscles around the airways tighten . this makes breathing difficult . using this medicine reduces the tightening of these muscles in the lungs , making it easier for air to get in and out of the lungs . if you use this medicine regularly , it will help to reduce the effects of copd on your everyday life .
do not use enurev breezhaler : if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). if you suffer from kidney problems . if you have an eye problem called narrow - angle glaucoma ( difficulty passing urine ). if any of these apply to you , tell your doctor or pharmacist before treatment is started . warnings and precautions talk to your doctor , pharmacist , or nurse before using this medicine : - if you experience tightness of the chest , coughing , wheezing or breathlessness immediately after using enure
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one inhalation once a day . this medicine should be used within 24 hours of your last meal . your doctor will tell you how many capsules to use and how long you should continue to use it . the maximum recommended daily dose is 75 inhalations per day . do not use more than this recommended dose . how to use enurev breezhaler this medicine comes as an inhaler and capsules ( in blisters ) that contain the medicine as inhalation
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious : very common ( may affect more than 1 in 100 people ): irregular heart beat high level of blood sugar ( hyperglycaemia ). typical symptoms are excessive thirst , hunger ( frequent urination ), rash , itching , hives , difficulty breathing , swallowing or dizziness . allergic reaction may include swelling mainly of the tongue , lips , face or throat ( angioedema ). if any of the side effects gets serious , or if you notice any side effects not listed in this leaflet , please tell your doctor
what enurev breezhaler contains - the active substance is glycopyrronium bromide . each hard capsule contains 63 micrograms of glycoprroniumbromide ( equivalent to 50 milligrams glycopyronium ). the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 milligram ( i . e ., one millilitre ) per kilogram of body weight each day . - the other ingredient in the inhalation powder is lactose monohydrate ( see section 2 ), magnesium stearate ( e470b ). what
riximyo contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to a specific target in a certain type of white blood cell called " b - lymphocyte ". by sticking to the target of the protein , riximyo slows down the rate of growth and the progression of the disease . your doctor will tell you how long you should continue the treatment . what are the other conditions that you need to look out for ? ruximyo is used to treat : a ) non - hodgkin ' s lymphoma this is
do not use riximyo : - if you are allergic to rituximab , other proteins that are derived from the needles of yew trees , or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : - you have a severe active infection at the moment , or have a weak immune system - you suffer from severe heart failure or severe uncontrolled heart disease - you are suffering from granulomatosis , polyangiitis , microscopic polyangiaitis or pemphigus vulgaris .
you will be given riximyo under the supervision of a doctor who is experienced in the use of this treatment . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you have any side effects , your doctor may decide to change your dose . your doctor will decide how many treatments you will receive . your first course of rriximyo is given as a drip ( intra - venous infusion ) into a vein . medicines given at the same time of each riximusyo administration you will also be given other medicines ( premedication )
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion , fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number of platelets
what riximyo contains - the active substance is rituximab . each 10 ml vial contains 100 mg of ritukimab ( 10 mg / ml ). each 50 ml vials contains 500 mg of dl ( 3 . 0 milligrams / ml ), of which at the end of the vial the amount is as follows : one ml of solution for infusion : one vial of 10 ml . - the other ingredients are : sodium citrate , polysorbate 80 , sodium chloride , sodium hydroxide , hydrochloric acid ( see section 2 " riluximyo
topotecan actavis is a medicine that contains the active substance topotecaan . it is used to treat the following conditions : - small cell lung cancer that has come back after chemotherapy - advanced cervical cancer that cannot be treated by surgery or radiotherapy . in this case topotecen actavis treatment is combined with medicines containing cisplatin .
do not use topotecan actavis - if you are allergic to topoteecan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if you : - are breast - feeding . your doctor will check your blood cell counts regularly . if they are too low , your doctor may decide to reduce the dose of the medicine you are taking . - have any kidney problems . if any of these apply to you , tell your doctor or pharmacist before you are given this medicine . see section " other medicines and topot
your doctor will determine the dose of topotecan actavis you will receive based on the severity of the disease and on results of blood tests carried out during treatment . the recommended dose of treatment for adults small cell lung cancer is 1 . 5 mg per square metre of body surface area once daily for 5 days . this treatment cycle will be repeated every three weeks . for cervical cancer , the usual dose is 0 . 75 mg per sq metre of surface area twice daily for 3 days . your doctor will decide on the dose that is right for you . your dose will depend on your condition and on which other anticancer medicines you
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects stop taking topotecan actavis and tell your doctor straight away if you notice any of the following serious sideeffects : infections very common ( may affect more than 1 in 10 people ): fever . this may be a sign of your general condition ( local symptoms such as sore throat , burning sensation , severe stomach pain , fever , diarrhoea ). bowel inflammation ( neutropenic colitis ) has been reported in patients treated with either of these active substances , or after they have been taken with topotecaan actingavis
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the vial after exp . store in a refrigerator ( 2 8 ). do not freeze . the drug product solution for reconstitution / dilution chemical and physical in - use stability has been demonstrated for 24 hours at 25 ± 2 and from 2 to 8 when stored in the refrigerator . from a microbiological point of view , the product solution should be used immediately . dilution in solutions for infusion ( nacl 0 . 9 %) glucose 5 mg /
what topotecan actavis contains - the active substance is topotan . each vial contains 1 mg or 4 mg of topotecaan ( as hydrochloride ). after reconstitution with 1 ml of water for injection , 1 mg / ml of solution contains 10 mg / m2 of the content of the vial . - the other ingredients are mannitol ( e421 ), tartaric acid , hydrochloric acid and sodium hydroxide ( see section 2 ). whattopotecans actavis looks like and contents of the pack topoten actavis is a clear , colourless
ralgmine hexal contains the active substance rivastigmine , which belongs to a class of substances called cholinesterase inhibitors . in patients with alzheimer ' s dementia or dementia due to parkinson ' s disease , certain nerve cells die in the brain , resulting in low levels of the neurotransmitter acetylcholine ( a substance that allows nerve cells to communicate with each other ). rivaldigmine works by blocking the enzymes that break down acetyllcholine : acetylchlorolinescerase and butyrylcholinesternase . by blocking these enzymes , r
do not take rivastigmine hexal : - if you are allergic to the active substance in this medicine or any of the other ingredients of this medicine ( listed in section 6 ). if you have had a previous skin reaction ( allergic contact dermatitis ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine . if any of these apply to you ( or you are not sure ), talk to the doctor or pharmacist before being given the product . if you suffer from : - irregular or slow heartbeat . - an active stomach ulcer . - difficulties in passing urine . - seizures .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to start treatment your doctor will tell you what dose of rivastigmine hexal to take . treatment usually starts with a low dose . your doctor may gradually increase your dose depending on how you respond to treatment . the highest dose that should be taken is 6 . 0 mg per kg of body weight each day . you should continue taking this medicine until your doctor tells you otherwise . if you have not taken more than three days of this medicine , do not take the next dose until you have
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following side effects . your doctor may need to change your medicine or stop it temporarily . the side effects are : very common ( may affect more than 1 in 10 people ) feeling dizzy loss of appetite stomach problems such as feeling sick ( nausea ) or being sick ( vomiting ) diarrhoea common ( might affect up to 1 in every 10 people ): anxiety sweating headache heartburn weight loss stomach pain feeling agitated feeling tired or weak generally feeling unwell trembling or feeling confused decreased appetite nightmares uncommon
keep out of the reach and sight of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and on the blister after exp . store below 30 . store in the original package in order to protect from moisture .
what rivastigmine hexal contains 64 - the active substance is rivetigmine hydrogen tartrate . - the other ingredients are : hypromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin , yellow iron oxide red iron oxide ( e172 ), titanium dioxide ( e171 ) and shellac . each vial contains 1 . 5 mg hard capsules . the other ingredient is : capsule content : capsule contents : capsule shell : shellac , hard capsules : capsule shells : capsule size : 1 . 25 mg hard capsule : capsule shape : capsule
cabometyx is a cancer medicine that contains the active substance cabozantinib . it is used to treat adults with kidney cancer ( renal cell carcinoma ) or liver cancer that has not responded to a specific anticancer medicine containing sorafenib . cabometyx works by blocking the action of proteins called receptor tyrosine kinases ( rtks ), which are involved in the development of new blood vessels . by blocking these proteins , the medicine can kill high amounts in cancer cells . if you have any questions about why this medicine has been prescribed for you , ask your doctor .
do not take cabometyx 45 - if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking cabomety 45 if you : - have high blood pressure - have or have had an aneurysm ( enlargement or weakening of a blood vessel wall ) or a tear in a blood valve wall - have diarrhoea - have recently had significant bleeding or surgery within the last month - have had surgical procedures or dental surgery - have inflammatory bowel disease - have crohn ' s disease
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . this medicine is for oral use . swallow the tablet whole with a glass of water . you may take cabometyx with or without food . your doctor may reduce your dose or stop your treatment temporarily if you experience serious side effects . duration of treatment your doctor will tell you how long you should continue taking cabometx . the usual starting dose is 60 mg cabomety twice a day for 2 weeks . you should usually start treatment at the same time
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with cabometyx : your doctor may prescribe other medicines to help control your side effects . tell your doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : symptoms include pain in the abdomen ( nausea , feeling sick ), vomiting , constipation and fever . these may be signs of a gastrointestinal perforation ( a hole in the stomach or intestine ). severe or uncontrollable bleeding . symptoms include vomiting blood , black stolls , bloody urine , headache , coughing up blood ,
what cabometyx contains - the active substances are cabozantinib and malate . each tablet contains either 20 mg cabozatinib ( s ) or malate ( 20 mg / ml ). each tablet is coated with a white to off - white lyophilised powder and contains a clear , colourless to pale yellow solution . - each tablet also contains a yellowish to pale brownish - yellowish - orange powder . - the other ingredients are tablet core ( tablet core ) : caboxyx 40 mg : the active substance is cabozutinib ; malate : each tablet consists of 60
pemetrexed hospira is a medicine used in the treatment of cancer . it is used in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . pemetrexED hospira will also be given to you by your doctor as an injection into the lung ( intravascularly ) before the initial treatment of patients with advanced stage of lung cancer . your doctor will decide how long you should be treated with pemrexedospira . if
do not use pemetrexed hospira : - if you are allergic ( hypersensitive ) to any of the active substances or any of those in this medicine ( listed in section 6 ). - if breast - feeding is not recommended during treatment . warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . children and adolescents do not give this medicine to children less than 6 months of age . breast -feeding should be stopped during treatment with pemrexedospira . if you have recently received or are about to receive a vaccine against yellow fever , your doctor will decide whether you should receive pemet
the recommended dose of pemetrexed hospira is 500 mg for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of the body . your doctor will work out this body surface area according to your weight and will determine the dose you should receive . treatment may be delayed depending on your blood cell counts and on your general condition . the hospital pharmacist or nurse will have mixed the pemetrewn hospira powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution for injection before it is given to you . you will be given pemet
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience any of the following : fever or infection ( common ): if you have a temperature of 38ºc or greater , sweating or other signs of infection ( since you may have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death : chest pain with a fast heart rate . pain , redness , swelling or sores in your mouth . allergic reaction : if you develop skin rash ( often with burning or prickling sensation ) or fever (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . infusion solution : chemical and physical in - use stability of the product has been demonstrated for 24 hours at refrigerated temperature . the reconstituted solution should be used immediately . parenteral medicines : if there is discolouration prior to administration , the product should be administered immediately . this medicine is for single use only . any unused solution must be discarded .
what pemetrexed hospira contains the active substance is pemetrehydrate . each vial of pempholed hospira 100 mg contains 100 milligrams of pemeterehyd ( as pemetretrexed disodium hemipentahydrate ). each single - use vial ( 500 mg ) contains 500 milligram of petrexed ( as pyrexed dispersion dihydrate ). the total recommended daily dose of the combined product is 1 , 000 mg . your doctor will decide on the dose that is right for you . the doctor will prescribe the most appropriate dose for you
ganfort contains two active substances called bimatoprost and timolol , which work together to reduce pressure in the eye . both belong to a group of medicines called prostamides . each contains a prostaglandin analogue ( analogue ) that is identical to the one in your eye . bimotoprost belongs to medicines called beta - blockers . what ganfort looks like and contents of the pack the eye is a clear , watery liquid . it is supplied in a clear glass eye drop . the clear liquid is injected into the eye by your eye specialist . the eye specialist has prescribed gan
do not use ganfort eye drops : if you are allergic to bimatoprost , timolol or beta - blockers ( see section 6 ) if you have respiratory problems such as asthma or severe chronic obstructive bronchitis or severe lung disease ( signs include wheeziness , difficulty in breathing and long - standing cough ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if you suffer from coronary heart disease ( symptoms include chest pain , tightness , breathlessness or choking ). heart failure has been reported in patients with low blood pressure 44 ( disturbances of heart rate , slow heart
always use ganfort exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one drop in your eye once a day , at the start of treatment . keep the bottle tightly closed in order to protect from moisture . do not put the bottle close to your neck . 5 . gently squeeze the bottle . 1 . wash your hands . tilt your head back . 2 . pull down your eyelid until there is a small pocket . 3 . put your eye back in place for a few minutes before you start treatment . 4 . close the lid of your eye .
like all medicines , ganfort can cause side effects , although not everybody gets them . stop using the drops and see a doctor straight away if you notice any of the following serious side effects after using a single dose ( multi - dose or single - dose ). very common side effects ( may affect more than 1 in 10 people ) - the eye redness . uncommon side effects these may affect up to 1 in 9 people or 100 people - sensitivity to light , eye pain , sticky eyes , dry eyes , feeling of something in the eye , small breaks in the surface of the eye ( inflammation ), difficulty in seeing clearly , red
keep this medicine out of the sight and reach of children . do not use ganfort after the expiry date which is stated on the carton and on the label after exp . this medicine does not require any special temperature storage conditions . if you are concerned about eye infections , you should contact your doctor straightaway ( see section 4 ). do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what ganfort contains - the active substance is bimatoprost ( 0 . 3 mg / 0 . 5 ml ) timolol . each ml of solution contains 5 mg of the same active substance as in the vial . - the other ingredients ( excipients ) in the solution are : - core : timolov maleate 6 . 8 mg - solvent : benzalkonium chloride ( a preservative ), sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate , purified water , hydrochloric acid and sodium hydroxide . what gansfort
gefitinib mylan contains the active substance gefitinib . it blocks the activity of a protein called epidermal growth factor receptor ( egfr ). this protein is involved in the growth and spread of cancer cells and is present in large amounts in patients with advanced stage of non - small cell lung cancer . this cancer is a disease in which malignant ( cancer ) cells form in the tissues of the lung .
do not take gefitinib mylan : if you are allergic to gefitoninib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if you : - have or have had any other lung problems . some lung problems can be serious and need medical attention . your doctor may need to adjust your dose of gefnitinib melan . - have problems with your liver . your dose should be adjusted before you start taking gefinib . children and adolescents do not give this medicine to
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 250 mg tablet once a day . you can take the tablet with or without antacids on an empty stomach ( see section 2 " gefitinib mylan contains lactose "). try to take your tablet at about the same time each day . if you have trouble swallowing the tablet whole , talk to your doctor . do not take any other liquids until your doctor tells you otherwise . the tablet should be swallowed whole with a glass of water , preferably within 20 minutes
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : allergic reaction with symptoms such as swollen face , lips , tongue or throat , difficulty to swallow , hives , nettle rash , difficulty breathing , serious breathlessness , sudden worsening breathlessness with a cough or fever . these may be signs of an inflammation of the lungs known as ' interstitial lung disease ' ( i . e . uncommon , may affect up to 1 in 100 people ). gefitinib may cause severe skin
what gefitinib mylan contains - the active substance is gefinib . each film - coated tablet contains 250 mg of gefginib . - the other ingredients are : tablet core : lactose monohydrate , microcrystalline cellulose , crospovidone ( type a ), povidaone ( k30 ), sodium laurilsulfate , magnesium stearate . tablet coating : polyvinyl alcohol , macrogol 4000 , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide red ( e 172 ). what gefitoninib melan
reblozyl contains the active substance luspatercept . it is used to treat myelodysplastic syndromes ( mds ). mds is a group of many different blood and bone marrow disorders in which certain types of red blood cells become abnormal . signs and symptoms include a low red blood cell count ( anaemia ) which cannot be controlled and can be caused by the lack of a sufficient number of redblood cell transfusions . your doctor has prescribed reblozel for you to treat anaemia in patients with mds who cannot be treated and can only be treated with a sufficient amount of red
do not take reblozyl : if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be pregnant ( see pregnancy , breast - feeding and fertility ). warnings and precautions talk to your doctor or pharmacist before taking this medicine if you have thalassaemia ( a condition where the spleen removed from the body ) or have had a blood clot . your doctor may recommend hormone replacement therapy if you had a previous blood clot , or if preventive measures ( such as medicines ) are not sufficient . tell your doctor straight away if you
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will carry out blood tests before you start using reblozyl . how much to use the recommended dose is one injection under the skin ( subcutaneous use ). the doctor will tell you how much you weigh . the injections will usually last about 1 . 0 mg / kg of body weight . this dose will be adjusted by your doctor depending on your blood pressure . if you have been prescribed replozyl for the treatment of myelodysplastic syndromes the maximum single
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you have difficulty in walking or speaking , dizziness , loss of balance and coordination , numbness or paralysis in the face , leg or arm , or in other parts of the body , or blurred vision . these may be symptoms of a stroke . blood clots swelling in the area around the eyes , face , lips , mouth or tongue throat allergic reactions including rashes 36 reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . store in a refrigerator ( 2 8 ). store in the original package in order to protect from light . after reconstitution , reblozyl may be stored at room temperature ( up to 8 ) for a single period of up to 24 hours at 2 8 . from a microbiological point of view , the product should be used immediately . any unused medicinal product or waste material should be disposed of in accordance with local requirements .
what reblozyl contains - the active substance is luspatercept . each ml of solution contains 25 mg or 75 mg of luspaterscept . after reconstitution with eachml of solution , each ml contains 50 mg / ml ( 23 . 5 mg / 0 . 25 mg ) of lsuspatercept ( as excipients ). - the other ingredients are citric acid monohydrate , sodium citrate 80 , sucrose , hydrochloric acid ( for ph adjustment ), sodium hydroxide ( ( e524 ) for ph adjustment . what rebl ozyl looks like and contents of the pack
fotivda contains the active substance tivozanib , which is a protein kinase inhibitor . by inhibiting the growth and spread of the cancer , it stops the activity of cancer cells and new blood vessels forming . fotivd is used to treat adults with advanced kidney cancer when other treatments ( alpha or interleukin - 2 ) have not helped to stop your disease or have not worked .
do not take fotivda if : you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). you are breast - feeding . you are taking st . john ' s wort ( hypericum perforatum ), a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine : if you have high blood pressure . your doctor will check your blood pressure regularly . you should not take a medicine while you are being treated with this medicine . if any of these apply to you , tell your
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of fotivda is 1340 mg twice a day ( 21 mg capsules taken 7 days apart ) taken 1 capsule of capsules taken 4 times a day . your doctor will tell you how many capsules to take . if you take more fotvda than you should if you have taken too many capsules , you may experience unacceptable side effects . if severe side effects occur , your doctor may reduce the dose or stop fotrevda therapy . the recommended daily dose
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure is a very common side effect ( may affect more than 1 in 10 people ). if you notice any of the following , talk to your doctor or pharmacist immediately : - stop taking fotivda and seek medical help immediately : if you have symptoms such as severe headaches , blurred vision , shortness of breath , changes in your mental state ( e . g . feeling anxious , confused or disorientated ). your doctor may want to monitor your blood pressure more closely while you are being treated with this medicine .
what fotivda contains - the active substance is tivozanib . each tablet contains 890 mg of tivuzanib ( as tivzanib hydrochloride monohydrate ). - the other ingredients are : tablet core : 890mg tiv ozanib , mannitol ( e421 ), magnesium stearate , gelatin , titanium dioxide ( e171 ), indigo carmine ( e132 ), yellow iron oxide ( e172 ), propylene glycol ( e1520 ) and strong ammonia solution ( containing titanium dioxide , e171 ) and tartrazine aluminium lake ( e133
stribild contains two active substances : elvitegravir ( an antiretroviral medicine known as an integrase inhibitor cobicistat , which is a booster ( pharmacokinetic enhancer ) of the activity of the immune system ( the body ' s natural defences ) of elvitabine ( an antiviral medicine called a nucleoside reverse transcriptase inhibitor ( nrti ) tenofovir disoproxil ( an antitroviral medication known as a nucleotide reverse transcriptase inhibitor ) stribild is given as a single tablet regimen for the treatment of human immun
do not take stribild : - if you are allergic to elvitegravir , cobicistat , emtricitabine , tenofovir , ten ofovir disoproxil or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . during treatment , you should tell your doctor if you have taken any medicine containing the active substance of tenofovegravira . your doctor may also monitor your kidney function . these medicines may include : alfuzosin ( used to
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults and adolescents 12 to less than 18 years of age 35 the recommended dose is one tablet once a day by mouth . swallow the tablet whole with a glass of water . you can take your tablet with or without food . your doctor may change the dose of your medicine depending on how you respond to the treatment . if you take medicines called oral supplements ( such as antacids or laxatives containing minerals such as magnesium , aluminium , calcium , iron , zinc ), take the tablet at least 4 hours
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . when treating hiv infection , it is not always possible to tell whether the unwanted effects are caused by stribild or by the illness itself . serious side effects tell your doctor immediately if you experience any of the following : lactic acidosis ( excess lactic
what stribild contains - the active substances are elvitegravir , cobicistat , emtricitabine , and tenofovir disoproxil . each tablet contains 150 mg of the two active substances , as well as 300 mg of each of the other ingredients , as shown in the table below . - the other ingredient is tablet core : amitriptyline ( e487b ), tenfentanyl ( e1521 ), carnauba wax ( e553b ), croscarmellose sodium , hydroxypropyl cellulose , lactose monohydrate , magnesium st
zyprexa contains the active substance olanzapine . zyprexa belongs to a group of medicines called antipsychotics and is used to treat the following conditions : schizophrenia , a disease with symptoms such as hearing , seeing or sensing things which are not there , mistaken beliefs , unusual suspiciousness , and becoming withdrawn . people with this disease may also feel depressed , anxious or tense . moderate to severe manic episodes , a condition with symptoms of excitement or euphoria . you have been shown to have been given zkyprexa to prevent recurrence of these symptoms in patients with bipolar disorder whose manic episode has responded to
do not take zyprexa if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). an allergic reaction may be recognised as a rash , itching , a swollen face , swollen lips or shortness of breath . if you have been previously diagnosed with eye problems such as certain kinds of glaucoma ( increased pressure in the eye ). if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor , pharmacist or nurse before you are given zypyxa . some patients with dementia have had serious
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the usual dose of zyprexa tablets is one 5 mg tablet once a day . your doctor may increase your dose to 20 mg twice a day depending on your symptoms . how to take your dose your doctor will tell you how long you should continue to take it . if you take more zypoxa than you should if you have taken more tablets than you have been told to , talk to a doctor or go to a hospital straight away . you may experience the following symptoms
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you have : unusual movement ( a common side effect that may affect up to 1 in 10 people ) mainly of the face or tongue ; blood clots in the veins ( an uncommon side effect which may affect upto 1 in 100 people ) especially in the legs ( symptoms include swelling , pain , and redness in the leg ), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing . if you experience any of these symptoms seek medical advice immediately ; a combination of fever , faster breathing ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . zyprexa will be stored by the healthcare professionals at the hospital or clinic . these measures will help to protect the environment .
what zyprexa contains - the active substance is olanzapine . each zzyprexa tablet contains 2 . 5 mg , 5 mg or 7 . 5mg , 10 mg , 15 mg or 20 mg . - the other ingredients are : tablet core : lactose monohydrate , hyprolose , crospovidone , microcrystalline cellulose , magnesium stearate . tablet coating : hypromellose ( e464 ), titanium dioxide ( e171 ), carnauba wax . see the end of this leaflet for important information about the different zypxa tablet strengths .
what prolia is prolia contains denosumab , a protein ( monoclonal antibody ) that is similar to another protein that is produced naturally in the body . it is used to prevent bone loss in adult patients with osteoporosis when treatment is not suitable . prolia helps to make bone stronger by making it easier for bone to break . it reduces the amount of oestrogen in the blood , which makes bones thin and fragile . what osteopORosis is and how it is caused by the lack of enough of a female sex hormone , testosterone , or glucocorticoids , the most common
do not use prolia : if you have low calcium levels in the blood ( hypocalcaemia ) if you are allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using prolia if : you have a skin infection with symptoms such as a swollen , red area of skin on one side of your leg that feels hot and tender ( cellulitis ) you have symptoms of fever . these symptoms may be due to an allergy to latex . the needle in the pre - filled syringe contains a derivative of latex
always use prolia exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . one pre - filled syringe contains 60 ml of solution for injection , which should be given within 6 hours . it can be given as a single injection under the skin ( subcutaneous ) in the front of your thighs , abdomen or upper arm . if you use more prolia than you should if you think you may have injected too much prolia , talk to your doctor , pharmacist or nurse straight away . you can also use stickers to help you remember to use it . your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking prolia and tell your doctor straight away if you notice any of the following skin infections ( cellulitis ). these symptoms may be due to prolia : swollen , red area of skin ( usually in the leg ), which feels hot and tender . these may be symptoms of fever ( see section " warnings and precautions "). prolia may cause pain in the mouth and / or jaw , swelling or non - healing of sores in the jaw , discharge , numbness or a feeling of heaviness , or loosening of a tooth .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the label of your pre - filled syringe after exp . this medicine does not require any special storage conditions . after first opening , the product should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 25 days at 2ºc - 8ºc unless dilution has taken place in controlled and validated aseptic conditions . however , if the injection has been
what prolia contains - the active substance is denosumab . each 1 ml pre - filled syringe contains 60 mg of denosumaab at a concentration of 60 mg / ml . - the other ingredients are acetic acid , glacial , sodium hydroxide , sorbitol ( e420 ), polysorbate 20 and water for injections . what prolia looks like and contents of the pack prolia is a clear to slightly yellow solution for injection in a ready - to - use pre -filled syringe with a needle guard . not all pack sizes may be marketed .
aimirix is a vaccine used to protect adults and children from 1 to 15 years of age against two diseases : hepatitis a and hepatitis b infection . the hepatitis a virus causes the liver to become swollen and inflamed , which can be caused by the virus . the virus infects faeces , serum or saliva . symptoms usually occur 3 to 6 weeks after infection . if you feel sick , have a fever , aches and pains , feel very tired , have dark urine , palefaeces or yellowish skin or eyes ( jaundice ). the severity and type of symptoms can vary from person to person . all
you must not be given ambirix if you are allergic to any of the active substances or any other ingredients of this vaccine ( listed in section 6 ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of your face or tongue . tell your doctor straight away if you think you may have had an allergy reaction to any vaccine . hepatitis a or hepatitis b diseases if you have a severe infection with a high temperature . the vaccine should be given at the same time as a minor infection such as a cold . warnings and precautions talk to your doctor , pharmacist or nurse before you are given
your doctor , nurse or pharmacist will give you ambirix as an injection into a muscle in the upper arm ( subcutaneous use ). your doctor or nurse will inject ambirux directly into a vein . the injection will be given into the thigh muscle . you will receive a total of two injections . the injections should be given within 12 months of the first injection . the second injection may be given between 6 and 12 months after the first . your doctor may decide to give extra doses to prevent future booster dosing . if you miss an appointment for two injections it is important that you make another appointment as soon as possible
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : allergic and anaphylactic reactions . the signs may include a rash , itchy , blistering , swelling of the eyes and face , difficulty in breathing or swallowing , a sudden drop in blood pressure and loss of consciousness . other side effects reported in clinical trials with ambirix were : common ( may affect up to 1 in 10 people ): headache loss of appetite feeling tired or irritable pain or redness where the
what ambirix contains 26 the active substance is hepatitis a virus . each 1 ml pre - filled syringe contains 720 micrograms of elisa units ( hepatitis b surface antigen ). the other ingredients are : 20 % human diploid ( mrc ), cells , aluminium hydroxide ( hydrated 0 . 05 %), saccharomyces cerevisiae , aluminium phosphate ( 0 . 4 %), sodium chloride , and water for injections . what ambiraix looks like and contents of the pack suspension for injection ( injection ) is a white , slightly milky liquid , supplied in a glass vial . ambir
besero is a meningococcal group b vaccine . bexsero is given to adults , adolescents and children from 2 years of age with disease caused by the neisseria meningitidis group b bacteria . these bacteria help to prevent infections ( such as meningitis , inflammation of the brain and spinal cord ) and sepsis ( blood poisoning ). the vaccine works by helping to protect against the disease .
do not use bexsero - if you are allergic to the active substance or any of the other ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are vaccinated . if you have a severe infection with a high temperature ( over 38 ). vaccination should be postponed until you have recovered from a minor infection such as a cold . if any of these apply to you , your doctor may postpone the vaccination until you return to your regular dosing schedule . tell your doctor if you suffer from haemophilia or any other problem that may prevent your blood from clot
always use bexsero exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one injection ( 5 ml ) in the muscle of the thigh or upper arm . your doctor will give you two injections ( 2 or 5 ml ). you will receive three injections of the vaccine followed by an additional injection ( booster ). the first injection will be given at least 2 months apart . the interval between injections will be approximately 1 month . your dose will be adjusted depending on the response to the vaccine . if you respond well to the booster , your dose may be adjusted .
like all vaccines , this vaccine can cause side effects , although not everybody gets them . stop using bexsero and tell your doctor straight away if you notice any of the following serious side effects : very common ( may affect more than 1 in 10 people ): pain / tenderness at the injection site , redness of the skin at the site of injection , swelling of theskin at the place of injection site hardness at the area of the injected site the following side effects have been reported with this vaccine : common : 10 or more common : fever , loss of appetite , or pain or tenderness around the injectionsite severe injection
what bexsero contains the active substance is recombinant neisseria meningitidis group b nhba fusion protein . 1 , 2 , 3 , 50 micrograms of recombinant nisseria manningitidis ( group b noada protein ) 1 , 3 3 , 40 microgram s recombinant neurites ( nhn ) group b fhbp fusion protein 1 , 4 , 5 , 6 , 7 , 10 , 20 , 25 microgramS . the other ingredients are : outer membrane vesicles ( e . coli cells ) produced by recombinant dna technology ( see section 2 "
nitisinone mdk contains the active substance nitisinONE . this medicine is used to treat a rare disease called hereditary tyrosinemia ( hdk ) in adults , adolescents and children from 1 year of age . due to this disease your body cannot break down the amino acid tyrosine ( amino acids are substances that are naturally present in the body ). by breaking down these amino acids , you remove them from your body . by reducing the amount of the harmful substances , this medicine helps to break down tyrosrine and help to lower the body ' s levels of low tyrorosine and phenyl
do not take nitisinone mdk - if you are allergic to nisinone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . pregnancy , breast - feeding and fertility you should tell your doctor if you have or have had any problems with your eyes during or shortly after your treatment . during or immediately after your first dose , you should have an eye examination . you may be at increased risk of eye problems due to inadequate dietary control . see section 4 for more information . your doctor may decide to stop the
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . treatment with this medicine will be started by a doctor who is experienced in the treatment of the disease ( hereditary tyrosinemia type 1 ). the recommended starting dose is 1 mg for every kg of body weight . this dose may be increased to a maximum of 20 mg for this patient population . swallow the capsules whole with a small amount of water or formula diet . if you take more nitisinone mdk than you should if you accidentally take too many capsules , contact your doctor immediately . if possible
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicinal product does not require any special storage conditions . after first opening the vial may be stored for a maximum of 2 weeks at a temperature not above 25 . store in the original package in order to protect from moisture .
what nitisinone mdk contains - the active substance is nisinone . each hard capsule contains either 2 mg or 2 mg of ninone ( as besilate ). each capsule contains 5 mg or 5 mg nitis inone (as besilade ). - the other ingredients are gelatin , titanium dioxide ( e171 ), black iron oxide ( e172 ) and shellac glaze ( e1520 ) to help preserve the hard capsules . what you will find - the hard capsule content is white to off - white powder . the capsules are supplied in cartons containing 15 . 7 hard gelatin capsules .
docetaxel accord will be given to you by a doctor or nurse who is experienced in the use of the treatment of tumours . the name of the medicine is docetxel accord . the active substance in this medicine is a substance derived from the needles of yew trees called taxoids ( h5n1 ) used to treat breast cancer , lung cancer or non - small cell lung cancer . the other ingredients are prostate cancer , gastric cancer and head and neck cancer . in advanced breast cancer the active substances in the medicine are docetaxelo , doxorubicin , trastuzum
do not use docetaxel accord : - if you are allergic ( hypersensitive ) to any of the active substances ( listed in section 6 ) - if your number of white blood cells is too low ( below 25 - 50 - 50 ) warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . before you have been given the first dose , you will have blood tests to check that you have enough blood cells and that your liver is working properly ( see section 4 ). during the first treatment , you may experience : - a reduction in the number of red and / or yellow blood cells
docetaxel accord will be given to you by a doctor or nurse . the dose will depend on your weight and your general condition . your doctor will calculate your body surface area in square meters ( m² ) and will determine the dose you should receive . method and route of administration docetaxell accord is given as an infusion into one of your veins . the infusion will last approximately one hour during which you will be in the hospital . frequency of administration you should usually receive your infusion once every 3 weeks . based on the results of your blood tests , your doctor may change the dose and frequency of dosing depending on
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . the most commonly reported adverse reactions of docetaxel accord are reduction in the number of red blood cells and white blood cells , alopecia , nausea , vomiting , sores in the mouth , diarrhoea and tiredness . the severity of adverse events of docelaxel and other chemotherapeutic agents may be increased during the infusion . allergic reactions may occur very commonly ( may affect more than 1 in 10 people ). fl
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the vial label after exp . store below 25 . store in the original package in order to protect from light . after dilution , the medicine should be transferred from the infusion bag and used within 6 hours ( corresponding to 25 hours of infusion ). the infusion solution should be used immediately . non - pvc bags may be stored for up to 48 hours at 2 to 8 . if not used immediately , in - use storage times and conditions prior to use are the responsibility
what docetaxel accord concentrate for solution for infusion contains 20 mg film - coated tablets : each ml of concentrate contains either : 20 mg docelaxel in 1 ml of solution , each vial of concentrate containing 20 mg of docetxel . each 4 ml ( 0 . 5 %) concentrate contains 80 mg docilaxel . every 8 ml ( 1 . 8 %) or 160 ml ( 2 . 0 %) of the total solution for injection contains 160 mg docetoxel . the other ingredients are : polysorbate 80 , ethanol anhydrous ( see section 2 " docel accord
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that affect the electrical activity of the brain . one of these active substances is called ' attention stimulant '. this medicine is used to reduce the amount of impulsive or hyperactive behaviour in adult subjects . your child ' s doctor has prescribed this medicine for the treatment of ' attention deficit hyperactivity disorder ' ( adhd ) in adult patients whose current stimulant medication is not controlling adhd symptoms . the medicine is intended to be used together with a treatment programme consisting of psychological therapy , educational therapy and social therapy . intuniv
do not take intuniv : - if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking this medicine if you have low or high blood pressure . heart problems tell your doctor straight away if you think you may have heart problems . you have ever fainted or have recently had thoughts or feelings of suicide or any other psychiatric conditions ( withdrawal symptoms ). increased heart rate . you are at high risk of high bloodpressure if any of these apply to you ( or you are in any doubt at all ), talk
your treatment will be started by a doctor who is experienced in the treatment of adolescent behavioural disorders . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . your doctor will start your treatment with 1 tablet of 1 mg per day . depending on how you respond to treatment , your doctor may increase your dose to 0 . 05 mg / 0 . 12 mg twice a day depending on your bodyweight . the starting dose of treatment should be 1 tablet once daily for 7 days . if you take more intuniv than
like all medicines , this medicine can cause side effects , although not everybody gets them . if you feel unwell , stop taking your medicine and seek medical advice straight away . serious side effects tell your doctor straight away if you notice any of the following side effects : feeling drowsy , feeling dizzy ( hypotension ), slow heart beat ( bradycardia ), feeling faint , loss of concentration ( syncope ), a serious withdrawal side effect with high blood pressure . symptoms may include headaches , feeling confused , nervousness , agitation and tremors ( hypertensive encephalopathy ). if any of these side effects occur , tell your
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister pack after exp . this medicine does not require any special temperature storage conditions . the tablets should be used within one month after first opening . blister pack do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what intuniv contains - the active substance is guanfacine hydrochloride . each prolonged - release tablet contains 1 mg of guanFacine . each extended - release dose ( 2 mg ) contains 2 mg guanfuine ( see section 3 under ' important information about some of the ingredients ') - the other ingredients ( excipients ) are : capsule content : 1 mg ( 3 mg ) guanfibre : 3 mg ( 4 mg ) ( 5 mg) guanfaine ( 6 mg ) 4 mg ( 7 mg ) and 5 mg ( 8 mg ) all of the active substances
ecalta contains the active substance anidulafungin . it is used to treat adults and children from 1 to 18 years old with a type of fungal infection that affects the blood or other internal organs called invasive candidiasis . the infection is caused by fungal cells called candida ( echinocandins ). these medicines prevent serious fungal infections by preventing them from growing . ecalta works by weakening the fungal cell walls . this is called epidermal growth factor receptor ( egfr ), which is involved in the growth and spread of germs in the blood and internal organs .
do not use ecalta : - if you are allergic to anidulafungin , other echinocandins , caspofungin acetate or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . your doctor may need to monitor your liver function . if you have liver problems , your treatment may be interrupted or you may be given anaesthetics during or after your treatment . if any of these apply to you ( or you are not sure ), tell your doctor or pharmacist before you
how much ecalta is given the treatment will be given to you by a doctor or nurse who is experienced in the use of this type of medicine . the recommended dose is one 200 mg / 100 mg tablet once a day . children and adolescents 1 to 18 years of age the recommended starting dose is 3 . 0 mg / 200 mg twice a day ( 1 . 5 to 100 mg per day ). the dose may be adjusted depending on the patient ' s weight and on how well the medicine works for them . how ecaltva is given your doctor will give you a slow infusion ( a drip ) into a vein ( intraven
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects : potentially life - threatening allergic reactions , including difficulty breathing or wheezing with an existing rash . ecalta may cause serious sideeffects such as convulsion ( seizure ), flushing , rash , pruritis ( itching ), hot flush , hives , sudden contraction of the muscles , wheeezing , coughing or difficulty of breathing other side effects very common side effects ( may affect more than 1 in 10 people ): low blood potassium ( hypokalaemia
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 8 ). do not freeze . the reconstituted solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 - 8 unless dilution has taken place in controlled and validated aseptic conditions . the infusion solution may be stored at room temperature ( up to 25 ) for
what ecalta contains - the active substance is anidulafungin . each vial of powder contains 100 mg of an idulafugin . - the other ingredients are : mannitol , polysorbate 80 , tartaric acid , sodium hydroxide , hydrochloric acid 30 . what Ecalta looks like and contents of the pack ecaltfa is supplied as a box containing 1 vial containing 100 mg concentrate for solution for infusion . the powder is white to off - white .
adenovi contains the active substance rurioctocog alfa pegol , which is produced by recombinant dna technology using pegylated human coagulation factor viii ( rviii ). how adynovi works rvviii is necessary for the blood to form clots and stop bleedings . in patients with haemophilia a , factor v iii is not produced in the body and does not work as well as it should , so it is missing or not working properly . adenovi is used for the treatment and prevention of bleeding in adults and adolescents 12 years of age and older with
do not use adynovi : if you are allergic to rurioctocog alfa pegol , octocog aluminium or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before using adynov : - if you have ever had an anaphylactic reaction ( a severe , sudden allergic reaction ) to any ingredient contained in adsynovi . allergic reactions may include rash , 95 hives , wheals , generalised itching , swelling of lips and tongue
treatment with adynovi will be started by a doctor who is experienced in the care of patients with haemophilia a . your doctor will decide on the most appropriate dose for you . the dose you receive will depend on your condition and on the type of bleeding you are at risk of . the doctor will determine the dose that is appropriate for you and will prescribe the replacement therapy that is right for you ( see section 2 ). the dose of adynov depends on your body weight and the factor viii levels needed to control the severity and location of the bleeding . the usual starting dose is one tablet once a day .
like all medicines , this medicine can cause side effects , although not everybody gets them . if sudden allergic reactions ( anaphylactic ) occur , the injection must be stopped immediately . early symptoms of allergic reactions may include rash , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , wheezing , tightness in the chest , feeling of being unwell , dizziness and loss of consciousness . if severe symptoms such as difficulty in breath or fainting occur , prompt emergency treatment may be required . patients receiving previous treatment with factor viii ( more than 150 days of treatment )
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . the powder vial may be kept at room temperature ( up to 30 ) for a single period of up to 3 months . after this period , this medicine expires at the end of this 3 month period or it can be stored for a maximum of 3 months , whichever is earlier . if not used immediately ,
what adynovi contains the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains nominally 250 , 500 , 1000 or 2000 iu of the active ingredient , ruriolocog alpha pegol . the solvent vial provides 5 ml of sterilised water for injections . the other ingredients are mannitol , trehalose dihydrate , histidine , glutathion , sodium chloride , calcium chloride diydrate , tris ( hydroxymethyl ) aminometh
rekovelle contains follitropin delta , a follicle stimulating hormone ( fsh ), which belongs to a group of hormones called gonadotropins . fsh is produced naturally in the body by the body and is very similar to a natural hormone ( hormones ) produced naturally by your own body . reproduction is a process in which the body produces its own hormones , called gonadsotropins , which are involved in the reproduction of women . recovelle is used to stimulate female fertility in women undergoing assisted reproduction programs ( i . e . in vitro fertilisation ( ivf ) or intracytoplasm
do not use this medicine if any of the above apply to you . if you are not sure , talk to your doctor , pharmacist or nurse before using rekovelle . warnings and precautions you should tell your doctor if : you have or have had your fertility problems . you are allergic to follicle stimulating hormone ( fsh ). you have enlarged ovaries , cysts on your ovaries ( polycystic ovarian disease ), bleeding from the vagina ( an early menopause ), malformations of the sexual organs ( see section " pregnancy , breast - feeding and fertility "). you have fibroids of the uterus
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the rekovelle dose will be given to you at the start of your first treatment cycle . your doctor will prescribe a type of anti - müllerian hormone to stimulate your ovaries to produce more stimulation with gonadotropins . the dose will depend on the amount of medicine in your blood and your body weight . you will be asked to take a blood sample during the last 12 months of treatment to measure how well the medicine is working and to adjust the dose of treatment based on your
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects caused by hormones ( infertility ) this medicine may cause a high level of activity in the ovaries ( ovarian hyperstimulation syndrome ). symptoms may include pain , discomfort , swelling of the abdomen , nausea , vomiting , diarrhoea , weight gain and difficulty breathing . if you notice any of these symptoms seek medical advice straight away . a side effect that may affect up to 1 in 10 people is headache . nausea ( the frequency cannot be estimated from the available data ) ovarian hyper stimulation syndrome ( pelvic pain or discomfort ) ovarian origin tired
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . after reconstitution , the product may be stored at room temperature ( up to 25 ) for a single period of up to 3 months . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 3 months at 28 to 25 unless dilution has taken place in controlled and validated ase
what rekovelle contains - the active substance is follitropin delta . each multidose cartridge contains 12 micrograms ( 0 . 36 millilitre of solution ). after dilution , each ml of solution contains 33 . 3 milligrams ( 1 . 5 millilitres ) of follitroin delta in each millilitere of solution . - the other ingredients are phenol , polysorbate 20 , l - methionine , sodium sulphate decahydrate , disodium phosphate dodecahhydrate , concentrated phosphoric acid , sodium hydroxide and water for injections .
the active substances of revinty ellipta are fluticasone furoate and vilanterol . each inhalation contains either of these active substances . when used in combination with a quick - acting inhaler ( such as salbutamol ), the two active substances are used to treat breathing problems and other symptoms of copd in adults and adolescents ( 12 years of age and older ) weighing 184 kg or more . the recommended dose is 92 / 22 . chronic obstructive pulmonary disease ( copd ) in adults , adolescents and children aged 12 years and older weighing 184kg or more and asthma in adolescents 12 years
do not use revinty ellipta - if you are allergic to fluticasone furoate , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using ellipta . ellipta has not been studied in patients with liver disease . it is not known whether ellipta causes side effects . if you have moderate or severe liver disease , your doctor may lower the dose of the lower strength of ellipta to 92 / 22 mg . tell your doctor if : you have heart problems , high blood pressure , tuberculosis (
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use asthma the recommended dose for asthma is one inhalation twice a day ( morning and evening ) with fluticasone furoate and 22 mg vilanterol . for severe asthma , your doctor may prescribe the higher strength inhalation ( two inhalations once a day ) of fluticasafuroate ( 22 mg per day ) and vilancerol . copd the recommended starting dose for copd is one and a half inhalations ( morning , evening and evening
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to ellipta are rare ( may affect up to 1 in 1 , 000 people ). if you experience any of the following symptoms while taking ellipta , stop taking this medicine and contact your doctor immediately : skin rash , hives , redness swelling , especially of the face or mouth ( angioedema ), feeling very wheezy or coughing , having difficulty in breathing , feeling weak or light headed , collapse or loss of consciousness . immediate breathing difficulties if you have immediate breathing problems while taking revinty ellipta your
what revinty ellipta contains - the active substances are fluticasone furoate and vilanterol . each 92 micrograms inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 92 microlitres ( mg ). - the delivered dose is as follows : - each 92 micrometre inhalation delivers a deliver dose ( mg ) to your child . - each 184 microgramsis inhalation contains 184 micrometres ( μg ). - each 28 - gramitone inhalation deliver a deliverance of 184 microlitre ( mg ), as per per per kilogrammetre (
atripla contains three active substances that are used to treat human immunodeficiency virus ( hiv ) infection : efavirenz , a non - nucleoside reverse transcriptase inhibitor ( nnrti ), emtricitabine , which is also known as a nucleosidermal necrolysis ( nrti ) and tenofovir , which are all known to be active substances and are known to contain the active substance ntrti . these active substances belong to a group of antiretroviral medicines which work by blocking the action of an enzyme ( reverse transcript
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet taken by mouth once a day . atripla should be taken on an empty stomach at least 1 hour before or 2 hours after food . some side effects ( such as dizziness and drowsiness ) have been reported . if you take more tablets than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , show the doctor your pack of tablets . you may need to take other medicines to control your hiv infection . it is
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects lactic acidosis ( excess lacticacid in the blood ) is rare ( may affect up to 1 in 1 , 000 people ). if you experience any of the following serious side effect , stop taking atripla and contact your doctor immediately
what atripla contains - the active substances are efavirenz , emtricitabine and tenofovir disoproxil . each atrippla film - coated tablet contains 600 mg of eflavirenz ( as mesilate ), 200 mg of emptricitubine and 245 mg of ten ofovir disproxil ( as fumarate ). - the other ingredients are : tablet core : croscarmellose sodium , hyprolose , magnesium stearate , microcrystalline cellulose , sodium laurilsulfate ( see section
orgalutran contains the active substance ganirelix . it belongs to a group of medicines known as anti - gonadotrophin , which are produced by recombinant dna technology without addition of any human - or animal - derived components . the natural gonadonrophin releasing hormone ( gnrh ) is produced by the body and belongs to the group of hormones responsible for the release of gonadotropins in women . follicles are small round sacs that contain the egg cells . the sacs release the immature egg cells to make follicles in the ovaries ( ovaries ). orgalut
do not use orgalutran if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be hypersensitive , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : you are hypersensitive to gonadotrophin releasing hormone ( gnrh ), or to a gnrh analogue . you have a moderate or severe kidney or liver disease . you are pregnant or breast - feeding . your doctor may need to monitor you more closely during treatment . allergic reactions if you experience allergic
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . orgalutran will be given to you by a doctor who is experienced in the treatment of assisted reproduction techniques ( i . e . in vitro fertilisation ( ivf ), ovarian stimulation , follicle stimulating hormone ( corifollitropin ) on day 2 or day 3 of each cycle . your doctor will give you a single injection of orgdalutran under the skin ( subcutaneously ) over a period of 5 to 6 hours . you will be monitored by your doctor while you are
like all medicines , this medicine can cause side effects , although not everybody gets them . a side effect very common ( may affect more than 1 in 10 people ) local skin reactions ( e . g . redness and swelling ). the local reaction usually disappears in about 4 to 1 in 100 people . headache , nausea , malaise ( rare ) may occur in up to 1 to 10 , 000 people . allergic reactions such as rash facial swelling , difficulty breathing ( dyspnoea ) swelling of face , lips , tongue , and / or throat , difficulty in breathing or swallowing ( angioedema , anaphylaxis
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe label after exp . store in a refrigerator ( 2 - 8 ). syringes should be clear , liquid - free solutions , and should not be re - used if not used immediately .
what orgalutran contains - the active substance is ganirelix . each vial contains 0 . 5 ml of acetic acid . - the other ingredients are mannitol ( e421 ) and water for injections ( see section 2 ). - the ph is sodium hydroxide ( e524 ) which is used to adjust the amount of acic acid in the vial . see section 3 " what you need to know before you start using orglutran " for further information on the contents of this medicine . what it looks like and contents of the pack orgaluitran is a clear , colour
what blitzima is blitzima contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to a specific target in a certain type of white blood cell called " b - lymphocyte " ( b lymphocytes ). how blitzima works blitzima can be used in adults to treat : a ) non - hodgkin ' s lymphoma ( a disease of the lymph tissue that makes the immune system stronger ). b ) a very small number of a type ( less than 1 / 10 of a million ) of a kind ( called a type b
do not use blitzima - if you are allergic to rituximab , other proteins that are derived from the needles of yew trees , or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe active infection with a weak immune system . if you suffer from severe heart failure or severe uncontrolled heart disease . warnings and precautions talk to your doctor , pharmacist or nurse before using blitzima if : you have ever had granulomatosis , polyangiitis , microscopic polyangiaitis or pemphigus vulgaris ( see section " other medicines and blitz
you will be given blitzima by a doctor or nurse who is experienced in the use of this treatment . they will watch you closely while you are being given this medicine , in case you experience any side effects . blitzima is given as a drip ( intravenous infusion ). medicines given before each blitzima administration you may be given other medicines ( pre - medication ) to reduce the risk of side effects during your treatment . if you have non - hodgkin ' s lymphoma you will receive blitzima alone blitzima once a week for 4 weeks . repeated treatment courses with blitzima are possible . your doctor will decide
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the label of the vial after exp . this medicine does not require any special temperature storage conditions . after dilution , chemical and physical in - use stability has been demonstrated for 8 hours at 25ºc . from a microbiological point of view , the product should be used immediately . if not used immediately , the solution should be stored in a refrigerator at 2ºc to 8ºc and should be administered in accordance with local requirements . the product must not be
what blitzima contains - the active substance is rituximab . each 10 ml vial contains 100 mg of ritukimab ( 10 mg / 50 ml ). each 50 ml vials contains 500 mg ritudimab in 10 ml . - the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what blitzima looks like and contents of the pack blitzima is a clear , colourless solution for infusion supplied in 2 ml glass vial . each pack contains 50 vials . not all pack sizes may be marketed .
roactemra contains the active substance toilizumab , a type of protein called monoclonal antibody ( maoi ) that attaches to a specific target in the body called interleukin - 6 ( interlukin ). this is involved in the inflammation in your body and makes it harder for your body to break down the protein . roactenra is used to treat symptoms such as pain and swelling in your joints when the disease has not responded to previous therapies , or if the disease remains largely unchanged . your doctor has prescribed roactemrea to treat moderate to severe active rheumat
do not use roactemra if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active , severe infection . warnings and precautions talk to your doctor , pharmacist or nurse before using the infusion . if you think any of these apply to you , tell your doctor or nurse straight away . you may need urgent medical attention if you experience allergic reactions such as chest tightness , wheezing , severe dizziness , light - headedness , swelling of the lips or skin rash . during the infusion , look out for signs of infection .
always use roactemra exactly as your doctor has told you . you should check with your doctor or nurse if you are not sure . the intravenous infusion will be given to you by a doctor or a nurse . the treatment will usually last about 8 hours . your doctor will decide how long you should be treated . the usual starting dose is one 8 mg tablet once a day . the maximum recommended dose is two 8 mg tablets twice a day ( morning and evening ). your doctor may decide to increase your dose to two 30 mg tablets three times a day for up to 8 weeks . your dose will be calculated by your doctor
like all medicines , roactemra can cause side effects , although not everybody gets them . the following side effects have been reported in patients taking the medicine ( see section 3 " warnings and precautions "): very common side effects ( may affect more than 1 in 10 people ): allergic reactions , including difficulty with breathing , chest tightness , light - headedness , rash , itching , hives , swelling of the lips , tongue or face . serious infections , including fever and chills , which may travel through the mouth and skin blisters and stomach ache signs and symptoms of liver toxicity ( rare , may affect up to 1
keep this medicine out of the sight and reach of children . do not use roactemra after the expiry date which is stated on the outer carton and on the vial label after " exp ". do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what roactemra contains the active substance is tocilizumab . each ml of solution contains 4 mg of 80 mg of tociluzumab ( 20 mg / ml ). each 10 ml vial contains 200 mg of the other ingredients ( see section 2 ). the other ingredient ( s ) are sucrose , polysorbate 80 ( e433 ), disodium phosphate dodecahydrate , sodium dihydrogen phosphate dihydrate and water for injections . see section 4 for further information about some of the ingredients . what the concentrate is used for the concentrate for solution for infusion is a clear , colour
onbrez breezhaler contains the active substance indacaterol which belongs to a group of medicines called bronchodilators . it relaxes the muscles in the walls of the small air passages in the lungs . onbrez bronz inhaler is used to treat breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways relax , making breathing difficult . this medicine relaxes these muscles , making it easier for air to get in and out of the lungs when you breathe in .
do not use onbrez breezhaler if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). if you have asthma . warnings and precautions talk to your doctor , pharmacist or nurse before using onbrezer . if you suffer from heart problems , epilepsy , thyroid gland problems ( thyrotoxicosis ) or diabetes . if any of these apply to you , tell your doctor or pharmacist before using this medicine . if your doctor thinks that you may be at an increased risk of developing a condition called bronchospasm , consult your doctor immediately . if
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the usual dose is one 150 microgram capsule twice a day . your doctor may increase your dose to 300 microgram once a day depending on how you respond to the treatment . you should use your inhaler at least 24 hours after you last inhaled it . how to use onbrez breezhaler you will find an inhaler and capsules ( in blisters ) that contain the medicine ( inhalation powder ) that you will need to inhale . the instructions for use
what onbrez breezhaler contains - the active substance is indacaterol . each onbrex breezyhaler 150 micrograms inhaler contains 150 microlitres of indacatersol . - the other ingredients are lactose and the capsule is made of gelatin . - each on brez breezy inhaler 300 microgram ( 400 microgram ) inhalation contains 300 microlitre of indiacaterol ( as indaconaterol maleate ). - printing ink : shellac , maize starch , soybean starch , gelatin . an inhaler consists of capsules in blisters . the capsules
clopidogrel hcs belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures in the blood , which clump together during blood clotting . by reducing the amount of this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process known as thrombolybosis ). clopidogsrel clcs is taken by adults to reduce the number of bloodclots ( thrombi ) forming in hardened blood vessels ( arteries ), an event known as atherothrombosis ,
do not take clopidogrel hcs : - if you are allergic to clopidineogrel or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain ( severe liver disease ). if this applies to you , tell your doctor . warnings and precautions if any of these apply to you ( or you are in any doubt at all ), talk to your doctor or pharmacist before taking clopridogrel ccs . if you have any risk of bleeding
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel hcs per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you a lower dose of 300 milligrams ( one 300 milliliter tablet ) taken once a day . then , the usual
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of an
what clopidogrel hcs contains - the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopilogrel ( as hydrochloride ). - the other ingredients ( excipients ) are ( see section 2 ' clopide contains hydrogenated castor oil '): tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenatedcastor oil tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow
febcroja contains the active substance cefiderocol . it is an antibiotic medicine that belongs to a group of antibiotics called " cephalosporins ". antibiotics are used to fight bacteria that cause infections . fetcroja works by stopping the growth of infections caused by bacteria that are resistant to other antibiotics .
do not use fetcroja : if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to other antibiotics ( e . g . cephalosporins ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : you have had a severe allergic reaction to certain antibiotics ( such as penicillins or carbapenems ). you have severe skin peeling or swelling of the hands , face , feet , lips , tongue or throat that may cause difficulty swallowing or breathing . your doctor
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how fetcroja is given it is given as an infusion ( a drip ) into a vein . it usually takes about 3 to 2 hours . your doctor will decide how many treatments you need and how often you need to use it . how often and for how long your treatment will be given the doctor will check you for infection . if your infection does not improve or if you feel any pain during the fetroja infusion , your doctor may decide to give you a lower dose . it is recommended that
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : - severe allergic reaction - sudden swelling of your lips , face , throat or tongue - a severe rash or other severe skin reactions - difficulty swallowing or breathing - this reaction may lead to diarrhoea , stools , blood or mucus . treatment may be stopped or medicines given to slow bowel movement . other side effects talk to your doctor or pharmacist if you get any of these side effects : common side effects ( may
what fetcroja contains - the active substance is cefiderocol sulfate tosylate . each vial contains 1 mg of ccfiderocol . - the other ingredients are sucrose , sodium chloride , and sodium hydroxide . what fetcroJA looks like and contents of the pack fetroja is a white to off - white powder for concentrate for solution for infusion . it is available in packs containing 10 vials .
depocyte is used to treat a condition called lymphomatous meningitis in adults , adolescents and children aged 2 years and above . lymphoma tumour cells are found in the membranes of the brain and spinal cord . depocyte works by blocking the growth and spread of cancer cells .
do not use depocyte if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). if you have a meningeal infection . warnings and precautions severe neurological side effects can occur with depocyte . symptoms of the nervous system may include convulsions , pain , numbness , tingling , blindness and visual disturbances . if you experience any of these symptoms , stop taking depocyte and contact your doctor immediately . you should not be given any dexamethasone tablets to treat unwanted effects . if your side effects do not improve or get worse , tell your doctor
there are strict laws on the use , handling and disposal of cancer . depocyte must not be kept in the lumber sac . only depocyte and water for injections must be kept out of the sight and reach of children . the recommended dose is 1 to 5 micrograms of dexamethasone per 5 ml of body weight . each depocyte dose will be monitored by your doctor if you experience any side effects . the dose of depocyte to be administered depends on the body surface area ( temperature 22 to 30 ). before withdrawing depocyte from the vial , you should take proper precautions to avoid exposure to a cytot
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these side effects with you and will explain the risks and benefits of your treatment . the following side effects have been reported : very common ( affects more than 1 user in 10 ) uncommon ( affects 1 to 10 users in 100 ) very rare ( affects less than 1 users in 1 , 000 ) not known ( frequency cannot be estimated from the available data ) very common : may affect up to 1 in 10 people not known : frequency cannot been estimated from available data reporting of adverse events if you get any side effects talk to your
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . depocyte may be stored at room temperature ( up to 25 ) for a single period of up to 4 months without being refrigerated again . if depocyte is not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 - 10 , unless depocyte has been stored in a
what depocyte contains - the active substance is cytarabine . each ml of solution for injection contains 10 milligrams ( mg ) of the active substances . one vial of 5 ml solution contains 50 mg of cytarbine . - the other ingredients are cholesterol , triolein , dioleoylphosphatidylcholine , dipalmitoylosphatidoylglycerol , sodium chloride and water for injections . what depocyte looks like and contents of the pack depocyte is a clear , colourless to pale yellow solution . it is supplied as an injection in a v
the active substance in bemrist breezhaler is indacaterol , which belongs to a group of medicines called bronchodilators . it relaxes the muscles in the small airways in the lungs , making it easier for air to get in and out of the lungs . mometasone furoate belongs to an important class of medicines known as corticosteroids , which are used to reduce the swelling and irritation ( inflammation ) in the smaller airways . this can lead to breathing problems and makes it harder for you to breathe . corticostromes reduce the number of attacks of asthma
do not use bemrist breezhaler if you are allergic to indacaterol , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : you have heart problems , such as an irregular or fast heartbeat you have thyroid gland problems you have diabetes , high blood sugar , seizures you have a low level of potassium in your blood you have severe liver problems . you have tuberculosis ( tb ) of the
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . bemrist breezhaler capsules should be swallowed whole with a glass of water . you can take the medicine with or without food . it is important that you continue to use the medicine until your doctor tells you otherwise . if your asthma does not improve or your symptoms get worse , you should contact your doctor . how to use and how much to use use be mrist breezyhaler as instructed by your doctor , pharmacist or nurse . you should not inhale or inhale bem
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious . tell your doctor straight away if you notice any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching and hives . allergic reaction uncommon ( might affect up to 1 in 100 people ): swelling , particularly of your tongue or lips , face or throat ( angioedema ). other side effects other side side effects include the following listed below . very common : these may affect less than 1
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . the capsules should be kept in the original blister in order to protect from light and moisture . throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what bemrist breezhaler contains - the active substances are indacaterol ( as acetate ) and mometasone furoate . each inhaler contains 125 micrograms ( 62 . 5 mg ) and 173 microlitres ( 23 . 0 mg ) of indiacaterol acetate . - the other ingredients are 150 microgram s indacate and 80 microlitre ( 23. 0 mg ). - the content of the inhaler is provided as white to off - white powder . - each dose of mometsone unfuroate is provided in a clear , colourless to
the active substance of zyllt , clopidogrel , belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). zylltic is taken by adults to prevent bloodclots ( thrombi )forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( such as stroke , heart attack , or death ). you have been prescribed
do not take zyllt if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , tell your doctor or pharmacist . warnings and precautions talk to your doctor , pharmacist , or nurse before taking zllt if : you have an increased risk of bleeding , such as - a medicalcondition that puts you at risk of internal bleeding ( such as , a stomach
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of zyllt per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may lower your dose to 300 mg once a day . your doctor will tell you the dose to take . if necessary , the dose may be increased to a maximum
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of an
what zyllt contains - the active substance is clopidogrel . each film - coated tablet contains 75 mg of clopridogrel ( as hydrogen sulphate ). - the other ingredients are : tablet core : lactose ( see section 2 under ' zllt contains lactose '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil in the tablet core and hypromellose ( e464 ), titanium dioxide ( e171 ), red iron oxide ( e172 ), talc and propylene glycol in the film - coating . what
lamivudine teva contains the active substance lamivudrine . lamivuda teva is used for the treatment of long term ( chronic ) hepatitis b infection in adults , adolescents and children aged 12 years and older , in combination with an antiviral medicine . the hepatitis b virus belongs to a group of medicines called nucleoside analogue reverse transcriptase inhibitors ( nrtis ). hepatitis b is a virus that infects the liver , and so is life - threatening . in patients with long term (" chronic ") infection , liver damage can occur . your doctor will test your liver before and during treatment with lamiv
you must not be given lamivudine teva : - if you are allergic , or think you may be allergic , to any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 28 talk to your doctor , pharmacist or nurse before you are given this medicine , as it may cause serious side effects . if you have liver disease such as hepatitis c . you are overweight . your doctor may need to do blood tests before you start your medication . see section 4 for more information . do not stop taking lamivuda teva without first checking with your doctor if your hepatitis is getting worse .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor lamivudine teva is used to treat your hepatitis b infection . your doctor will tell you exactly how many tablets of your infection to take and how long you should continue to take it . it is important that you keep taking it every day until your illness is completely gone . you should take lamvudine once a day at about the same time each day . if you have the impression that the effect of lamivu teva too strong or too weak ,
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects of lamivudine teva are related to other conditions linked to hepatitis b . the following side effects have been reported during therapy for ' hepatitis b ' in clinical trials : tiredness , respiratory tract infections , throat discomfort , headache , stomach discomfort , pain , nausea , vomiting , diarrhoea and increases in liver enzymes . these may be signs that the liver is not working properly and may tighten the muscles . allergic reaction ( rare , may affect up to 1 in 1 , 000 people ): swelling of eyelids ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . lamivudine teva should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what lamivudine teva contains - the active substance is lamvudine . each film - coated tablet contains 100 mg of lamludine - the other ingredients are : tablet core : microcrystalline cellulose , sodium starch glycolate , magnesium stearate tablet film - coating : hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , iron oxide yellow ( e172 ), iron oxide red ( e 172 ). tablet coat : shellac , talc ( e553b ), red ink ( e904 ), sunset yellow fcf ( e110 ).
nespo ( an anti - anaemic ) is used to treat your anaemia . anaemia occurs when your blood does not contain enough red blood cells . the symptoms can include fatigue , weakness and shortness of breath . it is usually caused by the lack of the natural hormone erythropoietin ( ee - rith - roe - poe - eh - eh ) in your kidneys . your doctor has given you nespo to encourage your bone marrow to produce more redblood cells ( e . g . darbepoetin alfa ). chronic renal failure ( symptomatic anaemia )
do not use nespo : if you have high blood pressure or are taking other medicines . if you think you may be allergic , ask your doctor or pharmacist for advice . warnings and precautions talk to your doctor , pharmacist or nurse before you are given neespo ( darbepoetin alfa ) or r - huepo . patients with highblood pressure who are taking medicines to treat sickle cell anaemia may experience epileptic fits ( seizures ). convulsions may be life - threatening . seizures have been reported in patients with liver disease who have taken drugs to treat anaemia . if
follow carefully all instructions given to you by your doctor , pharmacist or nurse . your doctor will carry out blood tests before you are given nespo to check your haemoglobin level . the usual starting dose is 10 micrograms per kilogram of body weight . if you are not sure about this , talk to your doctor or pharmacist . your dose may be increased or decreased depending on your condition . the doctor may increase or decrease your dose if necessary . if necessary , your doctor may give you a single injection under the skin or into a vein ( intravenous ). if your anaemia is not controlled with nes
like all medicines , nespo can cause side effects , although not everybody gets them . the following side effects have been reported : very rare ( may affect up to 471 in 10 , 000 people ) - high blood pressure ( hypertension ) - fluid retention ( oedema ) uncommon ( may effect up to 1 in 100 people ) blood clots ( thrombosis ) pain in the area injected rash , redness or swelling of the skin rare : may affect less than 1 in 10, 000 people - serious allergic reactions - sudden life - threatening allergic reactions ( anaphylaxis ) - swelling including the face ,
keep out of the reach and sight of children . do not use nespo after the expiry date which is stated on the carton and on the label of the syringe after exp . store in a refrigerator ( 2 8 ). do not freeze . keep your syringe in the outer carton in order to protect from light . after first opening : do not store above 30 and keep it at room temperature ( not above 30 ) for a maximum of 7 days . do this at the end of this 7 - day period . keep the bottle tightly closed with the cap on the bottle to protect it from moisture . nes
what nespo contains the active substance is darbepoetin alfa . each ml of a pre - filled syringe contains 10 , 15 , 20 , 30 , 40 , 50 , 60 , 80 , 100 , 130 , 150 , 300 or 500 micrograms . the other ingredients are sodium phosphate monobasic , sodium phosphate dibasic ( e1200 ), sodium chloride , polysorbate 80 and water for injections . the solvent is clear , colourless to slightly pearly liquid and cloudy . 1 ml solution for injection is provided in a carton containing 4 or 4 pre -
macugen is a solution for the treatment of macular degeneration in adults . it contains the active substance pegaptanib . this medicine helps to stop abnormal formation of new blood vessels in the eye . macugen is used in adults and adolescents to improve the treatment and control the condition in adults with macular dementia . people with this disease have vision loss caused by damage to a part of the retina called the macula . macula is the thin layer at the back of the eye called the ' retina ' ( amd ). as a result , abnormal blood vessels grow in the retina and become larger . this can damage the mac
do not use macugen : if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active or suspected infection in or around the eye . warnings and precautions talk to your doctor or pharmacist before using macugen . if you think you may have an infection or bleeding in the eye , stop macugen injection and contact your doctor immediately if you experience one or more of the following symptoms : eye pain , increased discomfort , worsening eye redness , blurred or decreased vision , increased sensitivity to light , small particles in your vision . these may be caused by
mugen will be given to you by a doctor or nurse who is experienced in giving injections of macugen . macugen is given as a single injection into the back of the eye . it is given every 6 to 9 weeks . the injection will be injected into the vitreous part of your eye ( the coloured part of the coloured eye ). macugen must be used in combination with antibiotic eye drops . your doctor will clean your eye and give you some local anaesthetic ( numbing medicine ) to reduce any pain that you may have after the injection . if you are allergic to antibiotics eye drops , you should not receive antibiotic
like all medicines , this medicine can cause side effects , although not everybody gets them . serious allergic reaction ( anaphylactic reaction or angioedema of which symptoms may include breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting , rapid pulse , stomach cramps , nausea , vomiting and diarrhoea ). frequency of these side effects cannot be estimated from the available data . an infection in the internal portion of the eye has been reported during macugen treatment . the symptoms are described in section 2 under " warnings and precautions " for patients with these symptoms . other side
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special temperature storage conditions . the medicine should be used immediately after preparation . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2ºc - 8ºc unless dilution has taken place in controlled and validated aseptic conditions .
what macugen contains - the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 mg of pegaptenib in 90 ml of solution . - the other ingredients are : sodium chloride , monobasic sodium phosphate monohydrate , dibasicodium phosphate heptahydrate , sodium hydroxide , hydrochloric acid ( for ph adjustment ) and water for injections . see section 2 . what macugen looks like and contents of the pack macugen solution for injection in a single dose pack is supplied in a pouch . each pack contains a pre - packed sy
palifermin belongs to a group of medicines called escherichia coli . palifermin works by blocking the growth of epithelial cells in the mouth and digestive tract , which are tissues that line the skin . by blocking these growths , the medicine helps to protect the mucosa from growing and growing in the digestive tract and tissues such as the skin and mucous membranes . the active substance in kepivance is used to treat oral mucositis ( soreness , dryness or inflammation of the mouth ) as an additional side effect that can occur during treatments for your blood cancer . if you have or have had
do not use kepivance - if you are allergic to palifermin , escherichia coli derived proteins or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . children and adolescents do not give this medicine to children under the age of 18 years . other medicines and kepacivance tell your doctor or pharmacist if you have recently taken or might take any other medicines . this is particularly important if your child is taking heparin . it is important to tell your physician if you recently took or may take
how much kepivance is given your doctor will decide on the dose you will receive . the usual dose of cancer treatment is one vial ( 60 mg ). your doctor or nurse will decide the dose that will be given to you . the dose will depend on your condition and your general condition . the recommended dose is one kilogram ( kg ) of body weight given as an intravenous injection ( into a vein ). how kepvance is administered kepvelance will be administered to you three days before chemotherapy ( followed by chemotherapy and radiotherapy ). it will take approximately 24 to 48 hours before the chemotherapy is given
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ): side effects include skin rash , itching , redness ( pruritus and erythaema ), an increase in the thickness in the mouth or tongue , change in colour of the mouth , generalised swelling ( oedema ), swelling of hands , ankles or feet , pain , fever and aching joints ( arthralgia ), altered taste , raised levels of lipase and amylase levels in the blood . digestive enzymes may be removed from the blood during treatment and
what kepivance contains - the active substance is palifermin . each vial contains 6 . 25 mg of paliferin . - the other ingredients are mannitol , sucrose , l - histidine , polysorbate 20 and diluted hydrochloric acid ( see section 2 ). what kepvelance looks like and contents of the pack kepalivance is a white powder supplied in a glass vial . each carton contains 6 vials .
cinacalcet accordpharma contains the active ingredient cinacalcitepine which increases the levels of calcium and phosphorous in the blood . it is used to treat problems with organs called parathyroid glands . parathyroids are four small glands in the neck , which are connected to the thyroid gland . your doctor has prescribed cinocalcate accordphara for the treatment of secondary hyperparathyroidism in adult patients with serious kidney disease who are not on dialysis or who are unable to take waste products because they have not been removed from their blood ( hypercalcaemia ).
do not take cinacalcet accordpharma : - if you are allergic to the active substance cinapalcate or any of the other ingredients of this medicine ( listed in section 6 ). - if there are low levels of calcium in your blood . your doctor will monitor your blood calcium levels regularly while you are taking cinocalcordpharma . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine : if you have ever had seizures ( fits or convulsions ). seizures may be life threatening . liver problems or heart failure have been reported in patients
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . cinacalcet accordpharma must be taken orally with or without food . you should swallow the tablet whole with a glass of water . you can take the tablet at any time of the day . the tablets should be taken with regular blood samples . duration of treatment if you have secondary hyperparathyroidism your doctor will tell you how long you should continue to take the tablets . the usual starting dose is 30 mg per day . your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : numbness or tingling around the mouth , muscle aches , cramps or seizures ( these may be signs that your calcium levels are too low ). hypocalcaemia ( swelling of the face , lips , mouth , tongue or throat that may cause difficulty in swallowing or breathing ( angioedema ). very common ( may affect more than 1 in 10 people ): nausea and vomiting . these side effects are usually mild to moderate and may occur within a few days to a few weeks . common (
what cinacalcet accordpharma contains - the active substance is cinacetalcep . each film - coated tablet contains 30 mg , 60 mg or 90 mg cinacealcip ( as hydrochloride ). - the other ingredients are cellulose , microcrystalline - crospovidone - magnesium stearate , hypromellose , titanium dioxide ( e171 ), triacetin , indigo carmine aluminum lake ( e132 ) and iron oxide yellow ( e172 ). what cincacalcitpharma looks like and contents of the pack √alc
jentadueto contains two active substances called linagliptin and metformin . linaglptin belongs to a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4 inhibitor ) metformatin belongs to the class of substances called biguanides . they work together to reduce blood sugar levels in adult patients with a type of diabetes called ' type 2 diabetes mellitus '. this medicine works by helping your body make better use of insulin . this medicine can be used alone or with certain other medicines used to treat diabetes ( such as sulphonylureas or emp
do not take jentadueto : if you are allergic to linagliptin , metformin or any of the other ingredients of this medicine ( listed in section 6 ). if you have severely reduced kidney function ( uncontrolled diabetes with severe hyperglycaemia ( high blood glucose ), nausea , vomiting , diarrhoea , rapid weight loss , lactic acidosis ( see section " risk of lacticacidosis "). what is ketoacidosis ? ketoconacidosis is a condition in which substances called ' ketone bodies ' accumulate in the blood and which can lead to diabetic pre - coma . symptoms include
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . jentadueto should be taken with or without food . your doctor will tell you how many individual tablets of linagliptin and metformin to take each day . you should continue taking this medicine until your doctor tells you otherwise . if you have the impression that the effect of this medicine is too strong or too weak , talk to your doctor . to reduce the chance of an upset stomach , your doctor may prescribe a starting dose of 5 mg
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms may be serious and require immediate medical attention . stop taking jentadueto and contact a doctor immediately if you experience any of the following symptoms : low blood sugar ( hypoglycaemia ) trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change or confusion ( hypocaemia is a very rare , may affect up to 1 in 10 , 000 people ), but very serious side effect called lactic acidosis ( see section " warnings and precautions "). stop taking the combination jent
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after " exp ". the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . blister : store in the original package in order to protect from light . this medicine does not require any special temperature storage conditions . if you notice any visible signs of tampering , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the
what jentadueto contains - the active substances are linagliptin and metformin hydrochloride . - each dosing tablet ( 2 . 5 mg / 850 mg ) contains 2. 5 mg linaglioptin and 850 mg of metformformin hydrochloride , - the other ingredients ( excipients ) are arginine , copovidone , magnesium stearate , maize starch , silica , colloidal anhydrous , hypromellose , titanium dioxide ( e171 ), talc , propylene glycol . - the film - coating is white to off -
edurant contains the active substance rilpivirine . edurant is used to treat human immunodeficiency virus ( hiv ) infection in adults , adolescents and children aged 12 years and older . it belongs to a group of hiv medicines called non - nucleoside reverse transcriptase inhibitors ( nnrtis ). it works by preventing hiv from multiplying and infecting other people who are infected by hiv . it is used in combination with other hiv treatments . your doctor will discuss with you which combination of medicines is best for you .
do not take edurant : - if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking this medicine . if you think any of these apply to you , tell your doctor , pharmacist or nurse before you are given the medicine . you should not be given edurent if you : - are taking the following medicines : - carbamazepine , oxcarbazepine or phenobarbital or phenytoin - medicines to treat some bacterial infections ( e . g .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults ( 18 years of age and older ) the recommended dose of edurant is 1 tablet of rifabutin per day . this is a medicine used to treat some bacterial infections . your doctor will tell you if you need to change the dose or stop taking edurent . if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse . warnings and precautions talk to your doctor : before you take the medicine , your doctor may tell you to
like all medicines , this medicine can cause side effects , although not everybody gets them . headache , nausea , difficulty falling asleep , insomnia , dizziness and changes in your routine liver tests ( transaminase ), increase in cholesterol and pancreatic amylase in your blood , abnormal dreams , rash , stomach pain , depression , tiredness , vomiting , drowsiness , decreased appetite , sleep disorders , stomach discomfort , depressed mood , dry mouth 36 low white blood cell and / or platelet count , decrease in haemoglobin in your bloodstream ( triglycerides , lipase , bilirubin ) in blood uncommon , symptoms of
what edurant contains - the active substance is rilpivirine . each film - coated tablet contains rilpaline hydrochloride equivalent to 25 mg of rilpelirine - the other ingredients are : tablet core : lactose monohydrate , croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose , magnesium stearate . tablet coating : the film - coating contains lactosemonohydrate , hypromellose 2910 ( e464 ), talc 6 cp , titanium dioxide ( e171 ), macrog
avandamet tablets contain two different medicines called rosiglitazone and metformin . these two medicines help to control the level of sugar in your blood when you have type 2 diabetes . people with type2 diabetes either don ' t make enough insulin to control their level of blood sugar levels , or they do not respond normally to the insulin their body produces to control sugar ( called ' ketoacidosis ') or they either stop making enough insulin . rosaiglitrazone and meetformin work together by helping your body make better use of the insulin it produces to lower your blood sugar . av
follow all your doctor ' s instructions carefully , even if they differ from the general information contained in this leaflet . check with your doctor or pharmacist if you are not sure . do not take avandamet if : you are allergic ( hypersensitive ) to rosiglitazone or metformin . you are breast - feeding . warnings and precautions talk to your doctor , pharmacist or nurse before taking avandamanet : if you have been in close contact with someone who has had a heart attack , severe angina , or heart failure in the past . if you suffer from severe breathing difficulties . if
always take avandamet tablets exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended starting dose is 2 mg rosiglitazone ( equivalent to 1000 mg metformin ). your doctor will tell you how many tablets you need to take . this dose will be gradually increased over 1 to 8 weeks . the maximum dose should be taken once a day for 4 weeks . your doctor may increase the dose to 400 mg once daily . the dose may be increased once daily if you have to take rosaiglitrazone ( corresponding to
like all medicines , avandamet can cause side effects , although not everybody gets them . allergic reactions have been reported with avandamanet . you may get raised and itchy rash ( hives ) swelling mainly of the face or mouth ( angioedema ), with difficulty in breathing collapse . if you get any of these symptoms , stop taking the medicine and contact your doctor straightaway . lactic acidosis has been reported in patients taking metformin . patients with severe kidney disease have reported symptoms of lacticacidosis such as rapid breathing , cold stomach pain , nausea and vomiting . these symptoms have also been
your doctor , pharmacist or nurse knows how to store avandamet properly .
what avandamet contains - the active substances are rosiglitazone and metformin . each tablet contains either : one tablet ( 800 mg ) of rosaiglitzaone and 500 mg metforma . each film - coated tablet ( 2 tablets ) contains two tablets ( 600 mg ). each tablet ( 500 mg ) contains three tablets ( 1 tablet ( 1000 mg ) metforman . each picture ( 4 tablets ) contain four tablets ( 400 mg ). - the other ingredients ( excipients ) in the tablet core are : rospiglitrazone 500 mg and met formin , sodium
clopidogrel mylan belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures in the blood , which clump together during blood clotting . by reducing the amount of this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process known as thrombolybosis ). clopidoggingrel melan is taken by adults to reduce the number of bloodclots ( thrombi ) forming in hardened blood vessels ( arteries ), an event known as atherothrombosis ,
do not take clopidogrel mylan 31 - if you are allergic to clopidineogrel or any of the other ingredients of this medicine ( listed in section 6 ). - have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . - have severe liver disease . if any of these apply to you , tell your doctor or pharmacist . warnings and precautions talk to your doctor , pharmacist or nurse before you are taken : - before you start taking the tablet , make sure that : - you know that you may be at increased risk of bleeding ( such as -
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel mylan per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you a lower dose ( up to 300 mg once a day ), but you should not take more than that . your doctor will tell
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of an
what clopidogrel mylan contains - the active substance is clopilogrel . each film - coated tablet contains 75 mg of clopiodogrel ( as hydrochloride ). - the other ingredients are : tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil ( see section 2 ' clopridogrel Mylan contains hydrogenatedcastor oil '); tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow
doptelet belongs to a group of medicines known as thrombopoietin receptor agonists . doptelet is used to treat chronic liver disease ( low platelet count ) with a condition called thromboocytopenia ( a medical procedure that reduces the ability of blood to clot and stop bleeding ).
do not use doptelet : - if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : - you have or have had blood clots in the veins or arteries . this is because it may increase the risk of blood clotting ( for example , if you have cancer ). - you are taking the contraceptive birth control pill or hormone replacement therapy . - you recently had surgery or are injured . 23 you are overweight . you have advanced chronic liver disease . children and
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will calculate your dose based on the results of your procedure . the usual starting dose is one 5 mg tablet once a day for up to 8 weeks . if you take more doptelet than you should if you accidentally take too many tablets , talk to a doctor or go to a hospital straight away . you may need to take the tablets with or without food . if possible , take your tablets with a glass of water . do not split , crush or chew the tablets . you can take dop
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with doptelet : very common ( may affect more than 1 in 10 people ): feeling tired uncommon ( likely to affect up to 1 in 100 people ): low red blood cell count ( anaemia ) blood clot in the portal vein ( a blood vessel that transports blood from the liver to the intestines ) upper abdominal pain swelling bone pain muscle aches fever reporting of side effects if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaf
what doptelet contains ∑ the active substance is avatrombopag . each film - coated tablet contains an active substance called avATrombapag maleate . ∑ each tablet contains 20 micrograms of avatormbopg . ∐ the other ingredients are : ∑ tablet core : lactose monohydrate ( see section 2 under ' important information about lactose '), microcrystalline cellulose , crospovidone type b [ e1201 ], silica , colloidal anhydrous , magnesium stearate , vinyl alcohol , talc , macrogol
rapiscan belongs to a group of medicines called ' coronary vasodilators '. these are used to monitor the heart arteries , heart rate and the muscles in the heart . rapiscan is used in adults to perform a type of heart scan called ' myocardial perfusion imaging '. the scan contains a radioactive substance called a ' radiopharmaceutical '. these images are taken using a machine that scans the muscles of the heart using a readmill . a scan is taken to measure the amount of a small amount of radiophileaceutical in the body . it is given into a vein by your hand . images are then taken
do not use rapiscan if you have slow heart rate , high degree heart block , sinus node disease , or if you are using a pacemaker . if you experience chest pain ( unstable angina ), stop treatment and tell your doctor straight away if you suffer from low blood pressure ( hypotension ), heart failure or allergic to regadenoson . children and adolescents do not give this medicine to children under 6 years of age because it has not been studied in this age group . warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine if any of the following apply to you : if
rapiscan will be given to you by a doctor or nurse who is experienced in the treatment of your heart and blood pressure . it is given into a vein ( intravenously ) over a period of 400 minutes . the recommended dose is one vial of a 5 ml solution the injection should be given once every 10 minutes depending on your weight . your doctor will also give you an injection of sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection ( injection in a vial ) for 5 minutes . this is because rapiscan contains a radioactive substance ( radiopharmaceutical ). the dose of rapisc
like all medicines , rapiscan can cause side effects , although not everybody gets them . most of the side effects are mild to moderate . however , some may be serious and require the rapid injection of 30 minutes or any treatment . tell your doctor straight away if you notice any of the following side effects : sudden stopping of the heart , which may be signs of damage to the heart ( heart block ), a disorder of theheart ' s electrical signal , rapid heart beat low blood pressure , fainting , mini strokes , weakness of the face and inability to speak . if any of these apply to you , tell the doctor straight
viagra contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . it works by helping to relax the blood vessels in your penis , allowing blood to flow into your penis when you get sexually excited . viagra will only help you to get an erection if you are sexually stimulated , and your doctor will tell you how long you should continue to take viagra . this is a treatment for adult men with erectile dysfunction ( impotence ). this is when a man cannot get , or keep a hard , erect penis suitable for sexual activity
do not take viagra if : you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). you are taking medicines called nitrates , which could lead to a dangerous fall in your blood pressure . these medicines are used to treat angina pectoris ( " chest pain ") in adults . if you are not sure , talk to your doctor or pharmacist before taking the medicines . you are also taking nitric oxide donors such as amyl nitrite , which can also lead , or have been used , to prevent , a dangerous drop in yourblood pressure .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended starting dose is 50 mg once a day . viagra film - coated tablets can be taken with or without food . if you take more viagra orodispersible tablets than you should if you accidentally take too many tablets of viagra , contact your doctor immediately . swallow the tablets whole with a glass of water . do not crush or chew the tablets . taking viagra at the same time each day will help you get an erection . you may also find it easier to take viagra
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects are usually mild to moderate . stop taking viagra and see a doctor straight away if you notice any of the following serious side effects : viagra may cause an allergic reaction ( may affect up to 1 in 100 people ). symptoms may include sudden wheeziness , difficulty in breathing , dizziness and swelling of the eyelids , face , lips or throat . chest pains may occur if you are in a semi - sitting position . you may need to take nitrates to relieve your chest pain . prolonged and sometimes painful erections (
what viagra contains - the active substance is sildenafil . each tablet contains 25 mg of sildenedafil ( as the citrate salt ). - the other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate . tablet coating : hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake ( e132 ). what viagra looks like and contents of the pack viagra film - coated tablets have a rounded - diamond shape and
sifrol contains the active substance pramipexole and belongs to a group of medicines known as dopamine agonists , which stimulate dopamine receptors in the brain . stimulation of the dopamine receptors triggers nerve impulses in thebrain that help to control body movements . sifrol is used to : : : treat the symptoms of primary parkinson ' s disease in adults . it can be used alone or in combination with levodopa . it is used in adults to treat the symptom of moderate to severe primary restless legs syndrome .
do not take sifrol - if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine if you have any medical conditions or symptoms of kidney disease . hallucinations ( seeing , hearing or feeling things that are not there ). most hallucinations are visual . dyskinesia ( e . g . abnormal , uncontrolled movements of the limbs ). in patients with advanced parkinson ' s disease , levodopa has not been studied . if you experience any of these effects , stop taking
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of sifrol for the treatment of parkinson ' s disease is 3 tablets per day . during the first week , the usual starting dose is 1 tablet ( 0 . 088 mg ) once a day . your doctor may increase your dose to 0 . 264 mg twice a day , depending on how you respond to the medicine . this will be achieved gradually over a period of 1 to 3 weeks . if your symptoms return after this time , your doctor will increase the dose to 1 tablet
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of these side effects is based on the following frequencies : very common ( may affect more than 1 in 10 people ) common ( likely to affect up to 1 in 100 people ) uncommon ( likely 1 in 1 , 000 to 10 , 000 people ) not known ( frequency cannot be estimated from the available data ) if you have parkinson ' s disease , you may experience the following side effects : - dyskinesia ( abnormal , uncontrolled movements of the limbs ) - dizziness - nausea ( sickness ) - urge to behave in an unusual
what sifrol contains - the active substance is pramipexole . each tablet contains 0 . 088 mg , 0 . 18 mg or 0 . 35 mg , corresponding to a concentration of 0 . 7 mg / m2 . - the other ingredients are : tablet core : aminotransferase ( e1201 ), pramipxole 0 . 125 mg ( 0 . 25 mg ), 0 . 5 mg dihydrochloride monohydrate , mannitol ( e421 ), maize starch , anhydrous colloidal silica , povidone k 25 , magnesium stearate .
emadine is a medicine used for the treatment of seasonal allergic conjunctivitis of the eye in adults . it is used to prevent allergic conditions from occurring in the eye . the allergic reaction may be severe and may be life - threatening . the most common signs of allergic conjutivitis are itching , redness and swelling on the surface of your eye . if you notice any of these , tell your doctor straight away . you may feel worse .
do not use emadine : - if you are allergic to emedastine or any of the other ingredients of this medicine ( listed in section 6 . warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . children and adolescents do not give this medicine to children or adolescents below the age of 3 years because benzalkonium chloride is present in the blood in children . do not use this medicine after the expiry date which is stated on the carton and on the label of the vial after exp . this medicine is not recommended for use in children younger than 6 years of age .
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use the recommended dose is 3 drops in each eye once a day . this medicine is for use in both eyes . use in children and adolescents do not use more than 1 drop in the affected eye each day ( see section 2 , " how to use emadine "). do not swallow the desiccant . do not chew or break the desecant . how to open and remove the emadrine bottle : wash your hands thoroughly before using it .
like all medicines , this medicine can cause side effects , although not everybody gets them . stop using the drops and see a doctor straight away . common side effects ( may affect up to 10 in 100 people ) effects in the eye : eye pain , itchy eye and eye redness . uncommon side effects : ( may effect up to 1 in 100people ) effects affecting the front part of the eye called corneal disorder . abnormal eye sensation , increased tear production , tired eyes , eye irritation , blurred vision , cornealing staining and dry eye . general side effects include headache , difficulty sleeping , sinus headache , bad
keep out of the reach and sight of children . do not use emadine after the expiry date which is stated on the carton and on the blister after exp . the unopened blister does not require any special storage conditions . store below 25 . store in the original package in order to protect from moisture and infections .
what emadine contains - the active substance is emadastine 0 . 5 mg / ml . - the other ingredients are difumarate , benzalkonium chloride , trometamol , sodium chloride , hypromellose , purified water , hydrochloric acid , sodium hydroxide ( for acidity levels and ph levels ). what emadrine looks like and contents of the pack emadINE is a liquid ( a solution ) supplied in a 5 ml or 10 ml plastic ( drop - plunger ) bottle with a screw cap . not all pack sizes may be marketed .
levetiracetam is an antiepileptic medicine ( a medicine used to treat seizures in epilepsy ). levetiratam actavis is used : on its own in adults and adolescents from 16 years of age with newly diagnosed epilepsy , to treat a certain form of epilepsy . epilepsy is a condition where the patients have repeated fits ( seizures ). the epilepsy is unique in that the fits initially affect only one side of the brain , but could thereafter extend to larger areas on both sides of your brain ( partial onset seizure with or without secondary generalisation ) and may thereafter affect all of your body surface area . levet
do not take levetiracetam actavis : - if you are allergic to the active substance leveturacetam , pyrrolidone derivatives or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . you should tell your doctor if you : - have kidney problems . - have any slow down in the growth or unexpected puberty development of your child . - are taking anti - epileptics ( see section 4 ). - have had thoughts of harming or killing themselves . - notice any symptoms of depression or suicidal ide
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of levetiracetam actavis twice a day , in the morning and in the evening . monotherapy dose in adults and adolescents from 16 years of age and older : the usual starting dose is 1 , 000 mg once a day . your doctor may increase your dose to 3 , 000mg once daily depending on how you respond to the medicine . the doctor will tell you how many tablets you need to take each day . if you have the impression that the effect of
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately , or go to your nearest emergency department , if you experience : weakness , feel light - headed or dizzy or have difficulty breathing , as these may be signs of a serious allergic ( anaphylactic ) reaction . swelling of the face , lips , tongue and throat ( quincke ' s oedema ). flu - like symptoms with a rash on the face followed by an extended rash with a high temperature and increased levels of liver enzymes seen in blood tests . reduction in a type of white blood cell 56 (
what levetiracetam actavis contains - the active substance is levetviracetam . each tablet contains either levetiraacetam as 250 mg or 250 mg of levetmiracetam ( as 500 mg ). - each film - coated tablet contains 500 mg or 500 mg of the active ingredient ( as 750 mg ). each tablet also contains an additional tablet ( as 1 , 000 mg ). the other ingredient ( s ) ( excipients ) ( e . g ., tablet core ) is lactose , pineapple , povidone , silica colloidal anhydrous , magnesium stearate .
the active substance umeclidinium bromide belongs to a class of bronchodilators . incruse ellipta is used to treat adults with chronic obstructive pulmonary disease ( copd ). copd is a long - term condition in which the airways in your lungs become damaged and difficult to breathe . this can lead to breathing difficulties , difficulties in breathing and tightening of the muscles around your airways . this medicine blocks the tightening of these muscles , making it easier for air to get in and out of the lungs . this helps to control your breathing difficulties and reduces the effects of copd on your
do not use incruse ellipta 27 - if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if you : - have asthma . this medicine is not recommended for use in patients with asthma . your doctor may need to adjust your dose . - have heart problems - have an eye problem called narrow - angle glaucoma ( an enlarged prostate , difficulty passing urine , or a blockage in your bladder ). - have severe liver problems . immediate breathing difficulties such as
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should inhale this medicine every day for 24 hours at the same time each day . use incruse ellipta every day until your doctor tells you otherwise . do not use more than your prescribed dose . if you use more incruce ellipta than you should if you have used more than the prescribed dose , contact your doctor immediately . symptoms of using too much of this medicine may include a sudden attack of breathlessness or wheezing
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions may occur uncommonly ( may affect up to 1 in 100 people ). if you experience any of the following symptoms while taking incruse ellipta , stop taking this medicine and seek medical help immediately : itching skin rash , hives and redness 29 common side effects may affect more than 1 in 10 people : faster heart beat painful and frequent urination these may be signs of a urinary tract infection ( common cold infection of nose , throat cough , feeling of pressure , pain in the cheeks and forehead ) inflammation of the sin
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the inhaler after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the sealed tray in the outer carton in order to protect from light . after first opening of the tray , the inhaled tray should be used within 6 months . once the tray has been opened , the active substance must be removed from the tray and used within 30 . discard the tray after this time period . write the date that incruse ellipta
what incruse ellipta contains - the active substance is umeclidinium bromide . each single inhalation provides a delivered dose of 55 micrograms ( 0 . 5 millilitres ) umecylidium . each delivered dose provides a deliver dose of 65 microgramms ( 1 . 0 millilitre ) of umelodiniumbromide ( 1 microgram ) per inhalation . - the other ingredients are lactose monohydrate ( see section 2 under ' incrusemipta contains lactose '), magnesium stearate ( e470b ). what incru
nucala contains the active substance mepolizumab , which is a monoclonal antibody . this is a type of protein that recognises and attaches to a specific target in the body . it is used to treat severe asthma in adults , adolescents and children aged 6 years and older . severe asthma affects many eosinophils ( an important type of white blood cell that helps the airways to open ) and affects the lungs . eosinsophilic asthma is the most common form of asthma . nucala helps to prevent asthma attacks by stopping the production of medicines called high dose inhalers that help
do not use nucala : if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : you have worsening asthma 58 you have experienced asthma - related side effects . your doctor may decide to treat your asthma with another medicine , such as a higher dose , or to temporarily stop your nebuliser treatment . if you think you may be allergic , ask your doctor for advice . injection site reactions medicines of this type ( monoclonal antibodies ) can cause severe allergic reactions
nucala is given under the skin ( subcutaneous injection ). adults and adolescents 12 years of age and older : the recommended dose is 100 mg given once a week ( 1 injection in the pre - filled pen ). if you have any further questions on the use of nucala , ask your doctor , pharmacist or nurse . duration of treatment your doctor will tell you how long you should continue to receive nucal . your doctor may decide to reduce the dose or stop the treatment . if you miss a dose of the dose , make another appointment as soon as possible . it is important that you do not miss a
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with nucala : allergic reactions allergic or allergic - like reactions may occur very commonly ( may affect more than 1 in 10 people ) after the injection . sometimes symptoms include symptoms such as chest tightness , cough , difficulty breathing fainting dizziness feeling lightheaded ( due to a drop in blood pressure ) swelling of eyelids , face , lips , tongue or mouth hives rash tell your doctor immediately if you have a reaction similar reaction to any of the other side effects listed above . very common side effects
keep out of the reach and sight of children . do not use nucala after the expiry date which is stated on the carton and on the label of the pre - filled pen after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the pen in the outer carton in order to protect from light . after first opening , the pen may be stored for up to 7 days in the refrigerator at 2 8 . discard after 7 days if not used by the end of this 7 - day period .
what nucala contains - the active substance is mepolizumab . each 1 ml ampoule contains 100 mg of mepoluzumab ( as besilate ). - the other ingredients are sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate , polysorbate 80 , edta disodium dihydrate and water for injections . what nukala looks like and contents of the pack nucal 1 mg is a clear , colourless to pale yellow solution . it is supplied in a pack of 1 ampoules or in a multipack of
what ninlaro is and what it is used for it is a cancer medicine that contains the active substance ixazomib , a ' proteasome inhibitor '. what is it used for and how does it work ? what is myeloma ? it is an advanced form of a cancer of the bone marrow . when it is first diagnosed as a form of multiple myelooma ( a disease where the immune system ( the body ' s natural defence system ) has failed to produce enough of a substance called proteasomes ). what is the purpose of using ninlar ? when is it given to you to treat multiple
do not take ninlaro - if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . do not take any more of the following : if you think any of these apply to you , tell your doctor or pharmacist before taking any other medicine . if you have any further questions on the use of this product , ask your doctor . if the effects of any of them are not mentioned in this leaflet , or if they are not clearly related to the safety of ninl
do not take ninlaro if you have multiple myeloma . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . do not take more than the recommended dose of one capsule per day . your doctor will tell you what dose of this medicine to take . how much to take your doctor may tell you to take one capsule of either lenalidomide or dexamethasone twice a day for 4 - week . you can take one of the following doses : - lenlaro once a day on the same day of the week . - dex
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( may affect more than 1 in 10 people ): low platelet counts ( thrombocytopenia ) nose bleeds that can easily bruise nausea , vomiting , diarrhoea numbness or tingling or burning of the hands or feet ( peripheral neuropathy ) swelling of the legs orfeet ( peripheral oedema ) skin rash ( itchy all over the body ). rare side effects may affect up to 1 in 1 , 000 people : severe skin rashes , red to purple bumps ( sweet
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store below 30 . store in the original package in order to protect from moisture . the capsule can be removed from the blister and left at room temperature ( up to 25 ) for a single period of up to six weeks . after this period , the capsule should be used or discarded . this medicine does not require any special temperature storage conditions . any damage or signs of tampering to medicine packaging should be investigated by your doctor or pharmacist .
what ninlaro contains the active substance in each capsule is ixazomib . each capsule contains 2 . 3 mg of ixasomib citrate . the other ingredients are : capsule content : microcrystalline cellulose , magnesium stearate , talc . the capsule shell contains gelatin , titanium dioxide ( e171 ), red iron oxide ( e172 ). printing ink : shellac , propylene glycol , potassium hydroxide , black iron oxide [ e172 ]. the printing ink contains : - one capsule of the 3 mg / 5 mg hard capsules , each containing ixezomib (
do not use palforzia : if you are allergic to peanuts ( arachis hypogaea ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . children and adolescents do not give this medicine to children less than 4 months of age or 17 years of age because treatment with peanut allergy may lead to an increase in the amount of peanut ( desensitisation ) in the blood . do not increase the dose or stop the treatment unless your doctor tells you to . there is no experience of allergic reactions to palforbzia . food allergies may occur with palf
do not take palforzia : if you are allergic to peanut or soya if you have severe asthma if your asthma is getting worse or you have a problem swallowing . if you suffer from long term problems with your digestive system such as a severe mast cell disorder or severe or life - threatening anaphylaxis . it may take up to 60 days for treatment to stop . if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor , pharmacist or nurse before taking the medicine . before you start taking palfourzia , you should discuss the symptoms of peanut allergy with
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you have been told by your doctor that you have an allergy , allergic reactions ( anaphylaxis ) may occur within 3 months of starting treatment with palforzia . initial doseescalation and up - dosing steps should be taken at the same time each day . your doctor will instruct you how to follow these treatment steps . if necessary , your doctor may instruct you to take a smaller dose . the initial dose elevation and subsequent doses may be repeated at intervals of up to 3 months
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with palforzia : severe allergic reactions if you have any of the following symptoms after taking palfORzia , stop taking the medicine and seek medical help immediately : trouble breathing , throat tightness , feeling offulness , trouble swallowing or speaking - changes in voice , dizziness or fainting severe stomach cramps , pain , vomiting , diarrhoea , severe flushing or itching of the skin palforsia may cause problems with the stomach and digestive system ( eosinophilic
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label after exp . the unopened vial does not require any special temperature storage conditions . store below 25 . keep this medicine in the original package in order to protect from light and moisture . remove any hard lumps of powder from the vial immediately after use .
what palforzia contains the active substances are : 0 . 5 mg , 1 mg , 10 mg and 20 mg . the other ingredients are : microcrystalline cellulose , colloidal anhydrous silica and magnesium stearate palfORzia 100 mg oral powder in capsules with opening microstalline crosculose ( e460 ), colloidal Anhydroussilica ( e463 ) and magnesium strearate ppalforza 300 mg oralpowder in sachet microcrycrystallose ( i464 ), colloid anhydrated silica ( i463 )and magnesium stearing
the active substance of zerene is benzodiazepine . it belongs to a group of medicinal products known as hypnotic actions . it is used to treat sleeping problems in adults . the duration of treatment is one month . your doctor will decide how long you should continue treatment . if you have problems sleeping , talk to your doctor .
you should not be given zerene : if you have hypersensitivity ( an allergy ) to zaleplon or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine : if your doctor has told you that you have a condition called zerenea sleep apnoea syndrome ( when you sleep for short periods of time ) if you suffer from severe kidney or liver problems ( myasthenia gravis ). if you feel very weak , tired muscles , severe breathing or chest problems . children and adolescents zere
always take zerene exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 10 mg capsule per day to be taken orally with or without food . if you have difficulty falling asleep , do not take the capsule . elderly ( over 65 years of age ) if you suffer from mild to moderate liver problems , your doctor may increase your dose to one 5 mg capsule once a day . if your doctor determines that you have mild tomoderate liver problems the dose may be increased to one or two 5 mg capsules per day depending on your response to the medicine .
like all medicines , zerene can cause side effects , although not everybody gets them . tell your doctor or pharmacist if you notice any other changes in your health . the frequency of possible side effects listed below is defined using the following convention : 36 very common ( affects more than 1 user in 10 ) uncommon ( affects 1 to 10 users in 100 ) not known ( frequency cannot be estimated from the available data ): very rare ( affects less than 1 users in 1 , 000 ) very rare : very rare rare : not known : frequency cannot been estimated from available data the following side effects have been reported : very common : d
what zerene contains - the active substance is zaleplon 5 mg . - the other ingredients are : tablet core : microcrystalline cellulose , pregelatinised starch , silicon dioxide ( e171 ), sodium lauryl sulphate , magnesium stearate . tablet coating : lactose monohydrate , indigo carmine ( e132 ), titanium dioxide . printing ink : gelatin , titanium dioxide , red iron oxide , yellow iron oxide ( e172 ), black iron oxide (> e172 ) ( only in the manufacturing process ) ( except in the processing process ). printing ink shell : shellac , lec
